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Abstract 
 
Directed evolution of antimutator E. coli 
 
Dacia Leon, Ph.D. 
The University of Texas at Austin, 2018 
 
Supervisor:  Jeffrey E. Barrick 
 
Biological systems are essential tools for addressing societal challenges. There 
have been several successes in this field, however, a strong hindrance lies in the ephemeral 
nature of these systems – cells are tiny factories that evolve. Evolution poses a problem 
because when a desired function is encoded into the DNA of the host organism, the host 
uses its own resources to perform the function and there is likely no associated fitness 
benefit. Therefore, there is strong selection for inactivation of the function due to the 
metabolic load imposed on cellular resources. One way to address this problem is to 
engineer evolutionary stability by lowering a host organism’s basal mutation rate and 
concomitantly reducing the probability that an encoded function will become mutated.   
In Chapter 1 of this dissertation, I discuss the nature of the metabolic cost 
associated with engineering biology and mechanisms by which host adaptation occurs. I 
also explore cellular pathways involved in genetic stability and examine previously 
characterized antimutators. Chapter 2 describes the first iteration of a directed evolution 
method used to engineer antimutators in Escherichia coli, Periodic Reselection for 
Evolutionarily Reliable Variants (PResERV). In this first PResERV experiment, I observe 
that the antimutator phenotype is due to mutations in genes involved DNA replication and 
 vii 
RNA metabolism (polA, polB, and rne). In Chapter 3, I perform the same PResERV 
experiment on a greater scale and characterize a series of antimutator strains. The causative 
alleles in many of these strains are in genes involved in the tricarboxylic acid cycle and 
electron transport chain (sucD and sdhA). These alleles are shown to reduce oxidative 
stress. Chapter 4 demonstrates results from another PResERV experiment using a clean-
genome E. coli strain, MDS42, as the host organism. In sum, this work shows the many 
mechanisms that lead to an antimutator phenotype, and these findings are used to build 
stable strains for reliable engineering of biology.  
Finally, there are two appendices (Appendix A and B) which discuss my work in 
examining the evolutionary path to citrate utilization in Lenski’s long-term evolution 
experiment (LTEE) and a do-it-yourself method for using gellan gum as an alternative to 
microbial agar media.            
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Chapter 1:  Introduction 
The future exists in our ability to domesticate biology and to use it as a tool to address 
societal challenges. Within the last decade, this notion has been widely discussed and there 
have been substantial efforts, with an increasing number of successes, aimed at using 
biology solve problems in areas such as drug development, bioenergy, production of 
industrial enzymes and chemicals, and agriculture1-6. The nascent stages of this effort 
consisted of devising solutions to a basic question – how can we make biology easy to 
engineer? One initial strategy was to regard biology through the lens of established 
engineering disciplines, such as electrical or software engineering. If a cell could be 
programmed as if it were a computer, then it could be engineered by using a standard set 
of parts. These parts would consist of the DNA elements needed for a given function to 
occur (promoters, genes, terminators, ribosome-binding sites, etc.) and could be combined 
to create more complex synthetic circuits or pathways. To process a desired output, the 
DNA encoding a new function is placed into a host organism, or chassis. This is an 
attractive approach due to the complementary aspects of the hybrid system. Biological 
systems are valuable in that they are inherently able to reproduce, but they lack 
standardization, predictability, and reliability. Engineered systems are the opposite. They 
are generally straightforward to construct and operate, but they are designed to be discarded 
after use and lack the ability to reproduce. If this idea could be realized to its full potential, 
and these fields were successfully merged, one could program cells to be replicating 
computers1.  
However, a computer is not always the best analogy for a cell. Cells are highly 
complex systems which are inherently ephemeral. Therefore, engineering biology is 
challenging. While recombinant DNA technology is widespread in research applications, 
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there have been very few marked successes in biological engineering that directly impact 
the daily lives of most people. Some of these examples are microbial synthesis of insulin, 
recombinant antibodies, the anti-malarial drug artemisinin, and more recently, the HPV 
vaccine. The first of these technologies was the commercial production of human insulin 
in Escherichia coli in 1978. Prior to this development, insulin was obtained from the 
pancreas glands of animals slaughtered for food, in which 8,000 pounds of animal pancreas 
were needed to produce one pound of insulin. Microbial production of insulin was seminal 
because it provided diabetic patients with human insulin instead of animal insulin, which 
was known to cause allergic reactions. Additionally, the dependency on large quantities of 
animal glands was eliminated. Production of human insulin in E. coli was achieved by 
inserting genes encoding for the two chains, “A” and “B”, and inducing their synthesis for 
purification. Each chain was independently purified and then co-incubated to produce an 
active protein by disulfide bond formation7.  
The more recent achievement of the production of the anti-malarial drug 
artemisinin in yeast in 2014 required extensive engineering and rewiring of the host 
metabolic network to generate high-titers at a low cost. Artemisinin extraction is 
traditionally plant-based and therefore there are drastic fluctuations in the availability and 
price of the drug. Engineering efforts were initially galvanized by a worldwide shortage of 
artemisinin. Production of artemisinin occurs by synthesis of a precursor, artemisinic acid, 
in an industrial Saccharomyces cerevisiae strain, CEN. PK2, followed by purification and 
chemical conversion to artemisinin. This process took ~10 years to develop8. Today, yeast-
based artemisinin is not yet commercially available due to price drops in plant-based 
artemisinin, but it is envisioned as a substitute when plant-based prices increase9. 
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METABOLIC COST AND ADAPTATIONS ASSOCIATED WITH ENGINEERING BIOLOGY 
Cells have a remarkable ability to adapt. Therefore, it is not surprising that routine genetic 
modifications, such as insertion of a deletion cassette into a chromosome, can cause a 
genomic imbalance that will give rise to compensatory effects. For example, deletion of a 
gene that causes a growth defect may incite the occurrence of mutations that restore the 
growth rate10. These secondary mutations may evolve rapidly to compensate for the change 
and one may not be studying the intended modification or synthetic device. This is 
frustrating for all aspects of scientific research – testing hypotheses, performing 
experiments, analyzing results, reproducing results, making conclusions, etc. Furthermore, 
unwanted adaptive mutations are a side effect in many genetic engineering techniques, so 
these unplanned changes in the DNA of an organism can happen even when there is not a 
large selection pressure for compensatory evolution11.  
Plasmids are workhorses for recombinant DNA technologies and biological 
engineering, even though they are known to cause a metabolic load on the host cell12. The 
nature of the burden imposed by engineered plasmids has recently begun to be elucidated. 
Intuitively, high copy plasmids are more costly than low copy plasmids, and perhaps a low 
copy plasmid could be made more costly by increasing plasmid protein production via 
stronger promoters driving gene expression and/or encoding more genes on the plasmid. 
There is some evidence to suggest that the nature of the plasmid-encoded elements, also 
known as plasmid composition, is outweighed by the plasmid copy number. Transcriptome 
profiles of E. coli cells were assayed to determine the effect of harboring two synthetic 
circuits encoded on low and medium copy plasmids. Profiles of cells containing the same 
copy number clustered together, indicating that, for these two circuits, the plasmid 
composition was not as important as the copy number in terms of the host cell response. 
Additionally, the predominant differences in gene expression between the circuits and an 
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empty plasmid control were in genes involved in amino acid biosynthesis. These results 
suggest that the metabolic load of the synthetic circuits is at the protein production level 
and that the host amino acid pools are limited13.  
Synthetic devices rely on host machinery for translation, which is a costly process 
requiring many ATP. There is some evidence to propose that when heterologous devices 
are inserted into cells, the main factor determining how burdensome they are is their impact 
on ribosome availability14-18. Modeling of the gene expression process in E. coli was used 
to determine that cells can tolerate up to an additional 46% of heterologous RNA and 33% 
of heterologous protein in order to maintain a normal growth rate. This model was used to 
predict the growth rates of cells containing plasmids differing in copy number. Many 
properties relating to DNA replication, transcription, and translation were considered in 
this model, and it was found that ribosomes were the limiting cellular resource in all 
scenarios14. These effects are also supported with experimental data. It was found that 
gratuitous overexpression (~30% of the total protein content) of either β-galactosidase or 
a nonfunctional EF-Tu caused ribosomal depletion and a decrease in protein synthesis 
capacity after induction17,18. Moreover, overexpression of a β-galactosidase was found to 
sequester free ribosomes away from translating other cellular proteins18. Therefore, 
overexpression of a protein that is not beneficial to host cell fitness can cause competition 
for limiting ribosomes and decrease the expression of other proteins that are likely needed 
for growth15.  
Lower growth rates can also be due to changes in energy metabolism. 
Transcriptome profiles of E. coli DH5α cells grown in a bioreactor and bearing an 
overexpression plasmid were shown to have reduced expression of glycolytic genes19. 
Furthermore, growth defects associated with protein overexpression can be corrected by 
overexpression of zwf, glucose-6-phosphate dehydrogenase, the branchpoint from 
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glycolysis into the pentose phosphate pathway. Increasing flux through the pentose 
phosphate pathway may alleviate a bottleneck in the cell’s reducing power and/or ability 
to synthesize building blocks for growth20. Another study demonstrated that during a high 
density fermentation involving plasmid-based overproduction of a protein, plasmid-free 
cells will arise due to segregation and are better able to compete with plasmid-bearing cells 
because these cells are impaired in their glucose uptake ability21. Over time, protein 
production ceases because the plasmid-free cells outcompete the plasmid-bearing cells. 
 One common way in which populations of cells will adapt to these changes induced 
by carrying a plasmid is by mutating the source of the cost. Homologous recombination 
can lead to rapid inactivation of a synthetic construct. In one case, the cost of a plasmid 
encoding GFP was alleviated by recombination between two identical transcriptional 
terminators flanking the gfp gene22. Mobile genetic elements can also alleviate unwanted 
load by mutating the gene responsible for the metabolic cost. For example, non-producer 
cells have been found to evolve within a population of cells engineered to produce 
mevalonic acid. The non-producers evolved because of insertion element transposition 
events that interrupted the genes in the mevalonic acid production pathway23. Additionally, 
synthetic circuits experience escape mutants. Expression of a population control circuit, in 
which an E. coli population is controlled by quorum-sensing and a toxic protein, produces 
escape mutants within 3-6 days of induction24. In order to reliably engineer biology, these 
sorts of inactivations need to be prevented 
 
CELLULAR PATHWAYS THAT CONTRIBUTE TO GENETIC INSTABILITY 
Instability stems from genome rearrangements and point mutations, that can either be silent 
or give rise to changes such as variation in genome size, disruption in coding sequences, 
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appearance of new sequences, translocations of sequences to different loci, etc. Mobile 
genetic elements are well-known offenders of these processes. Homologous recombination 
between related and repeated sequences within a single chromosome can also contribute. 
These events can cause gene conversion, inversions, duplications, amplifications, 
deletions, and translocations25. In addition, normal cellular functions such as replication, 
cellular metabolism, and transcription can lead to genome instability (Figure 1.1).  
Despite the great accuracy with which DNA is replicated by some polymerases, 
errors are nevertheless introduced into the newly synthesized template. Mispairing can 
happen during replication if the error is uncorrected by the polymerase proofreading 
domain or the DNA mismatch repair system (MMR). Whether an error is corrected can be 
dictated by the local sequence context with variables such as base stacking and GC content 
having an effect. Additionally, mutations can occur because of strand misalignment during 
replication. Template switching or strand slippage at sequences that have a high propensity 
to form hairpins (such as quasipalindromes) and long homopolymer runs lead to indels, 
base pair substitutions, and structural rearrangements. However, the most frequently made 
error by DNA polymerases is misincorporation of ribonucleotides. This error is largely 
precipitated by the imbalance in cellular nucleotide pools, in which NTPs are more 
abundant than dNTPs. Misincorporation of ribonucleotides leads to base substitutions, and 
surprisingly, these errors have a mild effect on mutation rate because they are almost 
always repaired by nucleotide excision repair (NER)26.  
Free nucleotides are highly susceptible to reactive oxygen species (ROS), 
especially guanine. Oxidized guanine forms 8-oxo-7,8-dihydroguanine (8-oxo-GTP) 
which can be incorporated into DNA by main replicative polymerases (for example, Pol 
III in E. coli) and genomic guanine can also be converted to 8-oxo-G by ROS. Sanitizing 
enzymes such as MutT (in E. coli) will eliminate the incorporation of 8-oxo-GTP by 
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converting it to 8-oxo-GMP, therefore acting as a defense against oxidized nucleotides27. 
However, if unrepaired, 8-oxo-G will pair with adenine instead of cytosine and lead to 
either A-T→C-G or G-C→T-A transversions26. Active oxygen species that are produced 
by aerobic metabolism are highly mutagenic. In E. coli, under normal aerobic conditions, 
it is estimated that ~3000-5000 oxidative DNA lesions per cell division are generated. 
Given the high production rate, oxidative stress may be the most prominent source of 
spontaneous mutations27. 
Cells contain an array of mechanisms for repairing DNA. As described above, 
MMR functions in post-replicative correction that removes problematic nucleotides 
immediately, before the next round of DNA replication occurs and they lead to mutations. 
Therefore, many native errors made by DNA polymerase are remedied. Other types of 
DNA lesions are commonly repaired by base excision repair (BER) and NER. BER will 
replace aberrant bases such as misincorporationed 8-oxo-GTP or uracil, abasic sites, or 
single-strand breaks by excising the damaged base via a DNA glycosylase, leaving an 
abasic site which is subsequently cleaved by an endonuclease, and repaired by DNA 
synthesis and ligation. NER repair targets bulky lesions that distort the integrity of the 
DNA helix, the most important of these lesions being pyrimidine dimers produced by UV. 
NER involves an initial recognition of the lesion by scanning DNA for helical distortions, 
an opening of the DNA helix near the lesion to remove the single-stranded segment 
containing the lesion, and the remaining gap is filled by DNA synthesis and ligation28. 
Many lesions produced by DNA damage will result in a block of normal genome 
replication. When this occurs, cells will use specialized polymerases that will perform 
translesion synthesis (TLS) to bypass lesions damaged by thymine dimers, bulky adducts, 
and abasic damage. In E. coli, there are three TLS polymerases encoded by polB (Pol II), 
dinB (Pol IV), and umuCD (Pol V)27.  
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These systems target errors that directly occur on a DNA template. However, 
transcription can also be a source of genetic instability29,30. There are several mechanisms 
involved in how transcription leads to damages of the primary DNA template. Given that 
replication and transcription occur on the same template, collisions can occur between the 
replisome and RNA polymerase and will lead to severe DNA distortions (one such 
conformation is known as a “chickenfoot”). In processing these distortions, double-
stranded breaks can be initiated. Other distortions, such as R-loops can form during 
transcription. R-loop formation happens when the newly transcribed RNA strand anneals 
back to the DNA template, forming a RNA:DNA hybrid. This exposes the non-template 
DNA strand as a single strand of DNA that is more susceptible to mutagenic chemicals, 
strand breaks, and secondary structures. These exposed DNA strands can range up to 1 kb 
in length. The level of transcription is important in these mechanisms, as highly transcribed 
genes experience more transcription-associated mutations29,30.   
Our goal is engineer host organisms with an increased genetic stability. 
Heterologous devices have a high propensity for inactivation by the host cell due to the 
imposed metabolic burden associated with device expression. Therefore, there is strong 
selection for inactivating mutations that will render the device non-functional. However, 
by engineering stable cells with a reduced basal mutation rate, we can lower the probability 
of inactivating mutations. As an initial step toward this effort, we need to understand 
previously identified mechanisms that resulted in cells with reduced mutation rates as 
compared to wild type, also known as antimutators.    
 
 9 
PREVIOUSLY DESCRIBED ANTIMUTATORS 
Interest in antimutators initially began because they were regarded as a powerful method 
to map the origins of spontaneous mutations. Understanding the mechanism by which an 
antimutator reduces spontaneous mutations can provide a direct link for how mutations 
occur in normal cells. However, mutators are historically the system of choice for studying 
mutational mechanisms. For example, by mapping the mutational spectra of E. coli mutants 
defective in various repair pathways, it was determined that oxidative stress was the main 
contributor to spontaneous mutations. Antimutators can provide insight about the source 
and nature of mutations that actually occur, instead of mutations that occur in the absence 
of certain pathways that induce elevated mutation rates31,32. Antimutators are difficult to 
study. There exist few selection strategies to isolate them and as a result, have mainly been 
identified through tedious screening methods or as suppressors to a mutator. Additionally, 
many antimutators tend to have a fitness cost33.  
 The first antimutators to be identified were DNA polymerase (Gene 43) variants in 
bacteriophage T434. Biochemical analysis of these mutants determined that the antimutator 
phenotype was due to a tradeoff causing increased proofreading efficiency with a 
subsequent decrease in polymerization rate. This effect has a deleterious effect on 
fitness31,33. Other antimutator polymerase variants have been identified in E. coli DNA 
Polymerase III and DNA Polymerase I35-37. For Pol III, the main replicative polymerase in 
E. coli, antimutator variants were found in the α subunit, dnaE, which catalyzes 
polymerization34,38. These variants are suggested to possess improved replication fidelity 
by increased nucleotide selectivity or better dissociation from terminal mismatches, 
allowing access to repair machinery for rapid correction of the error31,33. Unlike Pol III, Pol 
I is not essential. It participates in lagging strand synthesis, DNA repair, and replication of 
ColE1 plasmids. Antimutator variants of Pol I are purported to have enhanced nucleotide 
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selectivity or decreased extension of termini in the case of a mispaired primer33. In sum, 
DNA polymerases can be mutated, resulting in an antimutator phenotype.   
Alternatively, removal of error-inducing systems will also lead to reduced mutation 
rates. A reduced-genome strain of E. coli, MDS42, was improved by deleting the three 
DNA polymerases induced during the SOS response (Pol II, Pol IV, and Pol V). These 
polymerases are known to induce mutagenesis and therefore, deletion of these genes 
reduced the mutation rate of MDS42 even further. Removal of error-prone repair will 
promote the use of error-free pathways for repairing damaged lesions39. Repair and 
housekeeping protein variants have also been linked to an antimutator phenotype. MMR 
activity is decreased in stationary phase E. coli cells, indicating that these cells likely suffer 
a high propensity for DNA damage. Overproduction of the MMR protein, MutL, was 
shown to decrease mutation rates of E. coli cells in stationary phase. Therefore, it is 
possible that other repair proteins may lead to a similar phenotype40. Regarding 
housekeeping proteins, overexpression of nudG, a Nudix hydrolase with high specificity 
for oxidized pyrimidines, decreased mutation frequencies under normal growth conditions 
and in the presence of oxidative stress, induced by hydrogen peroxide. Thus, 
overexpression of nudG better sanitizes the nucleotide pool and therefore prevents 
incorporation of damaged nucleotides into DNA41.     
This dissertation describes mutations in other genes that lead to antimutator 
mechanisms identified via a directed evolution approach, Periodic Reselection for 
Evolutionarily Reliable Variants (PResERV). This methodology allows us to probe 
mechanisms that are non-obvious targets for reducing mutation rates, including mutations 
that do not have any trade-offs that would make cells containing them undesirable in 
biotechnology applications. PResERV enabled for identification of antimutator alleles in 
various pathways – DNA replication (Chapter 2), RNA processing (Chapter 2), and 
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central carbon metabolism (Chapter 3). Additionally, PResERV was performed on an 
already improved strain, MDS42, which resulted in further improvements and several 
interesting candidate mutations for follow-up studies (Chapter 4). This work expands our 
knowledge of genetic stability in E coli under typical laboratory conditions. Additionally, 
these antimutator strains can be used as hosts for biological engineering, which will inhibit 
the inactivation of engineered devices and ultimately allow engineers to tackle challenging 
problems.    
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Figure 1.1. Cellular mechanisms that contribute to genetic instability  
The sources of spontaneous mutations are shown in yellow circles, the cellular processes 
that contribute to these sources are in orange squares, and the mechanisms that suppress 
errors are in green text. Adapted from Maki (2002)27. 
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Chapter 2: Directed evolution of Escherichia coli with lower-than-
natural plasmid mutation rates 
 
This chapter is reproduced (with minor modifications) from its initial publication: 
 
Deatherage DE, Leon D, Rodriguez AE, Omar S, Barrick JE. (2018) Directed evolution 
of Escherichia coli with lower-than-natural plasmid mutation rates. Nucleic Acids Res (in 
press). 
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ABSTRACT 
Unwanted evolution of designed DNA sequences limits metabolic and genome 
engineering efforts. Engineered functions that are burdensome to host cells and slow their 
replication are rapidly inactivated by mutations, and unplanned mutations with 
unpredictable effects often accumulate alongside designed changes in large-scale genome 
editing projects. We developed a directed evolution strategy, Periodic Reselection for 
Evolutionarily Reliable Variants (PResERV), to discover mutations that prolong the 
function of a burdensome DNA sequence in an engineered organism. Here, we used 
PResERV to isolate E. coli cells that replicate ColE1-type plasmids with higher fidelity. 
We found mutations in DNA polymerase I and in RNase E that reduce plasmid mutation 
rates by 6- to 30-fold. The PResERV method implicitly selects to maintain the growth rate 
of host cells, and high plasmid copy numbers and gene expression levels are maintained in 
some of the evolved E. coli strains, indicating that it is possible to improve the genetic 
stability of cellular chassis without encountering trade-offs in other desirable performance 
characteristics. Utilizing these new antimutator E. coli and applying PResERV to other 
organisms in the future promises to prevent evolutionary failures and unpredictability to 
provide a more stable genetic foundation for synthetic biology. 
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INTRODUCTION 
Populations of cells engineered to function as factories or biosensors experience a failure 
mode that is peculiar to living systems: they evolve. Unwanted evolution is a foundational 
problem for bioengineering that limits the efficiency and predictability of metabolic and 
genome engineering efforts10,42-45. Often an engineered function diverts critical resources 
from cellular replication or otherwise interferes with growth or homeostasis11,46. In these 
cases, ‘broken’ cells with mutations that inactivate the engineered function can rapidly 
outcompete the original design5,16,47. The rate at which an engineered function decays 
within a cell population in this manner can be summarized as an evolutionary lifetime or 
half-life 5 or defined in terms of an evolutionary landscape by the rates at which various 
mutational failure modes occur and their respective fitness benefits16,47.  
It is sometimes possible to edit a genome to eliminate or reduce the rate at which 
certain types of mutations occur23,39,48-51 or to devise a way of reducing the burden of an 
engineered function42,52. However, given the complexity of DNA replication and repair 
processes and the multifarious ways that an engineered function can burden a host cell, a 
point is generally reached at which it is difficult to further improve upon the reliability of 
a cell. Directed evolution is an effective strategy for optimizing the performance of 
complex systems with many interacting components, even when they include unknown 
factors. For example, it has been used to engineer novel enzymes that outperform their 
natural counterparts53 and to tune artificial gene circuits to effectively perform logic 
operations54.  
Given the similarly complex constraints underlying cellular mutagenesis and the 
fitness burdens of diverse engineered functions, we reasoned that a directed evolution 
procedure, Periodic Reselection for Evolutionarily Reliable Variants (PResERV) (Fig. 
2.1), could be an effective strategy for improving the evolutionary reliability of an 
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engineered cell. In PResERV, one artificially selects for mutant cells that exhibit improved 
maintenance of a burdensome engineered function over tens to hundreds of cell divisions. 
We expected that PResERV might isolate cells with mutations that either reduced the rate 
at which failure mutations occurred or the fitness burden of the engineered function, or 
both, possibly in ways that would generalize to stabilizing other engineered functions in 
the evolved cells. Here, we describe E. coli strains evolved by PResERV that exhibit lower-
than-natural mutation rates for genes encoded on high-copy plasmids, thereby stabilizing 
them against unwanted evolution. 
 
RESULTS 
PResERV experiment with a ColE1 plasmid in E. coli  
We applied PResERV to E. coli K-12 strain BW2511355 transformed with pSKO4, a high-
copy-number pBR322 plasmid (ColE1-type origin) that encodes GFP under control of an 
inducible promoter22. GFP expression is a generic proxy for a costly engineered function 
in this scenario. A UV-mutagenized library of cells containing pSKO4 was propagated 
through daily 1:1000 serial transfers in the presence of antibiotic selection for plasmid 
retention. Under these conditions, cells with mutations in pSKO4 that inactivate or reduce 
costly GFP expression evolve, outcompete fully fluorescent cells, and constitute a majority 
of the population within a few days22. GFP fluorescence of cells in the PResERV 
population was periodically monitored by flow cytometry using the red fluorescent nucleic 
acid dye SYTO17 as a counterstain to improve detection of cells with a low GFP signal. 
When 75% or more of the cells exhibited reduced GFP signal, cell sorting was used to 
isolate ~105 cells that remained at least as fluorescent as the ancestor to continue the 
 17 
population. We subjected this population to a total of 8 sorts spread throughout 30 regrowth 
cycles (Fig. 2.2A).  
Six E. coli clones designated AER7–AER712 were isolated from the final 
population for further characterization. Five of these maintained more fully-fluorescent 
cells for more cell doublings than the unevolved wild-type strain with the wild-type pSKO4 
plasmid (Fig. 2.2B). Mutations in the plasmid, the E. coli chromosome, or both could have 
been responsible for these improvements. To determine which was the case, we cured these 
cells of their plasmids and retransformed them with the wild-type pSKO4 plasmid, and we 
also isolated plasmids from each of the evolved strains and transformed them into 
unevolved wild-type E. coli cells. For four of these strains (AER7, AER8, AER9, and 
AER12), the improvement in the evolutionary lifetime of GFP expression appeared to be 
mainly due to mutations in the E. coli chromosome rather than mutations in the pSKO4 
plasmid (Fig. 2.2C). 
 
Mutations in PResERV strains 
We sequenced the genomes of these four evolved clones to understand the genetic basis of 
their improved reliability (Fig. 2.3). In agreement with the re-transformation tests, no 
mutations were found in the pSKO4 plasmid in any of these strains. Each contained from 
four to ten mutations in the E. coli chromosome. These mutations could theoretically lead 
to the improved maintenance of GFP expression that we observed by reducing the burden 
of GFP expression from the plasmid or by reducing the rate at which mutations that 
inactivate GFP arise. Therefore, we examined the lists of mutations in these strains to see 
if they hit any genes known to be involved in these processes. 
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Two of these strains (AER7 and AER8) had eight identical mutations while a third 
strain (AER9) had these same eight mutations plus two additional ones. All three shared 
mutations in polB and rne that were candidates for affecting evolutionary stability. PolB 
(Pol II) is a stress-induced DNA polymerase that participates in translesion synthesis and 
nucleotide excision repair. The polB gene sustained two mutations in these PResERV 
strains: a missense mutation (H597Y) and a nonsense mutation earlier in the reading frame 
(S558*). The full-length PolB protein is 783 amino acids in length, and the stop codon 
mutation truncates the protein within its catalytic core56. Presumably, this results in a 
complete loss of Pol II activity in the mutant. Deletion of polB in the clean-genome E. coli 
strain MDS42 has been shown to lead to ~30% lower chromosomal mutation rates39. The 
rne gene (encoding RNase E) contains a missense mutation (L222S) in all three strains. 
RNase E regulates the copy number of ColE1 origin plasmids in E. coli by processing the 
RNA I antisense regulator of the RNA II replication primer57,58. Cells defective in rne 
accumulate higher levels of RNA I and have reduced plasmid copy number59. The site of 
the PResERV mutation is within the RNaseH-like domain of RNase E, which is involved 
in determining its RNA substrate selectivity, but its effect on the activity of this enzyme is 
not clear from the structural context60. 
The fourth sequenced strain (AER12) had a completely different set of four 
mutations, which included a missense mutation in polA (H734Y). PolA (Pol I) is the DNA 
polymerase that is utilized primarily for filling gaps during lagging strand synthesis and in 
DNA repair in E. coli. It is also responsible for extending the primer derived from RNA II 
during replication of ColE1-type plasmids58. Antimutator variants of PolA that lower the 
frequencies of mutations observed on a reporter plasmid have been identified previously 
by screening a sequence library created by mutagenizing an exo− PolA variant lacking 
3′→5′ exonuclease proofreading activity36. The exact same substitution that we observed 
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(H734Y) was found among the 592 active polymerase variants characterized in that study, 
but the effects of this specific mutation on polymerase function were not reported. H734 is 
located near the phosphate groups of the dNTP substrate when it is bound to the Klenow 
fragment of Pol I61, indicating that the PResERV mutation may have an effect on nucleotide 
binding. 
 
Evolutionary stability and mutation rates in PResERV and reconstructed strains 
To test whether these three mutations contributed to the increased evolutionary reliability 
of the PResERV strains, we tested E. coli strains in which we reverted the evolved alleles 
back to their wild-type sequences. We then propagated replicate populations of wild-type 
E. coli, two focal evolved clones (AER12, the strain with the polA mutation; and AER8, 
one of the three strains containing mutations in polB and rne), and four revertant strains 
(one for each mutation and also a strain in which polB and rne were both reverted) under 
the same conditions as the initial evolution experiment and monitored the loss of 
fluorescence over the course of ~100 cell doublings (Fig. 2.4). Mutations in polA and rne 
appeared to be responsible for most or all of the improved stability, as reverting these 
mutations reduced the evolutionary lifetime of GFP expression back to a level similar to 
that observed in the wild-type strain. In contrast, reverting the polB mutation alone or 
reverting it in a strain that also had the rne mutation reverted did not appreciably affect 
how rapidly GFP expression decayed. 
We next used Luria-Delbrück fluctuation tests62 to determine if the increase in 
evolutionary reliability in these strains was associated with a decrease in mutation rates. 
We first measured the rates of point mutations that reverted a stop codon in a ß-lactamase 
gene cloned into another pBR322-based plasmid designated pTEM-1.D254tag63. Mutation 
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rates to carbenicillin resistance, which requires mutating this stop codon to a sense codon, 
were significantly lower in each of the two focal evolved clones compared to wild type in 
multiple experiments (Fig. 2.5). In agreement with the changes in the evolutionary stability 
of GFP expression, reversion of either the polA or rne mutation raised the mutation rate to 
that of the wild-type E. coli strain, and reversion of the polB mutation had no detectable 
effect on the mutation rate (Fig. 2.6A). We also measured mutation rates in two further sets 
of fluctuation tests, selecting either for resistance to rifampicin or to d-cycloserine, which 
require mutations in genes located on the E. coli chromosome in both cases. We did not 
find any significant improvements versus the wild-type strain in these assays (Fig. 2.6B). 
Thus, it appears that PResERV discovered E. coli mutants that primarily display lower 
plasmid mutation rates, with much less of an effect, if any, on mutation rates in the 
chromosome. 
 
Plasmid copy number and GFP fluorescence in evolved strains 
Given previous reports of lower plasmid copy number when rne function is reduced in a 
temperature-sensitive mutant59 and that polA antimutator mutations can lead to slower rates 
of DNA replication36, we were concerned that a decrease in plasmid copy number in the 
PResERV evolved cells could give a false signal of improvement in our two assays. First, 
having fewer plasmids per cell would lower the GFP expression burden and thereby 
increase the number of cell doublings it would take for new cells that arise with mutated 
plasmids to outcompete cells with wild-type plasmids (i.e., it would increase the apparent 
evolutionary stability). Second, with fewer plasmids per cell there would be a smaller 
chance that any given cell would experience a mutation in one of its plasmids that would 
lead to resistance in the ß-lactamase stop codon reversion assay (i.e., it would reduce the 
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apparent mutation rate per cell). Therefore, we measured the copy number of the pTEM-
1.D254tag plasmid in the two focal evolved clones and four reconstructed strains using 
qPCR (Fig. 2.7A), and we also examined the per-cell GFP fluorescence from the pSKO4 
plasmid in each strain (Fig. 2.7B).  
We found that the polA mutation did reduce plasmid copy number somewhat. The 
evolved polA strain (AER12) had marginally fewer plasmids per chromosomal DNA copy 
when compared to wild-type (p = 0.0666, one-tailed t-test on log-transformed values) and 
also exhibited reduced GFP fluorescent intensity (p = 0.0142, one-tailed t-test on log-
transformed GFP+ subpopulation medians). Interestingly, other mutations in the evolved 
strain appeared to counteract the effects of the polA mutation, as reverting just this mutation 
to the wild-type allele increased both copy number (p = 0.0011) and GFP intensity (p = 
0.0003). GFP signal (p = 0.0108) and perhaps copy number (p = 0.0893) were even greater 
in this polA revertant that still contained all other evolved mutations than they were in the 
original wild-type E. coli strain. Overall, these results suggest that there is a trade-off in 
the evolved polA mutant between plasmid copy number and mutation rate. 
In contrast, plasmid copy number did not vary when comparing wild-type, the 
evolved strain with rne and polB mutations (AER8), and all three reconstructed strains 
reverting those mutations singly and in combination (one-way ANOVA, F4,10 = 0.439, p = 
0.778). Here, too, there was evidence that other mutations in this evolved strain may have 
increased GFP intensity, as all four of the AER8-derived strains considered together had 
indistinguishable fluorescence intensities (one-way ANOVA, F3,32 =1.153, p = 0.343) that 
were, as a group, significantly greater than that of the wild-type (p = 0.0112, one-tailed t-
test). Therefore, the evolved rne allele reduced plasmid mutation rates with no detectable 
trade-off in terms of plasmid copy number or gene expression. 
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To determine whether reduced plasmid copy number in the AER12 strain 
containing the polA mutation could explain the reduction of 20- to 60-fold in the plasmid 
mutation rate measured for this strain (Fig. 2.5 and Fig. 2.6A), we performed numerical 
simulations of the growth of cell populations that included multicopy plasmid replication, 
mutation, and segregation (see Methods). Our qPCR results indicate that the copy number 
of the pTEM-1.D254tag plasmid was reduced from ~410 plasmids per E. coli chromosome 
in the wild-type strain to ~185 in AER12. We simulated the results of fluctuation tests with 
410 mutational reporter plasmids per cell and with other parameters chosen to match the 
observed numbers of mutant cells per culture for each of our four different sets of mutation 
rate measurements comparing wild type and AER12. Then, we performed a new set of 
simulations with the same parameters but reducing the plasmid copy number to 185 to 
determine by how much this would reduce the apparent plasmid mutation rate inferred 
from the Luria-Delbrück analysis. We found that a reduction in copy number of 2.2-fold is 
expected to yield a roughly proportional change in the apparent mutation rate. The result 
varies slightly if one changes how many mutant plasmids in a cell are necessary for it to 
give rise to a mutant colony, a parameter that is unknown in our system but is likely one or 
a just a few plasmids with restored ß-lactamase copies per cell. For simulations requiring 
one mutant plasmid per cell we predicted a reduction of 2.00-fold (1.93–2.07, 95% 
bootstrap confidence interval, see Methods) in the apparent mutation rate in AER12. For 
three copies the reduction was 2.12-fold (2.05–2.20), and for ten copies it was 2.37-fold 
(2.24–2.51). We conclude that the reduction in plasmid copy number in AER12 is not 
sufficient to explain a majority of the reduction in plasmid mutation rates in that strain. 
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DISCUSSION 
Mutation rates in microbial populations reflect a dynamic balance between different 
evolutionary forces and inherent constraints on organisms that have DNA as their genetic 
material. On one side, there is a universal selection pressure to minimize mutation rates 
because most new mutations are far more likely to be deleterious to fitness than 
beneficial64-66. This risk associated with deleterious mutations contributes to genetic load. 
That is, there is a fitness cost associated with a given mutation rate in terms of the fraction 
of an organism’s offspring that will experience lethal or deleterious mutations that lead to 
their immediate or eventual extinction. If selection to reduce genetic load were the only 
evolutionary force in play, then a mutation rate of zero would be optimal. On the other side 
of the balance, there are at least three different forces or barriers that will prevent the 
evolution of lower mutation rates past a certain point in microbial populations: second-
order selection for evolvability and limits imposed by the strength of genetic drift and 
physiological constraints. 
New mutations may be a bad bet on average, but they do—more rarely—generate 
beneficial genetic diversity that is necessary to fuel adaptive evolution. Thus, under certain 
circumstances, mutation rates can evolve to rebalance the potential for beneficial mutations 
against the risk of deleterious mutations67-69. For example, laboratory populations of 
bacteria and yeast often evolve hypermutation (elevated mutation rates)70,71 because they 
experience strong and constant selection pressures that can indirectly favor more evolvable 
lineages that have a greater chance of sampling rare adaptive mutations72,73. The simplicity 
of laboratory environments compared to nature also means that there is less of a deleterious 
genetic load associated with evolving a high mutation rate in these experiments. Many 
mutations that would be lethal under other circumstances (e.g., that disrupt pathways for 
utilizing alternative nutrients or stress responses for contingencies that are never 
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experienced) will be effectively neutral in the comparatively monotonous environments of 
these experiments74,75. For similar reasons, hypermutators also commonly evolve in 
populations of bacteria during the long-term progression of chronic infections treated with 
antibiotics, such as for Pseudomonas aeruginosa in the lungs of cystic fibrosis patients76-
78.  
The molecular basis for the evolution of bacterial hypermutators in the laboratory 
and in the clinic is usually straightforward. Mutations disrupt major housecleaning 
enzymes (e.g., mutT) or DNA repair pathways (e.g., mutS), often leading to an increase in 
point mutations with a characteristic base substitution spectrum70,71,77,79. Interestingly, 
some experiments have shown that experimental populations that are started with or that 
spontaneously evolved hypermutation can subsequently evolve reduced mutation rates80-
83. This can occur when hypermutator populations are propagated through severe 
population bottlenecks, which exacerbates the genetic load associated with a given 
mutation rate while reducing the chances of sampling adaptive mutations80,81. Reduced 
mutation rates have also been observed to evolve after a population becomes well-adapted 
to its environment and opportunities for beneficial mutations diminish relative to the risk 
of deleterious mutations82,83. When the molecular mechanisms have been examined in 
detail, the evolution of lower mutation rates in these experiments has been found to occur 
through new mutations that partially compensate in some way for the defect in the 
hypermutator82, or by exact reversion of the mutation responsible for hypermutation83. The 
evolution of cells with a mutation rate that is lower than that of the ancestral, wild-type 
microbe has not been observed in these experiments. 
Despite the potential for evolving hypermutation, wild-type microbes isolated from 
nature almost always have very low mutation rates85. The uniformity of these baseline rates 
across many species isolated from diverse environments suggests that a different balance 
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of evolutionary forces than the one between genetic load and the potential for beneficial 
mutations is normally responsible for setting mutation rates in nature. If one assumes that 
wild-type microbes are already well-adapted to the combinations of complex and varying 
environments that they regularly experience, then there may be little or no benefit possible 
from further mutations. Under these circumstances there will only be selection to minimize 
genetic load. What then would set the lower bound on mutation rates? Because baseline 
mutation rates have been found to scale inversely with effective population sizes across 
many organisms, it has been argued that genetic drift is the dominant force opposing 
selection for even lower mutation rates84,85. This ‘drift barrier’ arises because once the 
mutation rate is sufficiently low, the very small and indirect marginal benefit for a new 
mutation that leads to an even lower mutation rate becomes so insignificant that it looks 
effectively neutral to natural selection. That is, natural selection does not have the power 
to favor this hypothetical new antimutator allele such that it will reliably increase in 
frequency on its merits and eventually fix in the population. 
Another potential barrier to the evolution of lower mutation rates considers the 
molecular biology of DNA replication and repair. Biochemical and genetic studies of 
bacteria over the past several decades have mapped a complex suite of pathways dedicated 
to maintaining genome integrity via overlapping and redundant mechanisms86. There is a 
direct fitness cost to a cell for expressing any protein11,46, and there may be other fitness 
costs associated with increased surveillance for DNA damage and enforcing replication 
fidelity, such as off-target promiscuous activities of housecleaning enzymes87 or slower 
rates of DNA polymerization in exchange for increased proofreading36. Thus, there must 
reach a point at which the direct fitness cost of evolving additional molecular machinery 
outweighs the diminishing indirect benefit of further reducing the genetic load from 
deleterious mutations. However, there is no evidence that this physiological lower limit on 
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mutation rates has been reached in natural microbes. Antimutators with reduced point 
mutation rates have been identified by genome-wide genetic screens37, targeted 
mutagenesis35,36, gene disruption39, and gene overexpression41. Some of these antimutators 
do exhibit growth trade-offs36,37, but some do not appear to have any deleterious side-
effects36,39,88, at least in the laboratory environments in which they have been tested. Yet, 
due to the intrinsic instability of DNA, which can be chemically damaged or miscopied in 
an dizzying variety of ways86, there must exist some finite, non-zero mutation rate at which 
this physiological genetic stability limit is reached. 
In this study, we show that imposing artificially strong selection for bacterial cells 
that are less likely to give rise to mutations in a reporter gene on a plasmid can overcome 
the selection pressures and other barriers that normally oppose the evolution of reduced 
mutation rates. Specifically, we developed and used a Periodic Reselection for 
Evolutionarily Reliable Variants (PResERV) directed evolution approach to isolate E. coli 
host strains with mutations in their chromosomes that lead to lower-than-natural mutation 
rates in genes encoded on high-copy vectors such as pUC and pBR322 from the ColE1 
plasmid incompatibility group. We sequenced the genomes of four improved PResERV 
strains to better understand the molecular basis for the improvements and found mutations 
in three key genes (polA, polB, and rne). Then, we characterized the effects these mutations 
had on the evolutionary stability of burdensome GFP expression, on plasmid and 
chromosomal mutation rates, and on plasmid copy number and gene expression in the 
evolved E. coli strains.  
One PResERV strain had a mutation in DNA polymerase I (polA) that reduced 
plasmid mutation rates by ~30-fold. Pol I is required for the normal replication of ColE1 
plasmids in E. coli58. Both hypermutator and antimutator variants of this polymerase have 
been shown to affect the fidelity of DNA replication36,89,90, so it was not surprising that we 
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identified a mutation in polA that increased genetic stability. In fact, the exact amino acid 
substitution in Pol I recovered by PResERV (H734Y) was found previously in a library of 
mutagenized exo– Pol I sequences36. Though the specific effects of the H734Y mutation 
were not reported individually in this study, many of these mutagenized Pol I variants were 
antimutators. Their improved fidelity was attributed to increased selectivity for the 
incoming nucleotide. The polA mutation that we recovered may act similarly, as it is 
located close to the binding site for the incoming dNTP61. Thus, our identification of a polA 
mutation was in essence a positive control that PResERV could successfully isolate 
generalizable antimutator alleles, as opposed to mutations that increased the evolutionary 
stability of just the pSKO4 plasmid in an idiosyncratic way (e.g., by reducing the cost of 
expressing GFP). 
Pol I has an outsized role in replicating ColE1 plasmids compared to its relatively 
minor roles in lagging-strand synthesis and DNA repair during normal replication of the E. 
coli chromosome. Pol I initiates plasmid DNA replication by extending a primer that is 
processed from the RNA II transcript derived from the plasmid origin. In the canonical 
model of plasmid replication, the DNA polymerase holoenzyme involved in chromosomal 
replication, which utilizes Pol III, takes over plasmid replication after Pol I extends the 
primer by ~400-500 nucleotides58. However, there is evidence that Pol I also replicates 
other portions of ColE1 plasmids, at least some of the time. When a hypermutator Pol I 
variant was expressed in E. coli cells, plasmid mutation rates were most elevated close to 
the origin of replication, within the expected 400-500 base-pair window, but mutation rates 
were still much higher than normal within a region extending at least 3700 base pairs 
downstream of the origin90.  
The reading frame for GFP on the pSKO4 plasmid used in PResERV is located 
from ~350 to ~750 base pairs downstream of the origin (as measured from the typical end 
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of the RNA II transcript after nucleolytic processing). This places at least part of the GFP 
gene within the region known to be heavily replicated by Pol I, meaning that we would 
expect to observe a particularly strong effect of a polA antimutator allele during PResERV 
and in subsequent decay experiments in which we monitored the evolutionary stability of 
GFP expression over multiple growth cycles. In contrast, the stop codon in b-lactamase on 
the pTEM-1.D254tag reporter plasmid that we used in fluctuation assays to measure 
plasmid mutation rates is located ~3000 base pairs downstream of the end of RNA II. We 
still see greatly reduced mutation rates in this reporter, corroborating the prior observations 
that changes in Pol I fidelity impact mutation rates across most or all of the sequence of a 
ColE1-type plasmid. Also in broad agreement with previous studies, which report that Pol 
I variants have less of an effect on chromosomal mutation rates compared to plasmid 
mutation rates89,90, we found no significant difference in chromosomal mutation rates from 
the PResERV polA antimutator allele. 
Our overall goal is to construct an E. coli cell that is more robust against unplanned 
evolution to serve as an improved ‘chassis’ for synthetic biology and biotechnology 
applications. For this purpose, the most useful antimutator alleles are those that increase 
the genetic stability of an engineered DNA sequence in a host cell without any trade-offs 
in other desirable traits. In one important respect, the PResERV polA mutation and many 
other polA antimutator alleles pass this test: they do not negatively affect E. coli growth 
rates89. However, the PResERV allele does exhibit a significant trade-off that diminishes 
its potential utility. Copy number of the pTEM-1.D254tag plasmid used to measure 
mutation rates was reduced by ~55% in strains with the evolved polA allele. This decrease 
is consistent with a reduction in GFP expression from the pSKO4 plasmid when the 
evolved polA mutation was present in a strain. We used numerical simulations to show that 
this slight reduction in plasmid copy number can explain only ~2-fold of the ~30-fold 
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reduction in plasmid mutation rates we observed in the evolved strain. Still, as ColE1 
plasmids are widely used for cloning and protein overexpression, where maximal yield of 
plasmid DNA or a protein encoded on the plasmid is the primary goal, this trade-off of 
much lower plasmid mutation rates at the expense of reduced plasmid copy number would 
not be favorable, on balance, for many biotechnology applications.  
Other mutations in Pol I have previously been found to reduce the copy number of 
high-copy ColE1 plasmid variants91. It has been hypothesized that they might have this 
effect by decreasing the frequency of initiation of DNA synthesis from the RNA II primer, 
by reducing the speed of DNA polymerization, or by some combination of the two. In 
biochemical assays, some of the exo– Pol I antimutator variants have been reported to have 
significantly reduced rates of polymerization36. They would presumably also reduce ColE1 
plasmid copy number, though this has not been tested. However, other antimutator Pol I 
variants apparently retain wild-type enzyme activity36. It is possible that these polA 
mutations do not exhibit any trade-off in plasmid copy number and would ultimately be 
more useful than the PResERV allele for constructing an improved E. coli host strain. 
The three other sequenced PResERV strains all shared mutations in two genes that 
also have known roles in DNA replication fidelity and regulation of plasmid replication: 
DNA polymerase II (polB) and RNase E (rne). Pol II is a repair polymerase induced by the 
SOS and RpoS responses92,93. We observed a mutation that creates a premature stop codon 
in polB at amino acid 558. This truncation likely results in a completely inactivated 
enzyme. There is also a second point mutation later in the polB reading frame in these 
strains that would result in an amino acid substitution (H597Y) if the nonsense mutation 
were not present. The occurrence of two nearby mutations in the same gene is probably 
due to our use of UV mutagenesis to create initial genetic diversity in the E. coli population 
at the beginning of PResERV, as clustered mutations can result from long-patch repair of 
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UV damage94. Despite the fact that UV damage induces the SOS response, we do not 
expect that these mutations in polB were favored due to any direct connection to the 
mutagenesis procedure. Loss of Pol II function does not appreciably affect cell survival or 
the overall level of mutagenesis after UV exposure unless other DNA repair pathways are 
also inactivated95. 
The connection between Pol II activity and E. coli mutation rates has multiple 
facets. On one hand, Pol II can act as a high-fidelity alternative to the other stress-induced 
polymerases (Pol IV and Pol V). As a consequence, inactivation of polB increases the 
incidence of point mutations arising from the repair of DNA double-strand breaks that 
occur during long-term carbon starvation96,97. However, Pol II also participates in 
mutagenic translesion synthesis pathways that repair other types of DNA damage in an 
error-prone manner. Accordingly, deletion of Pol II has been reported to have the opposite 
effect and reduce mutagenesis associated with certain DNA base adducts98,99 and in cells 
exposed to antibiotics that can cause DNA damage100. The mutagenic effect of polA 
activity appears to dominate in E. coli cells growing under standard laboratory culture 
conditions, as incorporating a deletion of polB into an engineered reduced-mutation variant 
of the MDS42 clean-genome E. coli strain lowered chromosomal mutation rates by 
~30%39.  
Despite these connections between Pol II and mutagenesis, the mutant polB gene 
sequence from PResERV was not associated with a significant change in mutation rates in 
our assays when we reverted it to the wild-type sequence in the evolved strain or in a strain 
in which the rne mutation found in the same evolved strains was also reverted. It is possible 
that this is due to epistatic interactions with the other five mutations common to this set of 
evolved strains, although none of these mutations affect genes with an obvious connection 
to DNA replication or repair processes. One or both of the Pol II mutations could have been 
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present immediately after UV mutagenesis at the beginning of PResERV and reduced 
mutation rates in this context. Then, subsequent mutations that arose in this winning lineage 
during the regrowth cycles of PResERV might have overshadowed the effect of the Pol II 
mutations by making them redundant. However, we believe this is unlikely to be the only 
explanation, as the evolved rne allele on its own seems to explain all of the reduction in 
mutation rates, whether or not the evolved polB sequence is present. It is also possible that 
some aspect of the environment experienced by cells during PResERV but not during the 
mutation rate assays introduced a stress that favored polB inactivation. For example, the 
PResERV cultures were often interrupted by diluting them into water and processing them 
through a cell sorter before the next growth cycle. In any case, it is clear that knockout of 
Pol II is not as effective at reducing mutation rates under normal growth conditions as the 
mutation in RNase E that is present in the same strains. 
RNase E is an endoribonuclease with global roles in RNA maturation, processing, 
and decay101. It is involved in tRNA, rRNA, and small RNA processing and has been 
reported to initiate the decay of ~60% of E. coli mRNAs102,103. RNase E is also specifically 
involved in controlling the copy number of ColE1 plasmids57,58. It does so by cleaving the 
regulatory antisense RNA I transcript at a specific site, which converts it into an inactive 
form that cannot bind to and inhibit processing of RNA II into a productive primer. RNase 
E is an essential gene, but eliminating its expression using a temperature-sensitive mutant 
has been shown to reduce plasmid copy number, as is expected from the resulting increase 
in levels of the active form of the RNA I inhibitor59. Despite this connection to the 
regulation of initiation of ColE1 plasmid replication and unlike the polA allele in the other 
PResERV strain, the evolved rne allele did not significantly change plasmid copy number, 
as measured using qPCR for the pTEM-1.D254tag mutational reporter plasmid or in terms 
of the fluorescence output from the pSKO4 plasmid. This rne allele demonstrates an 
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advantage of using the PResERV directed evolution approach. Although RNase E has a 
known role in ColE1 plasmid replication, it would not have been an obvious target for 
rationally engineering a more genetically stable host strain. 
The PResERV rne allele was responsible for a 6-fold reduction in plasmid mutation 
rates with no significant effect on chromosomal mutation rates. The altered amino acid 
(L222S) is located within its split RNaseH-like domain near the embedded 5′ sensor 
domain that is responsible for its preference for RNA substrates with a 5′ monophosphate60. 
It is unclear how this mutation might affect RNase E activity and lead to a reduction in 
plasmid mutation rates. It could potentially have a direct effect on processing of RNA I 
and/or RNA II that alters the balance of different DNA polymerases used to replicate and/or 
repair ColE1-type plasmids, though it is hard to imagine how this could happen without 
also affecting plasmid copy number. Alternatively, the rne mutation may have an indirect 
effect by altering the decay or maturation of other RNAs in a cell. RNAse E has been shown 
to affect the biogenesis and activity of small RNA103, many of which are involved in stress 
responses104, to point out one such possibility among many. It will take future work 
examining the biochemical effects of this mutation on enzyme activity and its global effects 
on the E. coli transcriptome to decipher why it has an antimutator effect on plasmid 
replication. Of the three mutations in the PResERV strains that we studied, this mutation 
in RNAse E appears to hold the greatest promise for applications in biotechnology, as the 
antimutator effect is not associated with any unwanted trade-offs in terms of growth rate 
or plasmid copy number in the standard culture conditions we used.  
Overall, we expect that the PResERV approach will be widely applicable and useful 
for isolating mutations that make engineered cells more robust against evolutionary failure 
by lowering mutation rates. One advantage of PResERV is that it is agnostic to the source 
of mutations and the type of host cell. It will select for mutants that eliminate the dominant 
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cause of mutations inactivating the reporter gene used for cell sorting, and it can be 
employed iteratively to further eliminate the next-most dominant source of mutations by 
subsequently introducing new genetic variation into the population and continuing the 
cycles of cell growth and sorting. When there is genome-wide genetic variation in the cell 
population, PResERV can discover mutations in genes of unknown function or pathways 
that do not have obvious connections to mutagenesis, like the rne mutation in this study. 
In the future, PResERV could also be used on libraries of cells that target variation to one 
key enzyme (e.g., polA) or to a suite of genes known to be involved in DNA replication 
and repair, by using multiplex genome editing methods105,106. The current study 
demonstrates proof-of-principle for the PResERV approach, but by examining just six 
isolates from one mutagenized population, it has clearly not identified all of the ways that 
mutations in the E. coli genome can lower mutation rates. 
An advantage of using directed evolution compared to screening approaches that 
have been used to isolate antimutators in the past 37 is that the cycles of regrowth between 
cell-sorting steps in PResERV implicitly favors isolating just those antimutator alleles with 
no trade-off in terms of a reduced growth rate. However, there are potential risks and 
pitfalls in any directed evolution approach. Selection will yield a reduction in the dominant 
type of mutation for a particular reporter gene and plasmid in a particular environment and 
host cell, but these improvements may not translate to other DNA constructs, growth 
conditions, or genetic backgrounds. In this study, we showed that there are consistent 
antimutator effects between two distinct ColE1-type plasmids with different reporter genes 
in the evolved E. coli strains. How the antimutator alleles isolated here behave in other 
environments needs to be further tested to ensure that they do not degrade performance in 
specific applications. In general, this risk can be mitigated by matching PResERV 
conditions as closely as possible to those relevant for applications of a strain (e.g., in an 
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industrial bioreactor) or by exposing cells to a variety of different environments during 
PResERV. It also remains to be seen whether the PResERV mutations would maintain their 
antimutator effects if they were engineered into other E. coli strain backgrounds that are of 
interest in biotechnology (e.g., BL21 for protein expression). 
One critical consideration for applying PResERV is knowing what types of 
mutations will inactivate the reporter gene used for cell sorting. Certain DNA sequences 
contain mutational hotspots such that a specific deletion or frameshift dominates among 
the mutations found to inactivate a reporter gene because it occurs at a rate that is many 
orders of magnitude higher than the point mutation rate49. Transposons are the most 
prominent source of mutations that disrupt other engineered DNA constructs22,23,107. The 
presence of any type of dominant mutation in the fluorescent reporter gene will concentrate 
PResERV on isolating mutants that ‘solve’ that particular mechanism of failure. In this 
study, we purposefully used a GFP reporter plasmid that had been edited to remove 
sequence-based mutational hotspots22, so that we could recover mutants that reduced point 
mutation rates. Because transposon mutations can be completely eliminated by using 
‘clean-genome’ strains that have these and other selfish DNA elements deleted from their 
genomes23,48,50,51, it would probably not be a very useful application of PResERV to 
employ it to find mutations that suppress their activity, at least in bacteria. Rather, we 
anticipate that PResERV is most useful for neutralizing point mutations, for which it is less 
obvious how to modify either the sequence of the DNA construct or a cell’s genome to 
improve genetic stability. 
One of the main challenges for implementing the PResERV approach in other 
contexts, as opposed to with a high-copy plasmid in a bacterial cell, is that expression of 
the reporter gene used to monitor for mutations must impose a large, dominant fitness 
burden on the host cell. This ensures, first, that cells with mutations in the reporter gene 
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will arise and reach a high frequency within a reasonable number of growth cycles so that 
one can complete multiple sorting steps to enrich for antimutator variants. Second, 
mutations that inactivate the reporter gene that is being monitored will be competing within 
these populations with other categories of beneficial mutations that improve growth for 
unrelated reasons (e.g., adaptation to the growth media). If the burden of the reporter gene 
is too small, then those other mutations will be favored over mutations that change GFP 
fluorescence, unfocusing evolution from the objective of PResERV. A related challenge, 
illustrated by the polA mutation in this study, is that it may be difficult to guard against a 
gradual and subtle loss of fluorescence over time during the sorting procedure, which can 
lead to the enrichment of mutations in the plasmid that modify the expression or burden of 
the reporter gene with undesirable side-effects. 
In summary, we showed that the PResERV directed evolution approach can isolate 
antimutator E. coli variants that exhibit reduced mutagenesis of ColE1-type plasmids. 
Since these high-copy plasmids are widely used in E. coli for cloning and recombinant 
protein expression, these or similar antimutator alleles may be broadly useful in 
biotechnology applications. Future applications of PResERV with the burdensome reporter 
gene encoded in the chromosome or on a plasmid with a different origin of replication, 
might enrich for host cell variants that have a higher fidelity for replicating other 
components of a bacterial genome. The PResERV approach could also potentially be 
applied to other cell types used for industrial bioproduction, such as yeast or Chinese 
hamster ovary cells, if suitable reporter genes for monitoring genetic stability can be 
devised for these systems. Despite decades of studying the mechanisms of DNA repair and 
replication, we do not know the fundamental physiological constraints that determine a 
lower limit on the mutation rates that could potentially be achieved by tuning or 
augmenting these processes. Ultimately, this overall strategy of lowering mutation rates to 
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arrest evolution promises to improve the foundations of synthetic biology so that cells 
engineered for any purpose will function more predictably and reliably. 
 
MATERIALS AND METHODS 
Culture conditions 
E. coli was grown as 10 mL cultures in 50 mL Erlenmeyer flasks with incubation at 37°C 
and 120 rpm orbital shaking over a diameter of 1 inch unless otherwise noted. The Miller 
formulation of Lysogeny Broth (LB) was used (10 g/L tryptone, 5 g/L yeast extract, and 
10 g/L NaCl). Media were supplemented with 100 µg/mL carbenicillin (Crb), 20 µg/mL 
chloramphenicol (Cam), 50 µg/mL kanamycin (Kan), 100 µg/mL rifampicin (Rif), and 1 
mM isopropyl β-d-1-thiogalactopyranoside (IPTG), as indicated. Bacterial cultures were 
frozen at –80°C after adding glycerol as a cryoprotectant to a final concentration of 13.3% 
(v/v). 
 
Strains and plasmids 
The progenitor strain (BW25113) of the Keio knockout collection55 was transformed with 
pSKO4. This plasmid contains the redesigned I7101 (R0010+E0240) circuit, which was 
edited to remove unstable repeat sequences in a prior study by Sleight et al., on the 
BioBrick cloning vector pSB1A2 backbone22. It is a ColE1 group plasmid with a pBR322 
origin of replication. Plasmid pTEM-1.D254tag encodes TEM-1 β-lactamase with the 
codon for an amino acid at a surface-exposed position in the enzyme’s structure at which 
multiple amino acid substitutions are compatible with enzyme function replaced with a 
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TAG stop codon63. pTEM-1.D254tag has a pBR322 origin of replication and additionally 
encodes the rop protein.  
 
UV mutagenesis 
BW25113 cells containing pSKO4 were cultured overnight to stationary phase in LB-Crb. 
Then, these cultures were pelleted by centrifugation and resuspended in an equal volume 
of sterile saline. Eleven 120 µl droplets of these cell suspensions were spotted on petri 
dishes and subjected to 27,500 µJ/cm2 of 254 nm UV radiation in a UVP CL-1000 
crosslinker. After UV exposure, 100 µl from each droplet was combined and pelleted by 
centrifugation to collect ~2.5×106 surviving cells. These cells were inoculated into 10 mL 
of LB-Crb and grown to a final density of ~2×109 cells/ml. This mutagenized library was 
archived as a frozen stock. 
 
PResERV directed evolution procedure 
All growth steps were conducted in 10 mL of LB-IPTG-Crb. We used 0.1 mL of the 
mutagenized library to found the experimental population. After overnight growth to 
saturation, we propagated the population through daily 1:1000 dilutions of saturated 
cultures into fresh media followed by regrowth. GFP expression was monitored using a 
BD Fortessa flow cytometer. Periodically, overnight cultures were diluted to ~2.5×106 
cells/mL in HPLC grade water and stained with 150 nM of the nucleic acid dye SYTO 17 
(Life Technologies). The GFP+ portion of the population was calculated as the percentage 
of SYTO 17 positive cells with at least the ancestral level of GFP fluorescence by flow 
cytometry. When fewer than 25% of cells in the population were GFP+, instead of a normal 
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transfer, the population was diluted to ~2.5×106 cells/mL in HPLC grade water and 
between ~4×104 and ~5×105 GFP+ cells were sorted into 10 mL of fresh LB-Crb using a 
BD FACSAria IIIu. The SYTO 17 dye was found to decrease cell viability, so we did not 
add this counterstain in the sorting steps, at the cost of less efficient enrichment of GFP+ 
over GFP– cells. 
 
Isolation of evolved cells and plasmids 
The evolved population was plated on LB-IPTG-Crb and six visibly GFP+ colonies were 
selected at random for further study. Each of these clonal isolates was grown overnight in 
LB-IPTG-Crb before isolating its plasmid and creating a frozen stock. To select for plasmid 
loss, we also diluted these cultures 1:1000 into media lacking Crb (LB-IPTG). After 
overnight growth, dilutions of the resulting cultures were then plated on LB-IPTG agar. 
GFP– colonies were patched onto LB-Crb agar to ensure the lack of fluorescence was 
caused by loss of plasmid rather than a GFP mutation. One colony which had been cured 
of its plasmid was selected for each of the original evolved clones and re-transformed with 
the wild-type plasmid. We were unable to cure one evolved strain (AER7) of the plasmid 
in this way. The wild-type BW25113 strain was separately transformed with the plasmids 
isolated from each of the six evolved clones. GFP decay experiments were carried out on 
the resulting eleven strains to examine them for evidence of increased evolutionary 
stability. 
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GFP decay curves  
For each of the strains tested, individual colonies were used to inoculate nine replicate E. 
coli populations. In order to more accurately estimate the number of cell doublings elapsed 
since the single-cell bottleneck, care was taken to include all cells in each colony in the 
first liquid culture by excising and transferring the piece of agar underneath and around 
each colony. Each population was then subjected to daily transfers under the same 
conditions as the PResERV experiment, while monitoring GFP fluorescence using 
SYTO17 staining and a BD Fortessa flow cytometer as describe above. For creating graphs 
of the percentage of cells remaining GFP+ over time, flow cytometry data were analyzed 
in R using the flowCore Bioconductor package (v1.42.3). Among the events exhibiting a 
SYTO17 signal, cells were classified as GFP+ if they were above a signal intensity 
threshold that was set based on the distribution of fluorescence values observed for the 
wild-type strain-plasmid combination in that experiment. For graphing and comparing the 
initial GFP fluorescence in each strain, median intensity values for the GFP+ subpopulation 
were log2 transformed before performing statistical analyses. 
 
Genome sequencing 
DNA was extracted from stationary phase E. coli cultures using the PureLink Genomic 
DNA Mini kit from Life Technologies. Purified DNA was fragmented using the Covaris 
AFA system, and samples were prepared using the NEBNext DNA Library Prep Reagent 
Set for Illumina kit from New England Biolabs. An Illumina HiSeq 2500 was used to 
generate 2 × 125 paired-end reads from each sample at The University of Texas at Austin 
Genome Sequencing Analysis Facility (GSAF). FASTQ files have been deposited in the 
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NCBI sequence read archive (SRP090775). Mutations in each of the evolved strains were 
predicted by using breseq (version 0.32.0a)108 to compare the Illumina reads to the E. coli 
BW25113 reference genome (GenBank:CP009273.1). Several genetic differences between 
this reference sequence and all four sequenced samples were assumed to have existed in 
the ancestral E. coli strain used to initiate the PResERV experiment and are not reported.  
 
Strain reconstruction 
Donor strains from the i-Deconvoluter library109 were used to revert the three candidate 
evolved alleles we tested in two evolved clones (AER8 and AER12) back to wild type 
sequences using P1 transduction as previously described110, except that only 2 µl of lysate 
was used in each transduction. Lysate from SMR20954, SMR20794, and SMR20838 was 
combined with the appropriate evolved strain with a mutation in polA, polB, or rne, 
respectively, and plated on LB agar plates containing Kan. Resultant colonies were 
screened for correct replacement via Sanger sequencing before FLP recombinase was used 
to remove the linked KanR cassette used for selection of transductants as previously 
described111. The strain with rne reverted to the wild-type allele was subjected to a second 
round of P1 transduction to also revert the polB mutation, and the KanR cassette was again 
removed via FLP recombination. 
 
Mutation rate measurements 
Luria-Delbrück fluctuation tests were carried out to measure mutation rates112. For plasmid 
mutation rates, strains cured of plasmid pSKO4 were transformed with plasmid pTEM-
1.D254tag after making any genetic modifications to revert evolved alleles. Cultures were 
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grown in LB-Cam to select for retention of this plasmid and plated on LB-Cam agar 
additionally supplemented with 500 µg/ml Crb to select for mutants. Thus, this assay 
measures the aggregate rate of all mutations that revert this stop codon to a permitted sense 
codon. Cells with the original, unmutated pTEM-1.D254tag plasmid were somewhat 
resistant to Crb, presumably due to some translational readthrough of the stop codon 
inserted into the β-lactamase gene on this high-copy plasmid. This background resistance 
is why an unusually high concentration of Crb (five times the level normally used to select 
for plasmid retention in this strain) was necessary to select for CrbR mutants. For 
chromosomal mutation rates, LB agar containing 100 µg/ml rifampicin (Rif) or 60 µg/ml 
d-cycloserine (DCS) was used for the selective conditions. Rif resistance requires specific 
point mutations in the rpoB gene113. In minimal media DCS resistance requires a loss-of 
function mutation specifically in the cycA gene114, but mutations in additional targets may 
also be possible in the rich LB media used here.  
Mutation rates were determined by taking an overnight culture of a strain and 
transferring ~1,000 cells from a dilution in sterile saline to each separate fluctuation test 
culture. After growth of the replicate cultures to saturation, the entire volume of each one 
was either plated on a selective LB agar plate or a dilution was plated on a non-selective 
LB agar plate. For CrbR plasmid and RifR chromosomal mutation rates comparing wild-
type, evolved, and reconstructed strains, we used 0.2 mL cultures in 18×150 mm test tubes 
containing non-selective media and incubated these cultures with orbital shaking. A total 
of 6 non-selective and 48 or 12 selective plates were used for plasmid and chromosomal 
mutations, respectively. For DCS chromosomal mutation rates, 1.0 mL LB cultures and 12 
selective media plates were used. Additionally, only a portion (25 µl) of these cultures were 
plated on the selection LB agar. For comparing CrbR plasmid mutation rates of wild-type 
and evolved clones (AER8 and AER12), we conducted three separate sets of fluctuation 
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tests using different growth formats. In the first, we grew 1 ml cultures in test tubes with 
orbital shaking and used 4 nonselective and 12 selective plates for each strain. In the 
second, we grew 200 µl cultures in test tubes with orbital shaking and used 12 nonselective 
and 48 selective plates for each strain. In the third, we grew 200 µl cultures in 96-well deep 
well microplates with no shaking and used 12 nonselective and 51 selective plates for each 
strain. In all cases, the liquid cultures in nonselective media were grown for 24 h, and 
mutant colonies on the selective plates were counted after 48 h of incubation. Colony 
counts on selective and non-selective plates were used to estimate mutation rates using the 
rSalvador R package (v1.7)115. We used its likelihood ratio methods for calculating 
confidence intervals and the statistical significance of differences between mutation rate 
estimates for two strains. 
 
Plasmid copy number determination 
Cells containing the pTEM-1.D254tag plasmid were revived in 5 mL LB-Cam with 
overnight growth from frozen stocks. These cultures were diluted 1000-fold into 10 mL of 
fresh LB-Cam and 1 mL of each culture was harvested when its growth reached 
exponential phase (OD600 ~0.5). Three cell pellets from different biological replicates were 
collected for each strain. Mixed plasmid and chromosomal DNA was isolated using the 
PureLink Genomic DNA Mini Kit (Invitrogen). Total DNA concentrations in these 
samples were determined using a Qubit Fluorometer (ThermoFisher).  
Primer pairs for qPCR were designed to amplify products from either the antibiotic 
resistance gene (cat) in the pTEM-1.D254tag plasmid or the ftsZ gene in the E. coli 
chromosome. The cat primers were 5′-GTGAGCTGGTGATATGGGATAG and 5′-
CCGGAAATCGTCGTGGTATT. The ftsZ primers were 5′-
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GCAAGGTATCGCTGAACTGA and 5′-CGTAGCCCATCTCAGACATTAC. For each 
DNA sample, separate amplification reactions with each of the two primer pairs were 
conducted using Power SYBR Green PCR Master Mix reagents and a ViiA7 Real-Time 
PCR System (ThermoFisher). These reactions were performed in 96-well PCR plates with 
a final volume of 15 µL per well and 500 nM of each primer.  
Standard curves for plasmid and chromosomal DNA were used to calculate the 
absolute concentrations of each type of DNA from Ct values116. The plasmid standard 
curve was constructed by amplifying pTEM-1.D254tag plasmid DNA isolated using the 
PureLink Quick Plasmid Miniprep Kit (Invitrogen), The chromosomal DNA standard 
curve was made by amplifying E. coli DNA isolated using the PureLink Genomic DNA 
Mini Kit (Invitrogen) from cells without a plasmid. Each curve consisted of a series of 10-
fold dilutions of template DNA. Plasmid copy number was calculated by averaging values 
from technical replicates for each biological replicate and then using the standard curves 
to estimate its plasmid:chromosome ratio.  Graphing and statistical analyses were 
performed using log2 transformed values of copy number estimates for each biological 
replicate. The mean copy number estimated for the pTEM-1.D254tag plasmid in the wild-
type BW25113 strain was 410. 
 
Scaling of apparent mutation rates with plasmid copy number 
We used numerical simulations to examine how the apparent per-cell mutation rates 
estimated from our fluctuation tests with the pTEM-1.D254tag plasmid would be expected 
to scale if there were a change in the copy number of this plasmid in an evolved E. coli 
strain. Python scripts for performing the simulations are available online 
(https://github.com/barricklab/plasmrs). In these simulations, a population begins with a 
 44 
single wild-type cell that contains a set number of copies (Np) of the mutational reporter 
plasmid. The population growth process is modeled by iteratively picking a random cell 
from the population to divide and replacing this cell with its two daughter cells. When a 
cell divides, its complement of plasmids is replicated by iteratively picking a random 
plasmid from the current population of plasmids in the cell to copy until there are a total of 
2Np plasmids. Each time a wild-type plasmid replicates there is a chance (µp) that the new 
copy is a mutant plasmid that has restored the β-lactamase reading frame. The resulting 
collection of 2Np plasmids, including any mutant plasmids that may have replicated or have 
newly arisen during division of this cell, are randomly allocated such that each daughter 
cell inherits exactly half of the plasmids. After cells divide enough times to reach a final 
population size (N), the number of mutant cells that would yield colonies on Crb agar (Nm) 
is counted as the number of cells that contain at least a minimum number of mutant 
plasmids needed to yield a resistant colony (Nr). After one hundred replicate cultures were 
simulated for each condition, we estimated the apparent mutation rate per cell (µ) from the 
observed distribution of mutant colony counts per culture (Nm) and the total number of 
cells per culture (N) using the rSalvador R package, in the same way that we analyzed 
experimental data.  
We specifically used these simulations to examine how the reduction in plasmid 
copy number observed in the AER12 PResERV strain with the polA mutation would be 
expected to impact its apparent mutation rate if the evolved strain maintained the same per-
plasmid mutation rate as the wild-type BW25113 strain. Because it was not 
computationally feasible to simulate E. coli populations as large as those used in our actual 
fluctuation tests (with ~5.0´107 to ~2.5´109 cells) we performed simulations that scaled 
the apparent per-cell mutation rate (µ) upward such that equivalent values of the expected 
number of antibiotic resistant mutant cells per culture (m = Nµ) were reached with smaller 
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values of N. We performed four different sets of simulations matching the µ and m 
parameter combinations for the wild-type BW25113 strain that we observed in fluctuation 
tests in the four different experimental blocks shown in the results section that compared 
the plasmid mutation rates of the wild-type and AER12 strains. These combinations were: 
µ = 4.69´10−8 and m = 104; µ = 2.89´10−7 and m = 27.7; µ = 2.36´10−8 and m =1.53; and 
µ = 2.14´10−7 and m = 20.5.  
For each set of simulations, we first determined an underlying per-plasmid mutation 
rate (µp) that matched the experimentally measured apparent per-cell mutation rate (µ) to 
within 5% by performing a series of simulations using N = 3.2´104 cells and Np = 410 
plasmids per cell. We repeated this procedure for each of three different values of Nr (1, 3, 
and 10). Then we performed five new simulations with each µp value corresponding to a 
different Nr across five different values of N (104, 1.8´104, 3.2´104, 5.6´104, and 105). 
Finally, we performed new simulations at these same fifteen combinations of µp, N, and Nr 
with Np = 185 and all other parameters left unchanged, in order to determine what the 
apparent mutation rate would have been in the fluctuation tests if plasmid copy number 
had decreased without any change in the underlying plasmid mutation rate. For each set of 
five pairs of simulations differing only in Np, we calculated R, the ratio of the apparent 
mutation rate for Np = 185 to that for Np = 410. We found no significant dependence of the 
logarithm of R on the logarithm of N across the range of values tested in any of these sets 
(p > 0.05, Bonferroni-corrected test for a nonzero slope in a linear regression model), 
justifying our inversely proportional rescaling of N and µ for the purpose of making the 
simulations feasible. We further found that the values of the logarithm of R within each of 
the three sets of simulations at a fixed Nr that varied µ and N were indistinguishable from 
one another (p > 0.05, Kruskal-Wallis tests). Therefore, we report only the overall mean of 
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the log-transformed R values for each set of 20 simulations at the same Nr and a bootstrap 
confidence interval on this statistic constructed from 100,000 resampled sets. 
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Figure 2.1.  Periodic Reselection for Evolutionarily Reliable Variants (PResERV) 
method  
 
PResERV begins with a population of cells expressing GFP to such a high level that it 
imposes a significant fitness burden. After mutagenesis, the population is cultured 
through enough cell doublings that mutants with reduced GFP expression arise and 
outcompete other cells. Periodically, the population is sorted to retain only those cells 
that remain as fluorescent as the original strain, enriching for mutant host cells with 
reduced mutation rates or a lower fitness cost for GFP expression. Once the evolutionary 
stability of GFP expression increases, fluorescent cells are isolated and their genomes are 
sequenced to identify and characterize the genetic changes that contribute to this 
improvement. Regrowth of cells during PResERV implicitly selects for only those 
mutants that achieve improved genetic stability without introducing any trade-offs that 
significantly reduce cellular growth rates. 
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Figure 2.2. PResERV applied to an E. coli plasmid  
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Figure 2.2 continued (A) Propagation and sorting regimen used to perform PResERV on 
an E. coli population in which GFP was expressed from plasmid pSKO4, a high-copy 
plasmid with a pBR322 origin of replication. The red diamond denotes the wild-type 
strain that was UV-mutagenized prior to beginning PResERV. Dashed grey and solid 
green bifurcating lines show when the population was sorted to retain fully fluorescent 
cells (GFP+). The blue circle indicates when fluorescent clones were isolated and 
sequenced. (B) Populations initiated from six different clones isolated at the end of the 
PResERV evolution experiment (blue and purple solid lines) were allowed to evolve 
alongside six replicates of the non-mutagenized, wild-type E. coli strain-plasmid 
combination (red dashed lines). Cells were considered GFP+ if they maintained a 
fluorescent intensity as measured by flow cytometry that was above a threshold level that 
was kept constant across all tested strains. (C) For each evolved PResERV strain, its 
plasmid was isolated and transformed into the wild-type strain containing no plasmid 
(dashed lines), and the evolved strain was cured of its plasmid and re-transformed with 
the wild-type pSKO4 plasmid (solid lines). Populations initiated from these strains were 
propagated and monitored as in B. The stability of AER7 re-transformed with the wild-
type plasmid was not determined because of difficulty curing the evolved plasmid from 
this strain. In panels B and C, the same colors are used for each PResERV strain. In both 
experiments, the percentage of GFP+ cells was measured by flow cytometry after the first 
35 cell doublings, corresponding to growth of the initial culture from a single cell on an 
agar plate, and then every 10 cell doublings afterward, corresponding to regrowth after 
daily subculturing steps that used a 1:1000 dilution into fresh media. 
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Figure 2.3. Mutations in PResERV strains  
The genomes of four evolved strains were re-sequenced to identify mutations that 
accumulated during the directed evolution procedure. The position column shows the 
coordinate of the first affected base pair defined relative to the E. coli K-12 BW25113 
genome (GenBank:CP009273.1). The mutation column shows base changes on the top 
strand of the genome, except for the IS1 element in AER9 that inserted in the reverse 
direction and duplicated bases 4,327,401–4,327,408 at the target site on each side of the 
new IS copy. The annotation column shows the amino acid changes and codon changes 
caused by single-base substitutions or the locations of bases affected within a gene for 
other mutations. The gene column includes arrows showing the genomic strand on which 
each mutated gene is located. 
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Figure 2.4. Evolutionary stability and mutation rates in PResERV and 
reconstructed strains  
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Figure 2.4 continued (A) Wild-type strain. (B) Evolved strain AER12 and a derived 
strain with its evolved polA allele reverted to the wild-type sequence. (C)  Evolved strain 
AER8 and derived strains with its evolved polB and rne alleles reverted, singly and in 
combination. In each panel, the strains being tested were first transformed with plasmid 
pSKO4. Then, nine independent populations were initiated from single colonies of each 
strain. The prevalence of GFP-expressing cells within each population was monitored by 
flow cytometry over multiple daily serial transfers. Evolved strains are shown with solid 
lines. Dashed lines indicate that a strain contains one or more wild-type alleles, as 
indicated in red type. Measurements were made after the first 35 cell doublings and then 
every 10 cell doublings thereafter.  
 
 
 
  
 53 
 
Figure 2.5. Plasmid mutation rates in PResERV strains  
Mutation rates to carbenicillin resistance (CrbR) due to reversion of a stop codon in the 
TEM-1.D254tag plasmid were measured using Luria-Delbrück fluctuation tests. Wild 
type and the two focal evolved strains were compared in three experiments under 
different growth conditions: (A) in 1 ml cultures in test tubes incubated with orbital 
shaking (B) in 200 µl test cultures in test tubes incubated with orbital shaking, and (C) in 
200 µl cultures incubated in 96-well microplates with no shaking. Each experiment 
included the wild-type E. coli strain for comparison (dashed horizontal lines). Error bars 
are 95% confidence intervals. 
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Figure 2.6. Plasmid and chromosomal mutation rates in PResERV and 
reconstructed strains  
(A) Mutation rates to carbenicillin resistance (CrbR) due to reversion of a stop codon in 
the TEM-1.D254tag plasmid were measured using Luria-Delbrück fluctuation tests. 
Wild-type and evolved strains with mutant polA, polB and rne alleles (mut) reverted to 
wild-type sequences (wt), individually or in combination, were examined. Strains related 
to the evolved clone with a polA mutation (AER12) were tested in one experiment (left 
panel), and strains related to the evolved clone with polB and rne mutations (AER8) were 
tested in another experiment (right panel). (B) Mutation rates to rifampicin resistance 
(RifR) (left panel) and d-cycloserine resistance (DCSR) (right panel) were measured using 
Luria-Delbrück fluctuation tests. Both of these resistance phenotypes require mutations in 
genes located on the E. coli chromosome. Each experiment included wild-type E. coli for 
comparison (dashed horizontal lines). Error bars are 95% confidence intervals. 
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Figure 2.7. Plasmid copy number and GFP fluorescence in PResERV and 
reconstructed strains  
(A) Plasmid copy number for wild-type, evolved, and reconstructed strains determined by 
qPCR. Wild-type and evolved strains with mutant polA, polB and rne alleles (mut) 
reverted to wild-type alleles (wt), individually or in combination, were tested. The 
horizontal dashed line indicates the estimated copy number in the wild-type strain. Error 
bars show the standard error of the mean on log-transformed values from three biological 
replicates. (B) Initial GFP fluorescence of wild-type, evolved, and reconstructed strains 
as measured by flow cytometry. The median per-cell fluorescence intensity of the GFP+ 
subpopulation of cells was determined for each of nine replicate cultures immediately 
after outgrowth in liquid culture (after ~35 cell doublings). The graphed values are the 
log-averaged values of these medians. Error bars are 95% confidence intervals calculated 
assuming the logarithms of the medians are normally distributed. The horizontal dashed 
line shows the value for the wild-type strain. 
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Chapter 3:  Reduced plasmid mutation rates in Escherichia coli evolve 
by mitigating the generation of reactive oxygen species through 
mutations that inactivate TCA cycle enzymes 
ABSTRACT 
Biological systems are innately ephemeral, which makes them challenging to engineer. 
Living cells are able to rapidly evolve, an especially useful strategy when affronted by 
stressful conditions. Engineered cells contain synthetic devices, encoding a desired 
function, that are metabolically costly because their expression will sequester cellular 
resources and cause a burden on fitness. Therefore, there is strong selection for engineered 
cells that inactivate the synthetic device in order to alleviate the fitness cost. We have 
developed a directed evolution method, PResERV, in which antimutator strains are evolved 
and due to their reduced mutation rates, have a lower probability of inactivating costly 
synthetic devices. Here, we evolved and characterized a series of E. coli antimutator strains. 
We determined the genetic basis of the antimutator phenotype to be largely caused by 
mutations in two genes related to central carbon metabolism, sucD and sdhA. Furthermore, 
these antimutator alleles function to mitigate intracellular oxidative stress, leading to less 
DNA damage, and the observed antimutator phenotype. The sucD and sdhA antimutator 
alleles are highly conserved, and were therefore found to reduce mutation rates in another 
E. coli strain, BL21. Notably, the sucD and sdhA alleles can be combined with a previously 
identified antimutator allele in rne, Rnase E, to reduce mutation rates even further. Our 
work provides genetically stable antimutator strains for scientists to tackle complex 
engineering problems and, describes a mechanism involved in the antimutator phenotype 
that will guide future construction of antimutator strains.  
 57 
INTRODUCTION 
Microbes are tiny factories. Their abilities have been successfully and unsuccessfully co-
opted by scientists for decades. The most quotidian examples of successfully engineered 
biologics are insulin, recombinant antibodies, the anti-malarial drug artemisinin, and more 
recently, the HPV vaccine. Biology can be engineered to address a wide variety of societal 
issues and the limit, should lie within the imagination of the scientist. Currently, there exist 
efforts to engineer biology for diverse applications in areas such as space exploration, 
biomaterials, plant and human probiotics, and diagnostic platforms. So, why haven’t more 
of these technologies transitioned as commonplace in our daily lives? Biological systems 
are inherently unpredictable, making them challenging to engineer.  
The difficulty exists in an idiosyncrasy common in all living cells – evolution. In 
order to engineer cells for a given purpose, synthetic devices encoding a desired function 
need to be inserted into a host cell and their expression is dependent on the host machinery. 
The host cell is not adapted to manage burdensome expression of this additional, foreign 
DNA and its intracellular stoichiometry becomes unbalanced. This stress favors mutants 
that can alleviate the burden by evolving, and subsequently breaking expression of the 
synthetic device. Unpredictability stems from these inactivating mutations which in turn, 
hamper engineering efforts. To address this problem, we need to properly redesign 
synthetic DNA constructs and host cells to resist evolution11,45,47.   
Evolutionary failure modes consist of several common themes. Some, such as 
recombination between homologous sequences and slippage errors due to simple sequence 
repeats, are easy fixes and can simply be avoided by omitting these sequences from the 
design of the synthetic device22,47,49. Other failure modes require extensive engineering and 
are independent of diligently crafted constructs. Host organisms contain active mobile 
insertion sequences (IS) that will readily eliminate engineered functions in a cell23. A 
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method to attenuate this problem is to build IS-free versions of host strains. IS-free hosts 
are better able to maintain expression of synthetic constructs and have reduced mutation 
rates39,48,50,107,117. However, these hosts do not help mitigate evolutionary failure by single 
base-pair changes, an even more challenging problem. To address this issue, we have 
developed a directed evolution method (Periodic Reselection for Evolutionarily Reliable 
Variants, PResERV) to evolve genetically stable, antimutator strains. These strains are 
resistant to evolutionary failure due to their reduced mutation rates and resulting lower 
probability of mutations that will inactivate an engineered function. 
 We previously performed a pilot PResERV experiment in E. coli, in which we 
identified antimutator alleles in polA, polB, and rne118. Here, we applied PResERV on a 
larger scale, using a similar experimental setup to identify more mechanisms linked to the 
antimutator phenotype. We evolved a series of antimutators via PResERV and determined 
that the genetic basis of their reduced mutation rates was mainly due to mutations in genes 
involved in central carbon metabolism, sucD and sdhA. Further characterization of these 
antimutator alleles demonstrated that they are complete inactivations of their respective 
protein complexes and ultimately serve to alleviate intracellular oxidative stress. 
Additionally, we found that the sucD and sdhA alleles reduce mutation rates in another E. 
coli strain, BL21, and function in combination with the rne allele, from the initial PResERV 
experiment, to lower mutation rates even further.  
 
RESULTS 
Directed evolution via PResERV 
To isolate new antimutator variants of E. coli, we employed an improved version 
of the Periodic Reselection for Evolutionarily Reliable Variants (PResERV) method 
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previously developed by our lab118. PResERV is a directed evolution approach that uses 
cell sorting to enrich for mutant cells that have a greater chance of continuing to express a 
burdensome fluorescent reporter gene over many generations of growth. Mutants that 
maintain long-term expression of the synthetic construct may have increased genetic 
stability due to evolving reduced mutation rates. In this study, we implemented sorting 
conditions that better enrich for fluorescent versus nonfluorescent cells by using a nonlethal 
lipophilic membrane dye and reducing the flow rate. We performed PResERV on five 
independently mutagenized and propagated populations of E. coli BW25113 harboring the 
plasmid pSKO4, a high-copy pBR322-derived plasmid expressing GFP. We performed an 
average of 10 sorts spread over ~350 generations (~30 days) of evolution. After evolution, 
we isolated 70 individual clones from each population to examine the time-course of GFP 
inactivation in the context of a single strain background. For follow-up studies and whole-
genome sequencing, we selected three clones per population (designated A, B, and C) that 
demonstrated an increased ability to maintain GFP production compared to wild type. 
 
Evolved strains have reduced mutation rates 
To determine if the improvement in the evolutionary stability of GFP expression 
was due to reduced mutation rates in the PResERV strains, we measured plasmid and 
chromosomal mutation rates in the 15 selected clones using Luria-Delbrück fluctuation 
tests (Figure 3.1). The assay for measuring plasmid mutation rates used the pBR322-
derived plasmid pTEM-1.D254tag63. It encodes a non-functional TEM-1 b-lactamase 
reporter gene that, when mutated, renders cells resistant to carbenicillin resistance. The b-
lactamase mutational reporter gene is inactivated by a nonsense mutation in the coding 
region. Therefore, this assay specifically captures the rate of point mutations on the plasmid 
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that convert this codon back to any one of multiple sense codons compatible with protein 
function118. We found that 12 of the 13 tested PResERV-evolved strains exhibited plasmid 
mutation rates that were significantly lower than the wild-type strain (p-adj > 0.05, 
Bonferroni-adjusted p-value) (Figure 3.1A). The reduction in mutation rates was as large 
as 10-fold in some strains.  
To determine whether there was a change in chromosomal mutation rates in the 
evolved strains, we performed fluctuation tests that selected for rifampicin resistant 
mutants (Figure 3.1B). Resistance to this antibiotic arises due to point mutations in the 
rpoB, in which ~100 single base-pair substitutions will result in rifampicin resistance113. 
Compared to the plasmid rates, there appeared to be a modest reduction in chromosomal 
mutation rates, in most evolved clones, though none of the clones were statistically 
significant (p-adj > 0.05, Bonferroni-adjusted p-value) (Figure 3.1B). This result is not 
surprising given that the GFP gene that was monitored for stability during PResERV was 
on a high-copy plasmid. Therefore, selection could only directly favor mutations that 
improved maintenance of this costly gene, which can be accomplished by reducing plasmid 
mutation rates.  
 
Most PResERV strains maintain wild-type plasmid copy number and growth rates 
Plasmid copy number can potentially affect the apparent mutation rate measured in 
a reporter gene on a plasmid. For example, if there are half as many plasmids in a cell, then 
its apparent mutation rate will be reduced by approximately two-fold118. Therefore, we 
measured the copy number of our ampR mutation rate reporter plasmid in the PResERV 
strains to determine whether any of the evolved clones adapted a lower plasmid copy 
number during PResERV evolution (Figure 3.2A). We found only two strains to be 
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affected, 3C and 5C, and these were discarded from further study. These had ~60 and 7-
fold reduced copy number, respectively. 
One advantage of selection during PResERV is that there is enrichment for 
antimutator alleles that lack any deleterious effects on growth. Cells must compete for 
resources within a population and iterative cell sorts will favor mutants that are more 
abundant in the population. Thus, PResERV is designed to discard slow growing mutants. 
We found that the PResERV antimutators have similar growth doubling times as wild-type 
in rich and minimal media, confirming that their decreased mutation rates do not come at 
the expense of a reduced growth rate, at least in the environment used for the PResERV 
experiment (Figure 3.2B). 
 
Mutations in the genomes of PResERV strains 
Given that PResERV involves directed evolution, our method allows us to explore new 
antimutator pathways that are non-obvious targets for reducing mutation rates. We found 
an average of six genomic mutations per clone and a total of 12 synonymous mutations 
altogether. There were no observed mutations in the pSKO4 plasmid. A subset of the 
whole-genome sequencing data showing genes hit by mutations in >2 strains and other 
mutations in genes with functions potentially related to mutation rates is summarized in 
Table 3.1. The most commonly mutated genes are sucD, sdhA, aspA, hofC, ulaR, and frlA. 
Many of these genes are major enzymes in central carbon and amino acid metabolism. In 
addition, there were mutations in several genes (btuE, dinF, and yjjX) involved in oxidative 
stress, which may be evidence of a causative mechanism for reducing mutation rates.   
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Mapping the antimutator phenotype 
To identify the alleles contributing to reduced mutation rates in the evolved strains we 
individually reverted 27 of the mutations in Table 3.1 in at least one PResERV evolved 
strain that had the mutation. We used fluctuation assays to quantify the effect of the 
reverted allele on plasmid mutation rates. Those alleles that partially or fully restored the 
wild-type mutation rate were classified as causative. For most of the PResERV strains we 
determined that the causative alleles were in these key genes – sucD, sdhA, adhE, dinF, 
and ygcL – and two of these genes, sucD and sdhA, were mutated in multiple PResERV 
strains. (Figure 3.3A, B, and D). These alleles were consistently causative, independent 
of the evolved strain background. The sucD allele (E98*) was identified in all three strains 
from one population (1A, 1B, and 1C), indicating that this mutation was likely present in 
the starting library of mutants and was enriched during PResERV evolution. Conversely, 
there were four sdhA alleles (Y78L, N156Kfs, Q173*, and Q509*) identified in five 
evolved strains from different populations (Table 3.1). This suggests a high level of 
parallel evolution occurring during PResERV.   
In some instances, we were unable to determine the causative mutations (Figure 
3.3C and E). For example, we reverted two alleles in aspA, another frequently mutated 
gene, and one allele resulted to be causative in only a single clone (Figure 3.3C, clone 3A). 
In the other clones, either another mutation was found to be causative (Figure 3.3B, clone 
2B) or the original evolved clone did not have a reproducibly low mutation rate across 
multiple fluctuation assays performed on different days (Figure 3.3C, clone 3B). 
Therefore, the evolved alleles in aspA did not appear to be consistently causative. Clones 
3A and 3B did not contain any other candidate mutations and possibly, the causative 
mechanism lies in a cellular regulatory change not described by mutations in the genome. 
Similarly, clones from population five proved difficult to diagnose. Clone 5A also 
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contained only one mutation, in sucC, which when reverted, did not appear to be causative 
and clone 5B did not have a reproducibly low mutation rate (Figure 3.3E, clones 5A and 
5B). Additionally, these two populations contained clones, 3C and 5C, that had problems 
with plasmid copy number (Figure 3.2A). Given these difficulties, our follow-up studies 
focused on those mutations that were bona fide causative.     
We independently reconstructed the causative alleles in a wild-type background to 
discern whether the antimutator phenotype was contingent solely on the single allele and 
not any other mutations present in the background of the evolved strain. We found that the 
sucD and sdhA mutations alone, in a wild-type background, resulted in an antimutator 
phenotype (Figure 3.4B). The other alleles (adhE, dinF, and ygcL), which were previously 
identified as causative failed to reproduce the antimutator phenotype in a wild-type 
background and were not included in further study.  
 
Loss of function mutations in sucD and sdhA reduce the E. coli basal mutation rate 
We focused further on mutations in two genes, sucD and sdhA, that encode subunits of key 
enzymes in the tricarboxylic acid (TCA) cycle and the electron transport chain (ETC). 
These genes are genomically located within a cluster, along with other TCA cycle genes, 
and the operon structure is illustrated in Figure 3.4A. Succinyl Coenzyme A synthetase 
(SucCD) catalyzes the conversion of succinyl-CoA to succinate and is the only TCA cycle 
step in which substrate level phosphorylation of ATP occurs119. It is a heterotetramer which 
consists of two ß (SucC) and α (SucD) subunits, and the α subunit hosts the catalytic 
phosphorylation site119,120. The causative PResERV evolved allele, E98*, is a nonsense 
mutation that likely renders the catalytic α subunit and the whole protein complex inactive. 
The subsequent metabolic reaction converting succinate to fumarate is catalyzed by 
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succinate dehydrogenase (SdhCDAB). Succinate dehydrogenase is the only TCA cycle 
enzyme that also functions in the ETC and is therefore embedded in the membrane121. The 
SdhCDAB protein complex is a trimer composed of four subunits in which two are 
structural, containing transmembrane domains (SdhCD), and the other two harbor electron-
shuttling cofactors, flavin and iron-sulfur clusters, that perform catalysis (SdhAB)122. The 
causative sdhA PResERV alleles consist of nonsense and frameshift mutations that 
expectedly result in a nonfunctioning sdhA subunit, which could lead to either a reduced 
or completely inactive enzyme complex.  
To further study the genetic basis of the PResERV sucD and sdhA alleles, we asked 
whether the sucD and sdhA evolved alleles were loss-of-function mutations. To do this, we 
assayed the mutation rate of sucD and sdhA KEIO deletion mutants (Figure 3.4B). In the 
case of sucD, the evolved allele and the KEIO deletion mutant had similar mutation rates, 
indicating that the PResERV sucD allele is indeed a loss-of-function mutation. A similar 
situation is observed with sdhA. There are two classes of sdhA alleles based on the fold 
reduction in mutation rate. The first class, Y78L, results in a modestly reduced mutation 
rate whereas the second class, that are expectedly loss-of-function (N156Kfs, Q173*, and 
Q509*), have a marked antimutator effect. The sdhA KEIO deletion mutant has a similarly 
reduced mutation rate as this second class of sdhA alleles, which demonstrates that these 
alleles are deletions of sdhA. The first class allele, Y78L, likely renders an intermediate 
antimutator phenotype because the mutation does not result in a complete knockout of 
sdhA.  
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Further dissection of the antimutator roles of succinyl-CoA synthetase and succinate 
dehydrogenase  
As described in the previous section, SucD and SdhA are components of a larger protein 
complex. Since deletion of these subunits results in an antimutator phenotype, what effect 
will deletion of the other protein subunits have on the mutation rate? To address this, we 
measured the mutation rates of sucC, sdhB, sdhC, and sdhD KEIO deletion mutants 
(Figure 3.4B). Deletion of the other succinyl CoA synthetase subunit, SucC, did not reduce 
the mutation rate. The catalytic residue of succinyl CoA synthetase resides in SucD and 
therefore, deletion of sucC may result in an enzyme with reduced activity instead of a 
completely non-functional variant. The antimutator phenotype possibly relies on the latter. 
Similarly, deletions of sdhB and sdhC, but not sdhD, resulted in lower mutation rates. The 
sdhB and sdhC deletions may lead to a complete inactivation of the succinate 
dehydrogenase enzyme complex, whereas deletion of sdhD could have little effect on the 
overall enzyme activity. In sum, our data support that the PResERV sucD and sdhA alleles 
are knockouts of their respective protein subunits, rendering a complete inactivation of the 
entire enzyme complex.   
 
Antimutator alleles function to alleviate DNA damage induced by ROS 
Reactive oxygen species (ROS) are toxic byproducts of aerobic cellular metabolism. The 
formation of these species, hydrogen peroxide (H2O2), superoxide (O2−), and hydroxyl 
radical (OH−), engenders damage to a cell’s basic building blocks – nucleic acids, proteins, 
and lipids123. Intracellular ROS is generated predominantly by enzymes in the TCA cycle 
and ETC124. Given that SucD and SdhA are key components in these pathways, we 
examined whether the antimutator sucD and sdhA alleles function to reduce intracellular 
ROS stress.  
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One method to study ROS stress is to induce its formation by using redox-cycling 
compounds such as paraquat. Redox-cycling compounds will diffuse into the cell and 
catalyze electron transfer from a redox enzyme to molecular oxygen. This reaction will 
generate hydrogen peroxide and superoxide, which can subsequently be converted into 
hydroxyl radicals125. Therefore, all three species are artificially induced within a cell based 
on the availability of electron-donating enzymes. Cells containing more of these enzymes 
will experience higher rates of lethality in the presence of paraquat. We assayed survival 
of the antimutator sucD and sdhA alleles after paraquat exposure (Figure 3.5A). The 
antimutator strains exhibited higher tolerance levels than wild-type and a control strain 
known to be more susceptible to redox-cycling drugs (Δzwf)126. These results suggest that 
the sucD and sdhA antimutator cells have lower levels of intracellular ROS.  
To directly capture intracellular ROS concentrations, we exposed the antimutator 
strains to an oxidation-sensitive fluorescent probe (2′,7′-dichlorofluorescin diacetate). This 
probe is activated intracellularly via oxidation by ROS and therefore, elevated 
concentrations of ROS will result in higher fluorescence levels. Our data demonstrate a 
significant decrease in median fluorescence, and therefore ROS levels, in the sucD and 
sdhA antimutator strains (Q173* and Q509*) as compared to wild-type and the Δzwf 
positive control (p < 0.05, Mann-Whitney U test) (Figure 3.5B).  
Based on our data, we propose that by reducing ROS stress, a sucD or sdhA 
antimutator cell experiences less DNA damage and therefore low mutation rates. This 
mechanism ultimately leads to the increased stability of synthetic constructs.  
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PResERV alleles reduce mutation rates in other strains 
Since these enzymes are widely conserved in other organisms, we hypothesized that the 
PResERV alleles could be ported into the genome of another E. coli strain, primarily used 
for plasmid-based recombinant protein production, BL21127,128. The wild-type strain used 
in this PResERV study (BW25113) is a K-12-derived strain whereas BL21 originated from 
E. coli B129,130. E. coli K-12 and B isolates have highly similar genomes and differ in that 
BL21 has a rapid growth rate, low accumulation of acetate, and improved protein 
production due to the absence of proteases130,131. Despite these physiological differences, 
our K-12-isolated PResERV antimutator alleles successfully reduced the BL21 mutation 
rate (Figure 3.6A). This reduction in mutation rate will allow for increased stability of 
protein expression plasmids in BL21. 
 
Total Antimutator Combination Organism (TACO) 
Our work characterizes mechanisms involved in genetic stability of synthetic 
constructs in order to engineer reliable, workhorse strains for biology. As a step towards 
this effort, we created Total Antimutator Combination Organisms (TACO) containing two 
antimutator alleles and assayed whether these alleles would function to reduce the mutation 
rates even further. We combined each sucD and sdhA allele with another antimutator 
mutation, rne (L222S), from a previous study118. Indeed, the double mutant TACO strains 
exhibited a further reduction in mutation rates when compared to the single mutants 
(Figure 3.6B). These engineering experiments are the nascent stages of future work. In 
principle, other versions of TACO can be created by combining different antimutator 
alleles in E. coli or other organisms of interest. These TACO strains can be utilized as new, 
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stable host organisms for biology and as examples of where the limits exist for reducing 
mutation rates.   
 
DISCUSSION 
Our study describes a series of antimutator strains that were evolved to maintain expression 
of a costly, high-copy (pSKO4) via PResERV. These strains have varied plasmid mutation 
rates across strains/populations, and many of these are marked reductions (1.5 to 15–fold). 
In contrast, chromosomal rates tended to be uniform and only modest reductions were 
observed (1.1 to 2–fold). This antimutator phenotype is caused by mutations in two genes, 
sucD and sdhA, which are common targets in this PResERV experiment. More than half 
of the 15 antimutator strains contained mutations in these genes. In further dissecting this 
phenotype, we determined that sucD and sdhA are loss-of-function mutations which 
ultimately lead to inactivation of their associated protein complexes, succinyl-CoA 
synthetase and succinate dehydrogenase, respectively. Moreover, inactivation of these 
protein complexes results in reduced intracellular ROS levels which likely accounts for the 
observed reduction in mutation rates. Given ubiquity of this mechanism across organisms, 
we ported the sucD and sdhA antimutator alleles into another E. coli strain, BL21, and 
found that they again function to reduce mutation rates. Finally, we were able to reduce 
mutation rates further and build even more stable strains by combining antimutator alleles 
to engineer TACO. In generating a series of stable strains and delineating their causative 
mechanism, our work provides resources for scientists to better understand and engineer 
biology.  
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Different mutational solutions to the same problem  
We previously performed the first PResERV pilot experiment to evolve 
antimutators with the same costly plasmid, pSKO4, that was used in this work118. Notably, 
the causative mutations and proposed mechanisms found in this initial study did not overlap 
with those described here, despite the same costly plasmid used for evolution. The initial 
PResERV pilot found that mutations in rne, polB, and polA lead to an antimutator 
phenotype. These mutational targets suggest that pathways such as DNA/RNA metabolism 
and processing are mechanistically involved, which is unlike the ROS mechanism that is 
extensively discussed in this work. Two main possibilities underlie this difference. Firstly, 
there were several changes to the PResERV protocol that primarily involved using a 
different fluorescent dye to visualize the population, a slower flow rate to better separate 
the fluorescent cells, and the PResERV pilot experiment consisted of a single population 
whereas this work evolved five populations in parallel.  
Secondly, the GFP decay genetic screen to identify putative antimutators from a 
whole population was unlikely saturated in both experiments. In the pilot experiment we 
selected six clones for characterization and in this work, we picked three clones per 
population. Since only a few clones were characterized in each study, we were unable to 
obtain a comprehensive idea of the genotypes present in the whole population and whether 
some of the mutations were present in both PResERV experiments. Despite this apparent 
dearth in characterizing antimutators, we were able to identify antimutator alleles that are 
non-obvious targets for genetic stability.  
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How do loss-of-function antimutator alleles in sucD and sdhA result in decreased 
ROS? 
Cells contain many intricate mechanisms for neutralizing oxidative stress. Namely, the 
most recognized systems are of transcriptional regulators SoxRS and OxyR, which respond 
to O2− and H2O2, respectively123,124. There also exist a myriad of strategies involving 
redirection of central carbon metabolism and these consist of two principal themes:    
1. Detoxification of ROS by α-keto acid TCA cycle intermediates 
2. Modification of the intracellular NADPH:NADH ratio because NADH is a known 
pro-oxidant that magnifies cellular oxidative tension  
These strategies are discussed below as they relate to either the sucD or sdhA antimutator 
alleles. 
 
sucD 
As described in Figure 3.4A, SucD is the α subunit of succinyl-CoA synthetase, 
and it converts succinyl-CoA to succinate. It contains the catalytic residue, His247, which 
is the site for autophosphorylation of the α subunit and the very first step in the reaction 
mechanism132. Enzyme variants of SucD containing mutations that disrupt this site are non-
functional133. The ß subunit, SucC, is the nucleotide-binding domain responsible for the 
final part of the reaction mechanism that involves of substrate level phosphorylation to 
generate ATP119,134. Therefore, deletion of sucC results in an enzyme complex that retains 
the ability to convert to succinate, but is impaired in synthesis of ATP135. Given these 
phenotypes and our data showing that the KEIO sucD deletion has a reduced mutation rate 
(Figure 3.4B), we conclude that the sucD antimutator allele is completely inactivating 
succinyl-CoA synthetase and therefore, rerouting flux through the TCA cycle.  A non-
functional succinyl-CoA synthetase can result in decreased intracellular ROS due to two 
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metabolic changes within the TCA cycle – accumulation of α-ketoglutarate (α-KG) and 
increased flux through the glyoxylate shunt.  
During oxidative stress, α-ketoglutarate dehydrogenase becomes inhibited by ROS 
and its substrate, α-KG will accumulate136. α-KG is a powerful antioxidant, scavenging 
ROS and concomitantly producing a readily usable metabolite, succinate. This strategy is 
advantageous because it does not rely on the availability of NADPH and in fact, more 
intracellular NADPH is generated via upregulation of the NADPH-producing enzyme, 
isocitrate dehydrogenase137.  In addition, NADH synthesis is limited by increased flux 
through the glyoxylate shunt, which is a known adaptation during oxidative stress138,139. 
These changes work to mitigate intracellular ROS via bypassing the main TCA cycle, 
generating fewer NADH molecules, and reducing flux through the ETC139. Furthermore, 
glyoxylate is another α-keto acid, analogous to α-KG, and will therefore serve to quench 
ROS resulting in production of formate138,140. Glyoxylate can also be enzymatically 
converted into glycine, a component of the major oxidative stress defense molecule, 
glutathione138. We hypothesize that these metabolic reconfigurations occur in a cell lacking 
succinyl-CoA synthase and therefore, mechanistically support the sucD antimutator 
phenotype.  
 
sdhA 
The enzyme complex of succinate dehydrogenase consists of two electron-shuttling 
subunits, SdhAB, and two membrane anchor proteins, SdhCD (Figure 3.4A). Succinate 
dehydrogenase performs two key functions. The initial part of the reaction mechanism, 
oxidation of succinate to fumarate, is performed by the cytoplasmic subunits, SdhA and 
SdhB. Following this conversion, the resulting electrons are transferred to the 
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transmembrane anchors, SdhC and SdhD, and are further transported through quinones to 
the rest of the ETC. In order for this cascade to occur, succinate dehydrogenase contains a 
series of redox cofactors, flavin adenine dinucleotide (FAD) and iron-sulfur clusters, to 
move electrons throughout the protein complex. Without this intact cascade, the redox 
potential of the enzyme is lowered and the initial oxidation of succinate to fumarate cannot 
occur. This precludes the movement of electrons from this reaction into the ETC121. 
Moreover, redox enzymes are known to produce ROS during normal catalysis by 
spontaneous enzyme autoxidation124. In succinate dehydrogenase, the FAD cofactor in 
SdhA is the primary site of autoxidation since it is predominantly solvent exposed141. 
Deletion of sdhA will prevent this autoxidation and will result in less ROS142. This 
mechanism supports the reduced mutation rates of the sdhA evolved alleles, ΔsdhA, ΔsdhB, 
and ΔsdhC – these mutations lead to complete inactivation of succinate dehydrogenase, 
less spurious ROS formation, and reduced mutation rates. However, ΔsdhD did not have a 
low mutation rate (Figure 3.4B). In the Sdh protein complex, SdhC anchors SdhAB and is 
tethered by membrane lipids. Therefore, if sdhC is deleted, there is no assembly of SdhAB 
and similarly, if sdhB is absent then SdhA cannot bind to SdhC. The presence of these 
subunits is interrelated, except with SdhD122. It functions to further stabilize the enzyme 
complex but is not required for activity. Deletion of sdhD likely results in an enzyme with 
partial activity, that remains a producer of ROS. Therefore, the sdhA evolved alleles are 
knockouts of the sdhA subunit, that causes inactivation of the whole enzyme, less 
intracellular ROS, and low mutation rates.     
Deletion of this ROS-producing enzyme induces modifications in flux through 
central carbon metabolism. Primarily, there is a metabolic shift towards the pentose 
phosphate (PP) pathway during oxidative stress in order to produce more NADPH and less 
NADH126,139,143. Increasing intracellular NADPH concentrations is a key defense against 
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ROS because it is an essential cofactor for many enzymes that attenuate ROS144. Unlike 
NADH, NADPH will not promote flux through the ETC or the Fenton reaction, which 
generates OH−139. Since there is less flux through the ETC, then general stress response, 
which is coordinated by rpoS, remains uninduced resulting in no mutagenic repair and 
further explains the low mutation rates of the evolved sdhA alleles (Figure 3.4B)145. In 
sum, the evolved sdhA alleles are deletions of succinate dehydrogenase, which cause less 
ROS generated by enzyme autoxidation and an upregulation of the PP pathway to produce 
more NADPH, further combating mutations produced by ROS.   
 
As demonstrated in this discussion of metabolic reprogramming, the sucD and sdhA 
antimutator alleles prime the cell’s intracellular environment to hamper oxidative stress 
formation. Less ROS production is achieved by accumulation of metabolic intermediates 
with antioxidant properties and redirection of central carbon metabolism to concurrently 
increase the intracellular NADPH:NADH ratio. Ultimately, less ROS translates to less 
DNA damage and explains the low mutation rates in our PResERV evolved antimutator 
strains146.  
 
Rational engineering of antimutators by targeting ROS pathways  
Based on this knowledge, we can begin to answer the following corollary – can we 
rationally engineer antimutators by reducing intracellular ROS? The NADPH:NADH ratio 
is central to ROS mitigation. This ratio can be artificially increased by upregulating flux 
through the main generator of NADPH, the PP pathway. Glucose-6-phosphate 
dehydrogenase (zwf) is the branch point where glycolysis diverts into the PP pathway, 
overexpression of this enzyme may yield more protective NADPH126. In addition, cells 
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contain many redox enzymes that are known to spuriously autoxidize and produce ROS, 
such as NADH dehydrogenase II (ndh) and xanthine oxidase (xdh)147-149. Similar to 
succinate dehydrogenase, inactivation of these enzymes could reduce ROS generation and 
concomitantly, mutation rates. Arguably, the most direct strategy may be reduction of ROS 
through upregulation of OxyR and SoxRS repair systems. For example, the OxyR pathway 
contains an antisense RNA, OxyS, that is synthesized in response to H2O2. Overexpression 
of OxyS is known to lower mutation rates in the presence of H2O2150. However, 
overproduction of enzymes that directly detoxify ROS, such as dismutases, may be 
detrimental and likely depend on the degree of overexpression151. It is important to note 
that some of these modifications may have negative secondary effects on growth and/or 
metabolism.   
 
Our work provides a platform for future engineering of genetic stability. This study 
is conceptually the simplest iteration of PResERV, because we employed a model organism 
harboring a synthetic device with minimal parts. PResERV is a universal method that can 
be expanded to other organisms and more elaborate synthetic devices. These sorts of 
experiments will provide a clear picture of genetic stability and how organisms deal with 
heterologous synthetic devices.   
 
MATERIALS AND METHODS 
Culture conditions 
E. coli was grown in 50 mL Erlenmeyer flasks with incubation at 37°C and 120 rpm orbital 
shaking over a diameter of 1 inch unless otherwise specified. Cells were grown as 10 mL 
cultures of Lysogeny Broth (LB) following the Miller recipe (10 g/L tryptone, 5 g/L yeast 
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extract, and 10 g/L NaCl). Media were supplemented with 50 µg/mL kanamycin (Kan), 20 
µg/mL chloramphenicol (Cam), 100 µg/mL rifampicin (Rif), 100 µg/mL carbenicillin 
(Crb), and 100 µM isopropyl β-d-1-thiogalactopyranoside (IPTG) as indicated. For long-
term storage, cultures were frozen at –80°C with glycerol as a cryoprotectant to a final 
concentration of 13.3% (v/v). 
 
Strains and plasmids  
The ancestor strain, BW25113, of the KEIO single gene knockout collection was 
transformed with the pSKO4 plasmid, which harbors a pBR322 origin of replication 
(ColE1)22,55. This plasmid has been previously edited to remove inactivating terminator 
sequences22,118. The reporter for plasmid mutation rates, pTEM-1.D254tag, encodes a non-
functional TEM-1 β-lactamase containing a TAG stop codon in the coding region of the 
gene63. It has a pBR322 origin of replication and encodes the rop protein for regulation of 
plasmid copy number. 
 
UV mutagenesis 
To create a UV library of BW25113 + pSKO4, cells were initially mutagenized under a 
range of conditions (0 to 30,000 µJ/cm2, every 2,500 µJ/cm2) to generate a kill curve. Three 
independent cultures of BW25113 + pSKO4 were grown overnight until saturation. 
Cultures were pelleted as 1 mL volumes and resuspended in an equal amount of saline. For 
each UV treatment condition, 100 µL cell droplets were pipetted onto an empty petri dish 
and placed inside a UV crosslinker (UVP CL-1000 Ultraviolet Crosslinker) for exposure. 
Additionally, a control with zero exposure was necessary to calculate the number of cells 
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in the starting population. Once irradiated, the droplets were serially diluted (3X by 1:100) 
and plated to yield countable colonies. The death curve was plotted as a function of the 
treatment condition (in µJ/cm2) by the number of colonies per treatment. As expected, high 
UV exposure levels yielded few to zero colonies per plate. We used these data to identify 
the optimal UV treatment to achieve a ~95-99% death rate. For generating a mutant library 
of BW25113 + pSKO4, we used an exposure of 27,500 µJ/cm2.  
UV libraries were created by growing five independent cultures of BW25113 + 
pSKO4. For each replicate, ten 100 µL cell droplets were aliquoted on an empty petri dish 
and irradiated at the appropriate treatment, as defined previously by the kill curve. The 
droplets were pooled individually per replicate, pelleted, and resuspended in 10 mL of 
media for recovery. We estimate that our library size is between 106 – 107 mutants. To 
ensure that the cells were properly mutagenized, we plated aliquots of the non-mutagenized 
(overnight cultures) and mutagenized cultures in order to verify that a ~95-99% death rate 
was achieved. Mutated cells were grown overnight and used as the starting populations for 
PResERV 
 
PResERV  
Five independently UV mutagenized populations of BW25113 + pSKO4 (LB-Crb) were 
used for PResERV. The fluorescence of each population (GFP excitation = 485, emission 
= 507) was measured daily. Depending on the percentage of fully fluorescing cells in a 
given population, cells were either directly transferred (1:1000 dilution) or sorted by FACS 
(BD FACSAria IIIu) prior to transferring into fresh media. We defined fully fluorescent 
cells (GFP+) by using the fluorescence intensity of wild-type BW25113 + pSKO4 cells. 
Therefore, the percentage of fully fluorescing cells was determined by gating the PResERV 
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populations against the wild-type BW25113 + pSKO4 positive control. If the fluorescence 
of this gate was ~10-15% of the total population, then the cells were sorted before 
transferring. If the fluorescence was below this threshold, then the cells were directly 
transferred without sorting.  
For FACS sorting, we used a non-toxic membrane dye, FM 4-64 (ThermoFisher, 
excitation = 515, emission = 640), in order to visualize cells against any media debris. Cell 
aliquots of 100 µL were stained with 5µg/mL of dye and incubated with shaking for 10 
minutes at 37°C. Once stained, cells were pelleted and washed with an equal volume of 
PBS. Cells were sorted by gating both for fluorescence of the membrane dye in addition to 
fluorescence of the GFP+ control, described above. In order to achieve proper recovery of 
this population, we sorted cells at a rate of 1,000 – 2,000 events/second and for a total count 
of 105 cells. Cells were immediately transferred into media post sorting. After a series of 
iterative cell sorts, the PResERV populations were plated to isolate single colonies for 
characterization and next-generation sequencing (NGS). 
 
Isolation of clones with increased GFP stability  
To identify candidate clones for further study, we performed a high-throughput screen to 
measure the stability of pSKO4 as compared to the BW25113 ancestor (LB-Crb). As a 
proxy for pSKO4 stability, we utilized the percent fluorescence of the pSKO4 GFP 
reporter. We picked 70 colonies from each of the five PResERV populations and inoculated 
them into 96-well plates (1 mL culture volume). Every 96-well plate included three 
replicates of the positive control, BW25113 + pSKO4, and three replicates of an empty 
plasmid negative control, BW25113 + pDED376. The plates were grown overnight at 250 
r.p.m. We assayed fluorescence of the culture plates by staining 100 µL of culture with FM 
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4-64, performing a 1:100 dilution in PBS, and measuring the fluorescence in a flow 
cytometer (BD LSRII Fortessa). For interrogating fluorescence, we utilized the same gate 
parameters as in PResERV and collected 10,000 events per sample. Once the fluorescence 
values were determined via flow cytometry, the plate cultures were diluted by 1:1000 and 
grown overnight. Fluorescence was monitored daily for nine days, prior to transferring the 
cultures into fresh media. We determined the stability of pSKO4 in the PResERV evolved 
clones by plotting the percent fluorescence by the number of generations (cell doublings). 
There were two criteria for selecting PResERV clones for further study. Firstly, the evolved 
clone must have the same starting fluorescence as the positive control and secondly, the 
evolved clone must maintain long-term fluorescence as compared to the positive control.  
 
Mutation rate measurements 
Chromosomal and plasmid mutation rates were determined via Luria-Delbrück fluctuation 
tests152. Strains were grown in LB overnight and diluted by 1:10,000 for one 24-hour cycle 
of preconditioning in LB media. For measuring plasmid rates, LB media was supplemented 
with chloramphenicol (LB-Cam) to select for the plasmid containing the reporter gene. 
Following the preconditioning step, cells for each strain were diluted to a concentration of 
1000 cells/200 µL. This concentration was utilized to start 20 independent cultures per 
strain, each with a volume of 200 µL. Cultures were grown for 24 hours before plating on 
non-selective and selective media. For each strain, six cultures were plated on non-selective 
media and 12 cultures on selective media to obtain counts for the population size and the 
number of mutants in each culture, respectively. When assaying chromosomal rates, the 
endogenous gene, rpoB, was used as the reporter. Independent cultures were plated on LB 
for the non-selective condition and LB-Rif for the selective condition. To determine 
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plasmid rates, we used pTEM-1.D254tag, described above63. Independent cultures were 
plated on LB-Cam for non-selective media and LB-Cam + Crb (500 µg/mL) for selective 
plates. Cultures plated on non-selective plates were diluted appropriately to yield countable 
colonies and incubated overnight. Cultures plated on selective media were not diluted and 
incubated for two days. Mutation rates and adjusted p-values (Bonferroni-corrected) were 
determined via the maximum likelihood method with SALVADOR 2.3 (R package). For 
each experiment, pair-wise comparisons were done against the wild-type control mutation 
rate153,154.   
 
Genome sequencing  
We performed NGS on three clones from each of the five, independent populations. For 
isolating genomic DNA, we used the PureLink Genomic DNA Mini Kit (Invitrogen). To 
fragment DNA, we performed a 20-minute digestion with dsDNA Fragmentase (NEB) to 
obtain fragments of ~250 bp in length. For preparing NGS libraries, we followed a protocol 
based on the Kappa LTP Preparation Kit manual KR0453 - v3.13 (Illumina). 2 x 150 
paired-end genome sequencing was performed using an Illumina HiSeq at the Genomic 
Sequencing and Analysis Facility, University of Texas at Austin. Data was analyzed using 
breseq (0.27.2a  revision ae9020001ca6)108.         
 
Absolute plasmid copy number 
Strains harboring pTEM-1.D254tag were grown overnight in LB-Cam. Cultures were 
diluted the following day by 1:100 and harvested in mid-exponential phase (OD600 = 0.5). 
We prepared DNA samples using a PureLink Genomic DNA Mini Kit (Invitrogen). For 
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calculating absolute copy number, we included genome and plasmid standard curves in all 
of our qPCR assays. The genomic standard curve template was generated by preparing 
genomic DNA from wild-type BW25113, lacking pTEM-1.D254tag. The plasmid standard 
curve template was created by isolating plasmid DNA from wild-type BW25113 + pTEM-
1.D254tag using a PureLink Quick Plasmid Miniprep kit (Invitrogen). All samples and 
standards were normalized to 2 µg/mL for qPCR analysis. Genome and plasmid standards 
were serially diluted by 10-fold in order to span a range of concentrations between 0.2 
ng/µL – 2.0 x 10-5 ng/µL. Samples were diluted by 1:100 for qPCR. We selected ftsZ as 
our target gene for the chromosome and cat for targeting the plasmid (~120 bp amplicon 
length). qPCR reactions were performed using SYBR Green PCR Master Mix 
(ThermoFisher) in a ViiA 7 Real-Time PCR System (ThermoFisher). The thermal cycling 
program was as follows: initial denaturation for 10 minutes at 95°C followed by 40 cycles 
of 95°C for 15 seconds and 54°C for 1 minute, and a final melt curve analysis with a 
temperature gradient of 0.05°C/second from 54°C to 95°C. The fluorescence signal was 
measured during the 54°C annealing/extension step. Following the qPCR assay, melt 
curves for each reaction were analyzed to ensure proper amplification of a single product. 
Plasmid:genomic DNA ratios were calculated from the average CT values of two technical 
replicates and using the standard curves as a reference.   
 
Growth rate measurements 
For LB growth curves, overnight cultures were diluted by 1:1000 into fresh media and 
preconditioned for 24 hours in 10 mL LB. After a 24-hour period of preconditioning, cells 
were diluted to 0.005 OD600 and transferred to a 96-well plate for OD measurements. OD600 
readings were recorded every 15 minutes using a Tecan Infinite M1000 PRO plate reader. 
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For minimal media growth curves, colonies were inoculated into 5 mL of LB, grown 
overnight, diluted by 1:1000, and preconditioned for 24 hours in 10 mL of M9 minimal 
media. Once preconditioned, growth measurements were conducted by diluting cells to an 
OD600 of 0.005 and taking time points every hour using a GeneSys 150 UV-Visible 
Spectrophotometer (ThermoFisher).    
 
Bacteriophage transduction 
P1 transductions were performed by first preparing the donor strain as a P1 lysate. A 5 mL 
culture of the donor strain was grown overnight and diluted by 1:100 into 5 mL LB 
supplemented with 0.2% glucose and 5 mM CaCl2. Cells were grown at 37°C for ~45 
minutes until the culture appeared slightly cloudy. At this point, 100 µL of pre-prepared 
phage stock was added to the culture. We grew the culture for ~3 hours until lysis was 
visible and 200 µL of chloroform was added to kill any remaining cells. The lysate was 
harvested and the supernatant was retained for transduction. To perform a transduction, we 
grew an overnight culture of the recipient strain, harvested 1.5 mL of cells, and resuspended 
in 0.75 mL volume with P1 Salts Solution (10 mM CaCl2, 5 mM MgSO4). 100 µL of 
recipient cells were mixed with 10 µL of donor lysate and incubated, with no shaking, at 
37°C for 30 minutes. Following the incubation, we recovered cells in LB supplemented 
with 200 µL of sodium citrate for 1 hour, shaking at 37°C. Cells were harvested and the 
entire mixture was plated on LB-Kan. This protocol is adapted from Thomason et al110.   
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Strain construction for reversion mutants 
Reversion mutants were made via P1 bacteriophage transduction. We constructed donor 
strains by genomically linking a kanR marker to an evolved allele. Markers were obtained 
from the i-Deconvoluter library which consists of a series of genomic FRT-Kan-FRT 
cassettes spaced every ~50 kb in intergenic regions. Given the ultra-dense nature of this 
library, we were able to insert markers within 50 kb of the mutated site109. These strains 
were used to transduce into the recipient evolved clones, containing the evolved alleles for 
reversion. Once transduced, recipient strains were sequenced to determine whether the 
evolved site was reverted back to wild-type. Strains containing the reverted allele were 
used for mutation rate measurements.             
 
Paraquat survival assay 
Overnight cultures in 5 mL LB were started from colonies and diluted by 1:1000 into fresh 
media. Cells were grown for 12 hours before treatment with 1.5 mM paraquat. Prior to 
treatment, cultures were diluted in saline and plated on LB to determine forming units 
(CFUs) before paraquat exposure. Paraquat-treated cultures were grown for another 12 
hours and then plated determine CFUs. The ratio of CFUs on treated:untreated plates was 
calculated per replicate and used to infer survival in paraquat.   
 
Intracellular ROS assay  
Overnight cultures in 5 mL of LB were diluted by 1:1000 into 50 mL of LB media and 
grown for 36 hours. ROS measurements were performed by harvesting 500 µL of cells for 
5 minutes (3,000 rpm) at 4°C. After this point, all samples were kept on ice. Pellets were 
washed twice with 500 µL of cold ROS phosphate buffer (137mM NaCl, 2.7mM KCl, 
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10mM Na2HPO4, 2mM KH2PO4, pH = 7.3). Cell pellets were resuspended in 1 mL of ROS 
buffer and 2 mM of the redox-active dye, 2',7'-Dichlorofluorescin diacetate (Sigma), was 
added. Samples were incubated in a 37°C heat block for 1 hour. After incubation, samples 
were subsequently washed with ROS buffer once and fluorescence was measured using 
flow cytometry (BD LSRII Fortessa, excitation = 490, emission = 519). Data were gated 
for positive values only, which resulted in a different number of events for each sample. 
For Figure 3.5B, we combined 2500 events at random for each of the four biological 
replicates and pooled them to plot as one fluorescence distribution. Statistical significance 
was determined by performing a Mann-Whitney U test with this dataset.       
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Figure 3.1. PResERV evolved strains have reduced mutation rates  
(A) Plasmid mutation rates to carbenicillin resistance (CrbR) were measured in the 
evolved PResERV strains via a reporter plasmid containing a nonsense mutation in ß-
lactamase (pTEM-1.D254tag). The inverted triangle ( ) next to the strain name 
designates evolved clones in which the plasmid copy is lower than wild-type (see Figure 
3.2A). (B) Chromosomal rates to rifampicin resistance (RifR) were reported as mutations 
in the chromosomal gene, rpoB. Each plot of mutation rate measurements contains a 
dashed horizontal line indicating the E. coli wild-type mutation rate for comparison. 
Asterisks (*) denote statistical significance as determined by adjusted p-values 
(Bonferroni correction). Pair-wise comparisons were done against the wild-type control 
mutation rate. Error bars are 95% confidence intervals estimated by the likelihood ratio 
methods from Luria-Delbrück fluctuation tests (see Methods).   
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Figure 3.2. Plasmid copy number and growth rates of PResERV strains  
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Figure 3.2 continued (A) Plasmid copy number of the evolved strains harboring the 
mutation rate reporter plasmid (pTEM-1.D254tag) determined by qPCR. The horizontal 
dashed line indicates the estimated copy number in the wild-type strain. Error bars show 
the standard error of the mean on log-transformed values from three biological replicates. 
(B) Growth curves of wild-type (solid, red) and the evolved clones (dashed, blue) in LB 
media (top panel) and minimal media (bottom panel). Data for LB curves are averages 
from two technical replicates. Data for minimal media curves are from a single replicate.    
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Figure 3.3. Mapping of causative PResERV mutations  
Plasmid mutation rates of wild-type (red and dashed horizontal line), evolved clones 
(blue), and the respective evolved clone containing a single allele reversion back to wild-
type (black). The gene encoding the reverted allele is indicated for each revertant. For 
causative mutations, the allele information is given. Wild-type measurements are the 
same data point in (A) and (B) and in (C), (D), and (E). In (C) and (E), a causative 
mutation could not be identified. The inverted triangle ( ) next to the strain name 
designates evolved clones in which the plasmid copy is lower than wild-type (see Figure 
3.2A). Asterisks (*) denote statistical significance as determined by adjusted p-values 
(Bonferroni correction). Pair-wise comparisons were done against the wild-type control 
mutation rate. Error bars are 95% confidence intervals estimated by the likelihood ratio 
methods from Luria-Delbrück fluctuation tests (see Methods). 
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Figure 3.4. sdhA and sucD antimutator alleles 
(A) Operon structure of sdhCDAB and sucCD. All PResERV mutations, causative (filled 
red circles) and non-causative (empty red circles), identified in this gene cluster are 
shown. Functional information is provided for both gene clusters. For the sdh genes, the 
role or cofactors present in each subunit is indicated. For the suc genes, the catalytic 
His247 residue is represented by a star. (B) Plasmid mutation rates of wild type (red and 
dashed horizontal line), the sucD and sdhA causative alleles reconstructed in a wild-type 
background (pink), and the respective deletion mutants of the associated protein complex 
(white). The specific evolved allele and deletion mutant is indicated. Asterisks (*) denote 
statistical significance as determined by adjusted p-values (Bonferroni correction). Pair-
wise comparisons were done against the wild-type control mutation rate. Error bars are 
95% confidence intervals estimated by the likelihood ratio methods from Luria-Delbrück 
fluctuation tests (see Methods). 
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Figure 3.5. Antimutator sdhA and sucD alleles function to relieve oxidative stress  
(A) Survival in the presence of a redox-cycling drug, paraquat, of wild type (red and 
dashed horizontal line), Δzwf (green), and the evolved sucD/sdhA alleles in wild-type 
background (pink). CFU counts were determined before and after paraquat treatment. 
Each circle represents the fraction of surviving cells from a single biological replicate. 
Bars show the average of the three replicates. (B) Intracellular ROS measurements of 
wild type (red and top dashed horizontal line indicates median), Δzwf (green), and the 
sucD/sdhA alleles in wild-type background (pink). Cells were exposed to a redox active 
fluorescent dye; high fluorescence values signify elevated levels of intracellular ROS. 
Data are combined fluorescence values of four biological replicates for each sample and 
were gated for positive values only, designated by the bottom dashed horizontal line (see 
Methods). Asterisks (*) denote statistical significance as compared to wild type (Mann-
Whitney U test). Diamonds within each violin plot represent median values.  
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Figure 3.6. Antimutator alleles reduce mutation rates when ported and combined  
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Figure 3.6 continued (A) Antimutator sucD and sdhA alleles were introduced into a 
commonly utilized E. coli protein expression strain, BL21, by transduction. Plasmid 
mutation rates of wild-type BL21 (red and dashed horizontal line) and BL21 allele 
exchange mutants containing the reconstructed sucD and sdhA antimutator alleles (pink). 
(B) The sucD and sdhA alleles were combined with a previously identified antimutator 
allele, rne, to build double mutant strains (TACO)12. Plasmid mutation rates for wild-type 
(red and dashed horizontal line), the single antimutator mutants (pink), and the double 
TACO mutants (yellow) were determined. Asterisks (*) denote statistical significance as 
determined by adjusted p-values (Bonferroni correction). Pair-wise comparisons were 
done against the wild-type control mutation rate. Error bars are 95% confidence intervals 
estimated by the likelihood ratio methods from Luria-Delbrück fluctuation tests (see 
Methods).   
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Table 3.1. Candidate antimutator alleles identified via PResERV  
 
Alleles are grouped by Clusters of Orthologous Groups (COG) function. The legend 
describes the type of mutation based on a given symbol. Colored symbols illustrate 
identical mutations found in different strains whereas unique mutations are represented as 
black symbols.  
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Chapter 4:  PResERV antimutators evolved from a clean-genome 
strain, MDS42 
INTRODUCTION 
Microbial genomes carry a multitude of mobile genetic elements that are highly disruptive 
to genetic stability. Movement of these elements creates problems for engineering efforts 
because they inactivate carefully crafted synthetic devices. For this reason, clean-genome 
host organism variants have been constructed that are unencumbered by mobile genetic 
elements48,50,117. The E. coli version, MDS42, has been deleted of insertion elements (IS) 
and other seemingly superfluous regions, such as prophage genes, resulting in a ~ 15% 
reduction in genome size. MDS42 has several interesting properties as compared to its 
progenitor – similar growth rate, reduced chromosomal mutation rate (1.5-fold), increased 
transformation efficiency and protein production, and resistance to IS-mediated 
inactivation of synthetic devices48,107. Given these improved properties, we wondered to 
what extent PResERV would be able to further decrease mutation rates in the MDS42 
strain. Therefore, we repeated PResERV on this clean-genome strain in the same way as 
described in Chapter 2 and Chapter 3 using the burdensome pSKO4 plasmid. Using the 
improved MDS42 host, in which an entire category of inactivating mutations have been 
eliminated by rational genome engineering, as a starting point for PResERV let us further 
probe the limits to reducing mutation rates by directed evolution and compare the 
antimutator alleles found in this host strain to those we found in the wild-type E. coli host 
(BW25113). 
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RESULTS 
Rapid inactivation of a costly plasmid in E. coli 
Synthetic devices can become non-functional when propagated inside of mutating, living 
cells. This process depends on the metabolic burden of the synthetic device: the higher the 
cost of the device, the shorter its lifetime in a lineage of replicating cells. One of the initial 
steps in PResERV is to characterize how this process happens with the host cell and 
synthetic device combination of interest. Measuring decay of a particular device is essential 
in order to know how often transfers should be performed and more importantly, when the 
population is maintaining device function for longer than the ancestor, at which point 
putative antimutator clones should be isolated and sequenced.  
 We measured the decay of the synthetic device used in this PResERV experiment, 
pSKO4, in the clean-genome strain MDS42 (Figure 4.1A). GFP fluorescence from this 
plasmid was relatively unstable in MDS42. Fluorescence was completely lost in all cells 
in the population within ~55 generations. For reference, inactivation of pSKO4 in 
BW25113 occurred after ~75 generations (Figure 4.1B). It was surprising that pSKO4 was 
more stable in BW25113 since MDS42 is purportedly an improved host strain. It has been 
shown to maintain the integrity of other costly plasmids for longer than its wild-type 
progenitor strain48,107. One possible explanation for our observation with pSKO4, is that 
MDS42 is designed to guard against IS element-mediated mutations and pSKO4 
inactivation may predominantly occur through other mutational mechanisms, such as point 
mutations. Other synthetic devices that are not often inactivated to mobile element 
insertions, such as pSKO4, may not have increased stability in MDS4222. Performing 
PResERV directed evolution with MDS42 provides a way to further improve this strain 
and prevent device inactivation by other mutational mechanisms.   
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PResERV evolution of MDS42 
PResERV was applied to four independent populations of MDS42 + pSKO4, designated 
MDS pop 1 through 4 (Figure 4.2). We set several guidelines for the PResERV evolution 
experiment. The initial time point shows fluorescence of the population after recovery from 
UV mutagenesis. Following the first transfer event, the fluorescence of the population 
drastically decreases in all populations. Possibly, pSKO4 is inactivated in many cells in the 
UV mutagenized population and these mutants subsequently outcompete those still 
expressing the plasmid. To enrich for the GFP+ population, we iteratively sorted for 
fluorescent cells during each of the subsequent 3-4 transfer events so that they became a 
majority of the population. Thereafter, regular serial transfers were performed for several 
days until fluorescence again dropped such that < 10-15% of the population was GFP+, at 
which point a single round of sorting was added to re-enrich for the GFP+ cells. 
In some cases, after a sort and recovery growth period, the population does not 
reach 100% fluorescence. In part, this may be due quick inactivation of pSKO4 by some 
mutants prior to them outcompeting the GFP+ population. It is also a function of how the 
data is plotted (see Methods for details). Fluorescence of a population measured at the 
single-cell level is a distribution. To summarize these data, we gated each population based 
on the fluorescence of the positive control, an overnight culture of the ancestral strain-
plasmid combination: MDS42 + pSKO4. If the peak of an evolved population is slightly 
shifted down in fluorescence, only a certain percentage of the population will be counted 
in the positive control gate. However, this does not mean that the rest of the population is 
non-fluorescent, as might be assumed from looking at the GFP decay plots. There still exist 
GFP-expressing cells in these populations. They are just not as highly fluorescing as the 
positive control. Our criteria for stopping the PResERV evolution experiment was 
determined by whether the population could maintain fluorescence throughout multiple 
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transfer events. This improvement versus the ancestral MDS42 + pSKO4 combination was 
eventually observed for all PResERV populations (Figure 4.2).  
 
Genetic stability of MDS42 PResERV evolved clones  
As an initial step in characterizing the evolved populations, we isolated individual clones 
and measured the rate of inactivation of pSKO4. We assayed eleven clones per population 
(Figure 4.3). For each population, we selected clones that maintained fluorescence for 
longer than the MDS42 ancestor for further characterization. Fluorescence distributions of 
the positive control, MDS42 + pSKO4, and the negative control, MDS42 + an empty 
plasmid, are shown in Figure 4.4. MDS42 inactivation of pSKO4 is bimodal, however, 
there is not a complete inactivation of plasmid function, as measured by GFP fluorescence. 
If the GFP was completely rendered non-functional, its fluorescence distribution would be 
similar to the empty plasmid control. The data indicate that pSKO4 is reliably mutated to 
be entirely non-fluorescent in wild-type MDS42 well before 95 generations and therefore 
we used this as our benchmark for selecting candidate antimutator clones. We selected 
clones that displayed higher fluorescence distributions at this time point and similar 
fluorescence values as the positive control at 45 generations (Day 1) (Figure 4.5). These 
evolved clones were further characterized via mutation rate measurements and whole 
genome sequencing.   
 
Mutation rates of evolved clones  
Given that the long-term maintenance of GFP+ could be a product of reduced mutation 
rates, we assayed plasmid and chromosomal mutation rates of the 15 MDS42 evolved 
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clones (Figure 4.6)118. Thirteen of these evolved clones had modest reductions in plasmid 
mutation rates ranging from 1.5 to 4.5-fold, and reductions of chromosomal rates ranging 
from 1.5 to 12-fold. In general, the MDS42 antimutators had greater reductions in the 
chromosomal mutation rate versus the plasmid. Conversely, the antimutators described in 
Chapter 2 and Chapter 3 had considerable reductions in the plasmid mutation rate and 
mild reductions in chromosomal rates. The wild-type plasmid mutation rate of MDS42 was 
~10-fold lower than BW25113 and the chromosomal rate was ~2-fold lower.   
A set of isolates from MDS population 2 exhibited higher plasmid and 
chromosomal mutation rates. Despite the high mutation rate, these strains could maintain 
long-term fluorescence of pSKO4. Therefore, they have possibly evolved an alternative 
method to alleviate the plasmid cost, unrelated to mutation rates. These strains were not 
studied further given that the goal was to find mutations that increase genetic stability for 
better maintenance of synthetic devices.  
 
Whole genome sequence analysis of MDS42 evolved clones 
To understand the genetic basis of these traits, we sequenced the genomes of the 15 MDS42 
evolved strains. Table 4.1 contains a complete list of all mutations. In the population that 
evolved hypermutation, MDS population 2, all of the sequenced clones contained a 
nonsynonymous mutation in mutT, a housekeeping enzyme encoding an 8-oxo-dGTP 
diphosphatase that functions to prevent incorporation of oxidatively damaged nucleotides 
into DNA/RNA87. Mutations that inactivate or reduce mutT expression are known to confer 
a hypermutator phenotype155,156. PResERV evolved clones carrying the mutT allele 
contained more mutations than other MDS42 PResERV clones, which makes it difficult to 
assign the causative mutation. Additionally, too severe bottlenecking of the population may 
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have aided the mutT hypermutator to fix in the population, especially if increased mutation 
rates helped it evolve to better grow in the medium. Due to this phenotype, mutations in 
this population were discarded as possible candidates for causative antimutator alleles.  
The most attractive antimutator candidates were found in MDS populations 1 and 
4. MDS population 4 strains (DL712, DL714, DL698, DL701, DL703, and DL707) carry 
a nonsense mutation in mdh, which encodes for a TCA cycle enzyme, malate 
dehydrogenase. Our previous knowledge on PResERV antimutator strains and reduction 
in oxidative stress via TCA cycle enzymes aided in identifying this mutation as a candidate 
(Chapter 3). Malate dehydrogenase catalyzes the oxidation of malate to oxaloacetate and 
concomitantly generates NADH157. NADH supplies the electron transport chain, and 
therefore a nonsense mutation may result in complete inactivation of the enzyme and 
reduced oxidative stress. In addition, Mdh is known to facilitate induction of stress induced 
mutagenesis via rpoS, deletion of this enzyme suppresses this pathway and leads to reduced 
mutation rates145. These mechanisms are similar to those discussed for the sucD and sdhA 
antimutator alleles in Chapter 3. It is likely that cells have adapted many ways to reduced 
oxidative stress, and therefore mdh may be an interesting candidate mutation to further 
support the involvement of this pathway in genetic stability.  
The remaining candidate mutations serve roles in a seemingly more direct 
connection to genetic stability, DNA/RNA metabolism. Strains from MDS populations 1 
and 4 contain nonsynonymous mutations in subunits of the main replicative polymerase in 
E. coli (DNA polymerase III), dnaX (DL660, DL662, and DL666) and dnaE (DL698, 
DL703, DL707), respectively. Notably, Chapter 2 describes causative antimutator alleles 
found in other polymerases, polA and polB. There are many examples of known 
antimutator DNA polymerases, therefore it is not surprising if the MDS42 PResERV dnaX 
and dnaE mutations lead to an antimutator Pol III36. Antimutors of dnaE have been 
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previously reported (Chapter 1)35. PResERV evolved clones DL660 (containing the 
evolved dnaX allele) and DL698 (containing the evolved dnaE allele) have lower 
chromosomal mutation rates. However, other clones containing these mutations did not 
(DL666, DL703, and DL707). These clones may contain other mutations that suppress the 
antimutator effects of dnaE and dnaX. Additionally, there is one PResERV clone that 
remains to be assayed (DL662). Regarding RNA metabolism, strains from MDS 
population 4 harbor mutations in rplE and deaD (DL712, DL714, DL698, DL701, DL703, 
and DL707). RplE is a 50S ribosomal subunit protein that forms the only protein-protein 
connection between both ribosomal subunits158. DeaD encodes an RNA helicase that, 
similar to the rne causative gene discussed in Chapter 2, is involved in a myriad of RNA 
processing activities. In sum, there are interesting candidate mutations found in the MDS42 
PResERV antimutators and many of these potentially overlap with antimutator 
mechanisms illustrated in Chapter 2 and Chapter 3. 
 
FUTURE DIRECTIONS 
A key immediate step in this work is to validate the putative causative antimutator 
mutations by either reverting interesting alleles (such as the ones discussed above) or 
porting alleles into a wild type background and measuring the effect on 
plasmid/chromosomal mutation rates. Once identified, specific assays can be performed to 
discern the mechanism of action. These mutations, along with those identified in Chapter 
2 and Chapter 3, can be combined to form different/better versions of TACO and 
introduced into other organisms to determine whether they still function to reduce mutation 
rates. Furthermore, there is an even more improved version of MDS42, known as MDS42 
LowMut, in which several SOS-induced DNA polymerases have been deleted (Pol II, 
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PolIV, and PolV) leading to a ~3-fold reduction in chromosomal mutation rates39. It would 
be interesting to use this strain for PResERV and/or introduce antimutator alleles from 
Chapter 2 and Chapter 3 into MDS42 LowMut to create a TACO strain with marked 
reductions in both plasmid and chromosomal mutation rates.       
 
MATERIALS AND METHODS 
Culture conditions 
E. coli was grown as 10 mL cultures in 50 mL Erlenmeyer flasks with shaking incubation 
at 37°C and 120 r.p.m. unless otherwise specified. Lysogeny Broth (LB, Miller) was used 
(10 g/L tryptone, 5 g/L yeast extract, and 10 g/L NaCl). Media were supplemented with 
100 µg/mL carbenicillin (Crb), 20 µg/mL chloramphenicol (Cam), 100 µg/mL rifampicin 
(Rif), and 1 mM isopropyl β-d-1-thiogalactopyranoside (IPTG), as indicated. Bacterial 
cultures were frozen at –80°C with glycerol (13.3% v/v final concentration) as a 
cryoprotectant for long-term storage.  
 
Strains and plasmids 
MDS42, a derivative of E. coli K-12 strain MG1655, was transformed with pSKO4. This 
plasmid contains a pBR322 origin of replication (ColE1) and has been previously 
reengineered to remove unstable sequences22. The mutation rate reporter plasmid, pTEM-
1.D254tag, harbors a β-lactamase gene with a nonsense (TAG) stop codon in the coding 
region, rendering the gene nonfunctional. This plasmid contains a pBR322 origin of 
replication along with the regulatory rop protein63.  
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UV mutagenesis  
To create a library of mutants for PResERV, MDS42 cells containing pSKO4 were UV 
mutagenized. Initially, a pilot experiment was performed under a range of conditions (0 to 
30,000 µJ/cm2, every 2,500 µJ/cm2) in order to generate a kill curve and identify the point 
in which a 95-99% death rate is achieved. Three independent cultures of MDS42 + pSKO4 
were grown overnight, cultures were harvested, and the pellets were resuspended in an 
equal volume of saline. For each UV treatment, 100 µL cell droplets were aliquoted onto 
an empty petri dish and exposed inside a UV crosslinker (CL-1000 Ultraviolet Crosslinker, 
UVP). A zero-exposure control was used to calculate the initial cell number. Cells were 
plated (LB-Crb) to determine colony counts and the kill curve was plotted against the 
treatment condition (in µJ/cm2). These data were used to identify the optimal UV treatment. 
For creating a mutant library of MDS42 + pSKO4, we used an exposure of 15,000 µJ/cm2.  
UV libraries were created by growing four separate cultures of MDS42 + pSKO4 
from independent colonies. Cultures were grown overnight, 1 mL of each culture was 
pelleted and resuspended in an equal volume of saline. Per replicate, ten 100 µL cell 
droplets were pipetted onto an empty petri dish, irradiated at 15,000 µJ/cm2, and pooled in 
10 mL of LB-Crb medium. These libraries were used as the starting populations for 
PResERV. To verify the ~95-99% death rate, we plated non-mutagenized and mutagenized 
cells. We estimate that each library contained between 106 – 107 mutagenized cells.  
 
PResERV directed evolution 
Four independently UV mutagenized populations of MDS42 + pSKO4 were used as the 
starting populations for PResERV. Once mutagenized, the library was recovered in fresh 
media (LB-Crb-IPTG) overnight before beginning transfers. GFP fluorescence (485 nm 
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excitation, 507 nm emission) was monitored daily via flow cytometry (BD LSRII 
Fortessa). The fluorescence of an evolved population was compared to the positive control, 
an overnight culture of non-mutagenized MDS42 + pSKO4. The entire fluorescence 
distribution of this control was used to gate the evolved populations. For a given 
population, if the fraction of fully fluorescent cells in this gate was below ~10-15%, then 
the population was sorted by FACS (BD, FACSAria IIIu) and the GFP+ cells in this sort 
gate were transferred into fresh media for regrowth. If the fraction of fluorescent cells in 
this gate was above the ~10-15% cutoff, cells were transferred without sorting.   
To visualize cells against media debris during FACS sorting and flow cytometry, 
we used a non-toxic membrane dye FM 4-64 (ThermoFisher 515 nm excitation, 640 nm 
emission).  To dye cells, 5µg/mL of FM 4-64 dye was added to 100 µL of cells and 
incubated with shaking for 10 minutes at 37°C. Cells were subsequently pelleted and 
washed with an equal volume of PBS. Cells were sorted by gating for GFP+ fluorescence, 
as described earlier, and for fluorescence of the membrane dye. Cells were sorted at a rate 
of 1,000 – 2,000 events/second for a total of 105 cells. After sorting, cells were recovered 
in fresh LB-Crb-IPTG media. Once it was determined that the population was maintaining 
a population of GFP+ cells for longer than the MDS42 ancestor, cells were plated to isolate 
single clones for further characterization and sequencing. All flow data (from cytometry 
and FACS) was analyzed in FlowJo (v10.5.0).    
 
GFP decay curves  
Stability of pSKO4 in MDS42 and the evolved PResERV clones was quantified using a 
GFP decay assay. For each strain, colonies were used to inoculate 10 mL of LB-Crb-IPTG 
and grown overnight until saturation. Each population was transferred daily under the same 
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conditions as the PResERV experiment and GFP+ fluorescence was measured prior to each 
transfer. Cells were stained with FM 4-64 as described above and fluorescence was 
measured by flow cytometry. For visualizing fluorescence data of the percentage of GFP+ 
cells in a population over time (as in Figures 4.1 – 4.3), cells were classified as GFP+ if 
they were similar to the MDS42 wild-type distribution, as explained above and this 
percentage of the population is plotted on the Y-axis. Additionally, the GFP+ cells also had 
to have wild-type levels of fluorescence when stained with the membrane dye FM 4-64. 
Therefore, our criteria gates for cells that are highly fluorescent and against any debris. 
GFP decay curve experiments were used to screen clones after PResERV for follow-up 
studies and NGS sequencing.        
 
Genome sequencing 
We performed next-generation sequencing (NGS) on individually isolated clones from 
each of the four, evolved populations. DNA was isolated using a PureLink Genomic DNA 
Mini Kit (Invitrogen). DNA was fragmented by performing a 20-minute digestion with 
dsDNA Fragmentase (NEB) to generate ~250-bp fragments. NGS libraries were prepared 
following a protocol based on the Kappa LTP Preparation Kit manual KR0453 - v3.13 
(Illumina). An Illumina HiSeq was used to sequence 2 x 150 paired-end reads per sample 
at the Genomic Sequencing and Analysis Facility, University of Texas at Austin. Data was 
analyzed using breseq (0.27.2a revision ae9020001ca6)108. The MDS42 reference genome 
was obtained from NCBI (NC_020518.1). 
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Mutation rate measurements  
Chromosomal and plasmid mutation rates were measured using Luria-Delbrück fluctuation 
tests152. Strains were preconditioned in 5 mL media overnight and then diluted by 1:10,000 
into fresh media and allowed to grow to saturation over an additional 24-hour growth cycle. 
For measuring plasmid rates, LB media was supplemented with chloramphenicol (LB-
Cam) to select for retention of the mutation rate reporter plasmid, pTEM-1.D254tag. After 
preconditioning in LB, cells were diluted to a concentration of 1000 cells/200 µL and used 
to start 20 independent cultures. Following 24 hours of growth, six cultures were plated on 
non-selective agar and 12 cultures were plated on selective agar. For chromosomal rate 
assays, the non-selective medium was LB and the selective medium was LB-Rif. For 
plasmid rates, the non-selective media condition was LB-Cam and the selective media 
condition was LB-Cam-Crb (500 µg/mL). Cultures that were plated on non-selective plates 
were diluted in order to yield countable colonies and the agar plates incubated overnight 
before counting colonies. Cultures that were plated on selective media were not diluted 
before plating and the agar plates were incubated for two days before counting colonies. 
Mutation rates were estimated from these colony counts via the maximum likelihood 
method with rSalvador 2.3115.  
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Figure 4.1. Inactivation of pSKO4 in E. coli 
 
GFP decay measurements of (A) five independent MDS42 cultures and (B) three 
independent cultures of BW25113 (orange). For reference, an empty plasmid control is 
shown in B (black). Data are plotted as described in Methods.    
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Figure 4.2. FACS sorting for MDS42 PResERV evolved populations  
 
GFP fluorescence during PResERV evolution of (A) MDS42 population 1, (B) MDS42 
population 2, (C) MDS42 population 3, and (D) MDS42 population 4. Sort events are 
denoted by an asterisk (*). Transfers are indicated by a line connecting each fluorescence 
measurement. Final plating of the population to isolate clones is designated by blue 
asterisk (*). Data are plotted as described in Methods.  
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Figure 4.3. GFP Stability of PResERV evolved isolates  
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Figure 4.3 continued Individual clones were isolated following PResERV evolution. 
Decay of pSKO4 is shown for (A) MDS42 population 2, (B) MDS42 population 3, and 
(C) MDS42 population 4. The solid orange line represents the positive control, MDS42 
containing pSKO4, the solid black line represents the negative control, MDS42 
containing an empty plasmid, and the dotted lines represent an evolved PResERV clone. 
Data are plotted as a function of days (transfers) as described in Methods. 
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Figure 4.4. Fluorescence distributions of MDS42 controls during a GFP decay 
experiment  
 
Two biological replicates of the (A) positive control, MDS42 + pSKO4, and the (B) 
negative control, MDS42 + an empty plasmid. Fluorescence was measured prior to 
transfer of cells into fresh media. Distributions for 45 generations (red), 95 generations 
(blue), and 125 generations (orange) are shown.    
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Figure 4.5. Fluorescence distributions of candidate antimutator strains  
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Figure 4.5 continued One biological replicate for each selected clone is pictured. 
Candidate clones from (A) MDS42 population 1, (B) MDS42 population 2, (C) MDS42 
population 3, and (D) MDS42 population 4 are shown. Fluorescence was measured prior 
to transfer of cells into fresh media. Distributions for 45 generations (red), 95 generations 
(blue), and 125 generations (orange) are shown.    
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Figure 4.6. Mutation rates of MDS42 PResERV evolved clones  
 
(A) Plasmid and (B) chromosomal mutation rates are shown for the MDS42 evolved 
clones. Each plot contains a dashed horizontal line indicating the MDS42 wild type 
(orange) mutation rate for comparison. The evolved clones (blue) are grouped by 
population. Error bars are 95% confidence intervals estimated by the likelihood ratio 
methods from Luria-Delbrück fluctuation tests (see Methods).   
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Table 4.1. Mutations in MDS42 PResERV strains  
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D
L698 
D
L701 
D
L703 
D
L707 
S321F (TC
T→
TTT) 
 
thrA →
 
 
aspartokinase/hom
oserine 
dehydrogenase 
 
 
 
D
L687 
D
L692 
D
L693 
D
L695 
 
 
 
 
 
 
 
 
G
37S (G
G
C
→
AG
C
) 
 
m
utT →
 
 
8-oxo-dG
TP diphosphatase 
 
 
 
 
 
 
 
 
 
 
 
D
L698 
 
D
L703 
D
L707 
D
444E (G
AC
→
G
A
A) 
 
dnaE →
 
 
D
N
A polym
erase III alpha 
subunit 
D
L660 
D
L662 
D
L666 
 
 
 
 
 
 
 
 
 
 
 
 
T142N
 (AC
C
→
AAC
) 
 
dnaX →
 
 
D
N
A polym
erase III, tau and 
gam
m
a subunits 
 
 
 
 
D
L692 
 
 
 
 
 
 
 
 
 
 
intergenic (+30/−1250) 
fdrA →
 / →
 ylbF 
predicted acyl-C
oA 
synthetase 
N
AD
(P)-binding/conserved 
protein 
 
 
 
D
L687 
D
L692 
D
L693 
D
L695 
 
 
 
 
 
 
 
 
I115L (ATT→
C
TT) 
 
ahpF →
 
 
Alkyl hydroperoxide 
reductase, FAD
/N
AD
(P)-
binding 
 
 
 
 
 
 
D
L695 
D
L709 
 
 
 
 
 
 
 
intergenic (−280/−99) 
 
citC
 ←
 / →
 citA
 
 
C
itrate lyase 
synthetase/sensory histidine 
kinase w
ith C
itB
 
 
 
 
 
 
D
L693 
 
 
 
 
 
 
 
 
 
T21P (AC
C
→
C
C
C
) 
 
ybfN
 →
 
 
Predicted lipoprotein 
 
 
 
 
 
 
D
L695 
 
 
 
 
 
 
 
 
intergenic (−136/−180) 
 
ybgS ←
 / →
 aroG
 
 
C
onserved protein/aldolase 
 
 
 
 
 
D
L693 
 
 
 
 
 
 
 
 
 
E337D
 (G
A
A→
G
AC
) 
 
poxB ←
 
 
Pyruvate dehydrogenase, 
thiam
in-depedent, FAD
-
binding 
 
D
L662 
 
 
 
 
D
L695 
 
 
 
 
 
 
 
 
G
267A (G
G
T→
G
C
T) 
 
focA ←
 
 
Form
ate transporter 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
intergenic (+1729/−942) 
 
m
doG
 →
 / →
 yceK
 
 
G
lucan biosynthesis 
protein/predicted lipoprotein 
 
 
 
 
D
L692 
 
 
 
 
 
 
 
 
 
 
K77N
 (A
AA→
AAC
) 
 
lpxL ←
 
 
AC
P-dependent 
acyltransferase 
 
 
 
D
L687 
D
L692 
D
L693 
D
L695 
 
 
 
 
 
 
 
 
K4Q
 (AAG
→
C
AG
) 
 
fabH
 →
 
 
AC
P synthase III 
 
 
 
 
 
 
D
L695 
 
 
 
 
 
 
 
 
intergenic (−177/−73) 
 
potA ←
 / →
 pepT 
 
Polyam
ine transporter 
subunit/peptidase T 
 
M
D
S pop 3
M
D
S pop 4
M
D
S pop 2
M
D
S pop 1
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Table 4.1 continued  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
annotation 
gene 
description 
D
L660 
 
D
L666 
 
 
 
 
 
 
 
 
 
 
 
 
Q
223H
 (C
AG
→
C
AT) 
 
nhaB ←
 
Sodium
:proton antiporter 
 
 
 
D
L687 
 
 
 
 
 
 
 
 
 
 
 
V156G
 (G
TA→
G
G
A) 
 
treA ←
 
Periplasm
ic trehalase 
 
 
 
 
 
D
L693 
 
 
 
 
 
 
 
 
 
D
319E (G
AT→
G
AG
) 
 
prfA →
 
Peptide chain release factor R
F-1 
 
D
L662 
 
 
 
 
 
 
 
 
 
 
 
 
 
M
93I (ATG
→
ATT) 
 
chaA ←
 
C
alcium
/sodium
:proton antiporter 
 
 
 
D
L687 
 
 
 
 
 
 
 
 
 
 
 
P291P (C
C
A→
C
C
C
) 
cis ←
 
C
ardiolipin synthase 
 
 
 
D
L687 
 
 
 
 
 
 
 
 
 
 
 
intergenic (−108/+595) 
yddV ←
 / ←
 yddW
 
 
predicted diguanylate cyclase/predicted  
lipoprotein 
 
 
 
 
 
 
 
 
D
L709 
 
D
L714 
 
 
 
 
intergenic (−178/+184) 
gadB ←
 / ←
 pqqL 
 
G
lutam
ate decarboxylase/predicted 
peptidase 
 
 
 
 
 
 
 
 
 
D
L712 
 
 
 
 
 
Δ1,174 bp 
ynfA–[speG
] 
ynfA, ynfB, [speG
] 
 
 
 
 
 
 
 
 
 
D
L712 
D
L714 
D
L698 
D
L701 
D
L703 
D
L707 
P29P (C
C
A→
C
C
G
) 
ribC
 ←
 
R
hinoflavin synthase, alpha subunit 
 
 
 
D
L687 
D
L692 
D
L693 
D
L695 
D
L695 
 
 
 
 
 
 
 
L286* (TTA→
TG
A)  
 
torY ←
 
TM
AO
 reductase III, cytochrom
e c-type 
subunit 
 
 
 
D
L687 
 
 
 
 
 
 
 
 
 
 
 
L131R
 (C
TG
→
C
G
G
) 
 
shiA →
 
Shikim
ate transporter 
 
 
 
 
 
 
D
L695 
 
 
 
 
 
 
 
 
A114A (G
C
T→
G
C
G
) 
yeeY ←
 
Predicted D
N
A-binding transcriptional 
regulator 
 
 
 
 
 
D
L693 
 
 
 
 
 
 
 
 
 
F35C
 (TTT→
TG
T) 
 
yegU
 →
 
Predicted hydrolase 
 
 
 
D
L687 
D
L692 
D
L693 
D
L695 
 
 
 
 
 
 
 
 
Y115D
 (TAC
→
G
AC
) 
 
nrdA →
 
ribonucleoside diphosphate reductase 
1, alpha subunit 
 
 
 
 
 
 
 
 
D
L709 
D
L717 
 
 
 
 
 
 
C
oding (321/1218 nt) 
yfbQ
 →
 
 
Predicted am
inotransferase 
 
M
D
S pop 3
M
D
S pop 4
M
D
S pop 2
M
D
S pop 1
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Table 4.1 continued  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
annotation 
gene 
description 
 
 
 
 
 
D
L693 
 
 
 
 
 
 
 
 
 
A76A (G
C
A
→
G
C
C
) 
ypfE ←
 
predicted carboxysom
e structural 
protein w
ith predicted role in ethanol 
utilization 
D
L660 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Intergenic (−46/+126) 
 
gltW
 ←
 / ←
 rrsG
 
 
tR
N
A-G
lu/16S ribosom
al R
N
A
 
D
L660 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
noncoding 
(273/1542 nt) 
rrsG
 ←
 
16S ribosom
al R
N
A
 
 
 
 
 
D
L692 
 
 
 
 
 
 
 
 
 
 
V489V (G
TT→
G
TG
)  
 
recN
 →
 
R
ecom
bination and repair protein 
D
L660 
D
L662 
D
L666 
 
 
 
 
 
 
 
 
 
 
 
 
V268V (G
TT→
G
TC
) 
 
proW
 →
 
G
lycine betaine transporter subunit 
 
 
 
 
D
L692 
 
 
 
 
 
 
 
 
 
 
*374C
 (TG
A→
TG
C
) 
hypD
 →
 
Protein required for m
aturation of 
hydrogenases 
 
 
 
 
 
 
 
D
L709 
D
L717 
 
 
 
 
 
 
T319T (AC
C
→
AC
T) 
am
iC
 ←
 
N
-acetylm
uram
oyl-L-alanine am
idase 
 
 
 
D
L687 
 
 
 
 
 
 
 
 
 
 
 
M
1M
 (ATG
→
C
TG
) 
m
scS ←
 
M
echanosensitive channel 
 
 
 
 
 
 
 
 
 
 
 
 
D
L701 
 
 
L112* (TTA→
TGA) 
 
yggH
 ←
 
            tR
N
A m
ethyltransferase, 
                   S
AM
-dependent 
 
 
 
 
D
L687 
 
 
 
D
L695 
 
 
 
 
 
 
 
I106L (ATT→
C
TT) 
 
yglE →
 
Predicted tartrate:succinate antiporter 
 
D
L662 
 
 
 
 
 
 
 
 
 
 
 
 
 
intergenic (−43/‑245) 
yqjH ←
 / →
 yqjI 
predicted siderophore interacting 
protein/predicted transcriptional 
regulator 
 
 
 
D
L687 
D
L692 
D
L693 
D
L695 
 
 
 
 
 
 
 
 
K22Q
 (AA
A→
C
A
A) 
 
yqjG
 →
 
Predicted S-transferase 
 
 
 
 
 
 
 
 
 
D
L712 
D
L714 
D
L698 
D
L701 
D
L703 
D
L707 
coding (1877‑1878/1890 
nt) 
deaD
 ←
 
ATP-dependent R
N
A helicase 
 
 
 
D
L687 
D
L692 
D
L693 
D
L695 
 
 
 
 
 
 
 
 
V446G
 (G
TG
→
G
G
G
) 
 
nanT ←
 
Sialic acid transporter 
 
 
 
 
 
 
 
 
 
 
 
 
 
D
L701 
 
 
intergenic (−74/−306) 
nanR ←
 / →
 dcuD 
 
D
N
A-binding transcriptional regulator/ 
Predicted transporter 
 
M
D
S pop 3
M
D
S pop 4
M
D
S pop 2
M
D
S pop 1
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annotation 
gene 
description 
 
 
 
 
 
 
 
 
 
D
L712 
D
L714 
D
L698 
D
L701 
D
L703 
D
L707 
K54* (AAA
→
TAA) 
 
m
dh ←
 
M
alate dehydrogenase, N
AD
(P)H
-
binding 
 
 
 
D
L687 
D
L692 
D
L693 
D
L695 
 
 
 
 
 
 
 
 
D34N (GAT→
AAT) 
 
m
dh ←
 
M
alate dehydrogenase, N
AD
(P)H
-
binding 
 
 
 
 
 
D
L693 
 
 
 
 
 
 
 
 
 
T422T (AC
T→
AC
G
) 
secY ←
 
Preprotein translocase m
em
brane 
subunit 
 
 
 
 
 
 
 
 
 
D
L712 
D
L714 
D
L698 
D
L701 
D
L703 
D
L707 
V489V (G
TT→
G
TG
) 
rplE ←
 
50S ribosom
al subunit protein L5 
 
 
 
D
L687 
D
L692 
D
L693 
D
L695 
 
 
 
 
 
 
 
 
K639T (A
AA→
AC
A) 
nirB →
 
N
itrite reductase, large subunit, 
N
AD
(P)H
-binding 
 
 
 
D
L687 
D
L692 
D
L693 
D
L695 
 
 
 
 
 
 
 
 
V422V (G
TT→
G
TG
) 
yhgF →
 
Predicted transcriptional accessory 
protein 
 
 
 
D
L687 
D
L692 
D
L693 
D
L695 
 
 
 
 
 
 
 
 
K199N
 (A
AA→
AAC
) 
prlC
 ←
 
O
ligopeptidase A
 
 
 
 
D
L687 
 
 
 
 
 
 
 
 
 
 
 
intergenic (+330/−469) 
hdeD →
 / →
 gadE 
 
  acid-resistance m
em
brane protein/ 
D
N
A-binding transcriptional activator 
 
 
 
 
 
 
 
 
 
 
D
L712 
D
L714 
D
L698 
D
L701 
D
L703 
D
L707 
intergenic (−49/+319) 
gadW
 ←
 / →
 gadX 
 
D
N
A-binding transcriptional activator/ 
     D
N
A-binding transcriptional dual 
                        regulator 
 
 
 
 
 
 
 
D
L695 
D
L695 
 
 
 
 
 
 
 
L180L (C
TT→
C
TG
) 
yhjK ←
 
Predicted diguanylate cyclase 
 
 
 
D
L687 
D
L692 
D
L693 
D
L695 
 
 
 
 
 
 
 
 
L428W
 (TTG
→
TG
G
) 
yicM
 ←
 
predicted transporter 
 
 
 
 
 
D
L693 
 
 
 
 
 
 
 
 
 
L334F (TTA→
TTC
) 
ade →
 
C
ryptic adenine deam
inase 
 
 
 
 
 
 
D
L695 
 
 
 
 
 
 
 
 
S267A (TC
A→
G
C
A) 
bglF ←
 
Fused beta-glucoside specific PTS 
enzym
e 
 
 
 
D
L687 
D
L692 
D
L693 
D
L695 
 
 
 
 
 
 
 
 
coding (23/693 nt) 
om
pL ←
 
Predicted outer m
em
brane porin L 
 
 
 
 
 
 
 
 
 
 
D
L712 
D
L714 
D
L698 
D
L701 
D
L703 
D
L707 
F269F (TTT→
TTC
) 
priA ←
 
Prim
osom
e factor 
 
M
D
S pop 3
M
D
S pop 4
M
D
S pop 2
M
D
S pop 1
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Table 4.1 continued  
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
annotation 
gene 
description 
 
 
 
D
L687 
D
L692 
D
L693 
D
L695 
 
 
 
 
 
 
 
 
H70P (CAT→
CCT)  
fabR
 →
 
D
N
A-binding transcriptional repressor 
 
 
 
 
 
 
 
D
L709 
D
L717 
 
 
 
 
 
 
coding (424-432/705 nt) 
fabR
 →
 
D
N
A-binding transcriptional repressor 
 
 
 
 
 
 
 
 
 
D
L712 
D
L714 
D
L698 
D
L701 
D
L703 
D
L707 
coding (637/705 nt) 
fabR
 →
 
D
N
A-binding transcriptional repressor 
 
 
 
 
 
 
D
L695 
 
 
 
 
 
 
 
 
Intergenic (−1/85) 
soxS ←
 / →
 soxR 
 
D
N
A-binding transcriptional dual 
regulator/D
N
A-binding transcriptional 
regulator, Fe-S
 center for redox 
 
 
 
D
L687 
D
L692 
D
L693 
D
L695 
 
 
 
 
 
 
 
 
L325V (TTG
→
G
TG
) 
nrfA →
 
N
itrite reductase, form
ate-dependent, 
cytochrom
e 
 
 
 
 
 
D
L693 
 
 
 
 
 
 
 
 
 
L51* (TTA→
TGA) 
 
proP →
 
Proline/glycine betaine transporter 
 
 
 
 
 
 
 
D
L709 
D
L717 
 
 
 
 
 
 
E213* (GAA→
TAA) 
 
aspA ←
 
Aspartate am
m
onia-lyase 
 
 
 
 
 
 
 
 
 
 
 
D
L698 
 
D
L703 
D
L707 
intergenic (+11/−26) 
glyV →
 / →
 glyX 
 
tR
N
A-G
ly/tR
N
A-G
ly 
 
 
 
 
 
 
 
 
 
 
 
 
D
L698 
 
D
L703 
D
L707 
intergenic (+18/−19) 
glyV →
 / →
 glyX 
 
tR
N
A-G
ly/tR
N
A-G
ly 
 
 
 
 
 
 
 
 
D
L695 
 
 
 
D
L698 
 
D
L703 
D
L707 
intergenic (+21/−16) 
glyV →
 / →
 glyX 
 
tR
N
A-G
ly/tR
N
A-G
ly 
 
 
 
D
L687 
 
 
 
 
 
 
 
 
 
 
 
F129V (TTC
→
G
TC
) 
rpII →
 
50S ribosom
al subunit protein L9 
 
 
 
 
 
 
D
L695 
 
 
 
 
 
 
 
 
S184S (TC
T→
TC
G
) 
valS ←
 
Valyl-tR
N
A synthetase 
 
M
D
S pop 3
M
D
S pop 4
M
D
S pop 2
M
D
S pop 1
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Table 4.1 continued Strains are grouped by population. Annotations denote synonymous 
(green), nonsynonymous (blue), and nonsense mutations (red). Mutations in intergenic 
regions are designated by the location of the mutation in relation to coding genes flanking 
either side. In the case of large deletions, the deleted genes are specified. For changes 
greater than a single base-pair, the site of the mutation is indicated, followed by the total 
length of the open reading frame. For example, the “coding (321/1218 nt)” mutation 
occurs after the 321st base of the 1218 nucleotide reading frame of this gene. Gene 
orientations are indicated by arrows. Gene descriptions were obtained from EcoCyc.  
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Chapter 5:  Conclusion and Future Directions 
Engineered biological systems are becoming more commonplace solutions to societal 
challenges. One of my favorite examples, is the microbial production of a protease, 
chymosin. Hard cheeses are traditionally made using rennet, an ingredient that is harvested 
by slaughtering young calves and extracting the inner lining of their fourth stomach. The 
rennet of young calves contains high quantities of chymosin, the main coagulating agent 
that is used to separate milk into solid casein curds. Chymosin is only present in young 
calves, it aids them in digesting milk from their mothers. In the 1970s, there was an 
increasing demand for cheese, and given the dearth of rennet from young calves, a logical 
alternative was to produce calf chymosin in a microbial host. Fermentation via a microbial 
host produces large quantities of chymosin. After fermentation, chymosin is extracted and 
the host is killed to avoid any cross-contamination with the downstream cheese-making 
process. Today, almost all hard cheeses are made using recombinantly synthesized 
chymosin with products such as CHY-MAX and MAXIREN that rely on Aspergillus niger 
and Kluyveromyces lactis as hosts, respectively. Compared to rennent-derived chymosin, 
recombinant chymosin is cheaper, uncontaminated (animal rennet contains other 
enzymes), and leads to more consistent flavors during cheese-making159. 
Production of a single protein in a microbial host is generally straightforward. 
However, not all engineering of biological systems is quite so simple. Host organisms are 
known to mutate in order to adapt to the metabolic load imposed by the engineered 
function, making extensive engineering efforts challenging. Therefore, in order to make 
biological engineering easier and more reliable, we need to build genetically stable host 
organisms and understand the mechanisms involved in evolutionary stability. The 
complexity of genome engineering efforts is increasing, and evolutionary stability will 
become more important as more complex functions are encoded in microbial hosts. The 
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host cell burden will increase causing an increase in mutation rates as complex functions 
require more DNA. An important aspect of this dissertation is that it describes both the 
engineering of evolutionary stability and the cellular mechanisms responsible.     
Genetically stable strains, also known as antimutators, are difficult to study because 
their isolation proves challenging. This dissertation demonstrates a new method, Periodic 
Reselection of Evolutionarily Stable Variants (PResERV), in which antimutators are 
selected via directed evolution. By performing PResERV in E. coli, I have been able to 
isolate and characterize a series of antimutator strains. Moreover, my work was not an 
exhaustive search for E. coli antimutators, although PResERV could easily be applied to 
perform such an investigation. PResERV is a universal method that can likely be applied 
in most microbes. Nearly all antimutators in the literature are reported in E. coli and 
Saccharomyces cerevisiae, and therefore there exists an untapped potential for discovering 
antimutator mechanisms in non-model organisms. Are the antimutator mechanisms 
similar? Different? Why? This knowledge will allow us to better understand genetic 
stability and what sorts of cellular processes perturb the integrity of the genome. 
This dissertation describes a number of antimutator alleles in the following genes: 
polA, polB, sucD, sdhA, and rne. Antimutator alleles in polA and polB have been previously 
reported. These alleles support two of the most well-documented antimutator mechanisms. 
First, DNA polymerase variants with increased proofreading or fidelity (polA) and second, 
deletion of error-correcting DNA polymerases (polB) lead to lower mutation rates. Given 
that polA and polB have been previously implicated in an antimutator phenotype, they act 
as a positive control for PResERV and essentially support that PResERV can identify bona 
fide antimutators. Additionally, this dissertation also expands our knowledge on new 
antimutator mechanisms by linking mutations in sucD, sdhA, and rne to reduced mutation 
rates. Succinyl-CoA synthetase, sucD, and succinate dehydrogenase, sdhA, are components 
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of central carbon metabolism (TCA cycle and electron transport chain). The antimutator 
alleles are deletions of these genes and their respective enzyme complexes, which lead to 
reduced oxidative stress, less DNA damage, and lower mutation rates. However, it still 
remains unclear why oxidative stress mitigation, a general cellular mechanism, leads to 
reduced mutation rates on a plasmid versus the chromosome. Future work will be needed 
to address this question. RNase E, rne, is involved in a myriad of processes dealing with 
RNA metabolism. More follow up studies, such as RNA-Seq are needed in order to tease 
apart a specific role. This dissertation reports on many other putative antimutator alleles 
for which the molecular mechanisms of action remain to be elucidated. 
Antimutator alleles can be further characterized by their mutational spectrum. 
There exist novel, sequence-based methods, such as maximum-depth sequencing (MDS), 
to capture the nature of the mutations found in a given reporter gene160. Comparing the 
antimutator mutational spectrums with wild type will allow us to understand which 
mutations are corrected by the antimutator allele. For example, in the case of sdhA and 
sucD, we would expect that these cells have fewer GC to TA transversions caused by the 
main species generated during oxidative stress, 8-oxo-G. Additionally, MDS will allow us 
to calculate mutation rates from the sequence data. These data will be further support for 
the reductions in mutations rates observed via the Luria- Delbrück fluctuation assay.    
 Using antimutators as host strains for reliable engineering of biology is a new 
strategy that is presented extensively in this dissertation. Antimutator alleles (sucD and 
sdhA) can be ported to reduce mutation rates in another E. coli strain, primarily used for 
plasmid-based protein production (BL21). In addition, antimutator alleles (sucD, sdhA, and 
rne) can be combined to reduce mutation rates even further and build a Total Antimutator 
Combination Organism (TACO). These efforts are the nascent stages of creating 
antimutator host variants. Next steps consist of porting antimutator alleles into other 
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organisms to diagnose conservation of antimutator mechanisms across species and building 
different versions of TACO to understand which (and why) antimutator alleles function in 
combination. Additionally, it is important to address whether these antimutator alleles will 
reduced mutation rates in other conditions. For example, the PResERV experiments 
described in this dissertation were evolved in LB media using shake flasks. Will these 
mutations work in an industrial process? And, what trade-offs exist with lowering mutation 
rates? It is likely, at least in the case for the TCA cycle mutants, that the antimutator will 
have slower growth on certain carbon sources given that the antimutator mutations elicit a 
diversion of flux through the TCA cycle. Other antimutator alleles, such as those involved 
in DNA replication, may have different trade-offs. Understanding these limitations will 
provide a better picture of whether the antimutator phenotypes will transfer to different 
scenarios. An almost immediate follow-up question that is rarely addressed in this 
dissertation is – what sorts of synthetic devices will benefit from an antimutator host? What 
is the relationship between different fold reductions in mutation rate and the cost of a 
heterologous construct? There is some mathematical modeling that demonstrates that 
increased production load and escape rate results in a generally rapid appearance of 
mutated, non-producer cells23. It will be important to assay the evolutionary failure of 
constructs with differing characteristics such as a biosynthesis pathway, a toxic protein, or 
a circuit. Evolutionary failure is commonly experienced in industrial fermentation 
processes. For example, engineered strains in a large-scale fermentation will cease to make 
product after a certain number of generations, due to mutations alleviating the imposed 
metabolic load of the engineered function. Ultimately, I hope this work will have some 
translation into an industrial strain to benefit issues faced in industry.   
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Appendix A: Innovation in an E. coli evolution experiment is contingent 
on maintaining adaptive potential until competition subsides 
 
This chapter is reproduced (with minor modifications) from its initial publication: 
 
Leon D, D'Alton S, Quandt EM, Barrick JE. (2018) Innovation in an E. coli evolution 
experiment is contingent on maintaining adaptive potential until competition subsides. 
PLoS Genetics 14, e1007348.  
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ABSTRACT  
Key innovations are disruptive evolutionary events that enable a species to escape 
constraints and rapidly diversify. After 15 years of the Lenski long-term evolution 
experiment with Escherichia coli, cells in one of the twelve populations evolved the ability 
to utilize citrate, an abundant but previously untapped carbon source in the environment. 
Descendants of these cells became dominant in the population and subsequently diversified 
as a consequence of invading this vacant niche. Mutations responsible for the appearance 
of rudimentary citrate utilization and for refining this ability have been characterized. 
However, the complete nature of the genetic and/or ecological events that set the stage for 
this key innovation is unknown. In particular, it is unclear why it took so long for citrate 
utilization to evolve and why it still has evolved in only one of the twelve E. coli 
populations after 30 years of the Lenski experiment. In this study, we recapitulated the 
initial mutation needed to evolve citrate utilization in strains isolated from throughout the 
first 31,500 generations of the history of this population. We found that there was already 
a slight fitness benefit for this mutation in the original ancestor of the evolution experiment 
and in other early isolates. However, evolution of citrate utilization was blocked at this 
point due to competition with other mutations that improved fitness in the original niche. 
Subsequently, an anti-potentiated genetic background evolved in which it was deleterious 
to evolve rudimentary citrate utilization. Only later, after further mutations accumulated 
that restored the benefit of this first-step mutation and the overall rate of adaptation in the 
population slowed, was citrate utilization likely to evolve. Thus, intense competition and 
the types of mutations that it favors can lead to short-sighted evolutionary trajectories that 
hide a stepping stone needed to access a key innovation from many future generations. 
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AUTHOR SUMMARY 
Key innovations are rare, game-changing moments in evolution when a species or 
population achieves new success by escaping its normal constraints. We examined a case 
in which bacteria that had been maintained in the laboratory for fifteen years evolved to 
exploit a previously untapped nutrient in their environment. Why didn’t this highly 
beneficial innovation evolve earlier? We found that two distinct mechanisms suppressed 
this innovation at different times in the history of the population. Early on, competition 
drove any new cells that started on the path to evolving the innovation extinct. Later, 
genetic changes accumulated in the population that shut down the potential to benefit from 
the new nutrient. After competition abated somewhat and further genetic changes restored 
a beneficial path to the innovation, it evolved. This example illustrates how stiff 
competition can force evolving populations to adopt short-sighted, incremental solutions 
that block or significantly delay achieving innovative breakthroughs. 
 
 
INTRODUCTION 
Escherichia coli can more effectively uptake iron when a small amount of citrate, about 10 
µM, is added to chemically defined media161. In 1950, when DM (Davis-Mingioli) medium 
was initially designed, the recipe used 1700 µM citrate. DM medium was formulated to 
isolate auxotrophic mutants by the penicillin method. It was shown that the addition of 
citrate improved the lethality of penicillin, thereby reducing the number of false-positives 
when selecting for auxotrophs. The penicillin method was widely used, and DM was 
adopted as a chemically defined medium for other types of experiments as a 
consequence162. The elevated concentration of citrate was typically unnecessary in these 
new circumstances, but it remained unaltered as new labs and generations of scientists 
inherited the same DM recipe. 
 126 
The Lenski long-term evolution experiment (LTEE) consists of twelve E. coli B 
populations that have been propagated daily in glucose-limited DM medium for over 
60,000 generations163,164. A relatively low concentration of glucose (139 µM) was used in 
the LTEE to restrict the cell density and thereby reduce the chances that stable ecology 
reinforced by cross-feeding interactions would evolve, which has largely been the case 
except for in one population165,166. The low-glucose formulation of DM used in the LTEE 
means that the standard amount of citrate present (1700 µM) represents a substantial 
nutrient pool that could be exploited, but the ancestral strain of E. coli is unable to utilize 
citrate under the conditions of the LTEE. Citrate is an untapped niche. 
After 31,500 generations, a mutant in one of the LTEE populations, designated Ara-
3, evolved the ability to utilize citrate as a carbon source. Descendants of this mutant that 
were able to fully exploit this additional carbon source evolved by 33,000 generations and 
dominated thereafter167. Previous work has demonstrated that the evolution of citrate 
utilization in the LTEE proceeded through three stages typical of any key innovation: 
potentiation, actualization, and refinement167-170. The principal mutations involved in the 
latter two steps have been characterized. Actualization refers to the first manifestation of a 
rudimentary Cit+ phenotype. The actualizing mutation is a tandem duplication of the rnk-
citG region of the E. coli chromosome that includes the citrate:succinate antiporter gene, 
citT. This duplication results in an arrangement in which one of the two copies of citT is 
now downstream of the aerobically-active rnk promoter (Prnk). Thus, the actualization step 
results in CitT production under the LTEE conditions168.  
However, early Cit+ cells with the citT duplication are able to uptake and metabolize 
only a small fraction of the citrate present during one 24-hour growth cycle of the 
LTEE167,171. Subsequently, refinement mutations improved the rudimentary Cit+ trait in 
their descendants such that they became capable of utilizing all of the citrate in DM during 
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each growth cycle (Cit++ phenotype). One critical mutation for refinement activated 
expression of dctA, a C4-dicarboxylate:H+ symporter gene. DctA allows active transport of 
C4-dicarboxylates, including succinate, into the cell. Because CitT is an antiporter that 
couples export of these compounds to citrate import, expression of DctA creates a 
sustainable cycle for importing citrate that is powered by the proton gradient169. The dctA 
mutation refines the rudimentary Cit+ trait into the Cit++ phenotype that was responsible 
for the population expansion observed at ~33,000 generations in the LTEE167.   
While the actualization and refinement stages of Cit+ evolution in the LTEE are 
understood, the mechanistic basis of potentiation has remained elusive. The critical 
diagnostic characteristic of a potentiated strain is that is has an increased chance of giving 
rise to a Cit+ descendant after further evolution168 Blount et al. identified potentiated strains 
by performing ‘replay’ experiments167. In these experiments, pre-Cit+ clones isolated from 
the LTEE population at various time points were tested to determine whether they were 
capable of evolving citrate utilization. Cit+ cells rarely arose in these replay experiments. 
When they did, the Cit+ trait re-evolved more often in clones selected from later time points 
that were closer to when the citT duplication first arose in the LTEE population. 
The phylogenetic distribution of the LTEE strains giving rise to Cit+ variants in the 
replay experiments suggests the existence of at least two critical junctures at which the 
potential for evolving Cit+ increased168. By 20,000 generations, the LTEE population had 
diversified into three long-lived clades that co-existed at least until full citrate utilization 
(Cit++) evolved at ~33,000 generations. E. coli isolates from all of these groups evolved 
Cit+ in the replay experiments, whereas no strains from earlier than 20,000 generations did, 
suggesting that all three clades share some determinant of potentiation. A significantly 
higher proportion of clones from the clade that gave rise to citrate utilization in the LTEE 
were able to evolve Cit+ in the replays, suggesting that they share a second determinant for 
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increased potentiation not present in the other clades. Due to the extreme rarity of Cit+ 
arising in these replay experiments even after months of evolution167, it is not realistic to 
use this approach to further narrow down the genetic basis of potentiation.  
In this study, we tested the viability of the critical actualizing mutation for Cit+ 
evolution in a series of pre-Cit+ isolates from the LTEE by measuring the effect of 
activating citT expression on competitive fitness. We found that activating citT expression 
slightly increased the fitness of the ancestral strain and some later pre-Cit+ clones. 
Unexpectedly, activating citT expression was highly deleterious in certain strains from 
intermediate time points, and we did not find any strains that benefitted significantly more 
from this mutation than the ancestral strain did. We conclude that potentiation for the 
evolution of citrate utilization in the LTEE is due to the interplay of genetic factors in 
specific strains and the population at large. First, adaptation had to occur via a genetic 
trajectory that maintained the potential for evolving Cit+ by a beneficial mutational step in 
order for the innovation to remain accessible. Second, the rate of adaptation in the overall 
population needed to slow to a pace at which early variants with the weakly beneficial Cit+ 
trait could avoid being driven extinct by competitors before refining mutations arose. 
 
 
RESULTS 
Cit+ was only slightly beneficial when it evolved in the LTEE 
By definition, the first E. coli cell that evolved the citT-activating mutation that was 
ultimately successful in the LTEE was fully potentiated when this mutation arose. The 
earliest Cit+ descendant of this cell that has been identified is strain ZDB564 from 31,500 
generations. At this time Cit+ cells were still extremely rare in the population170, which 
means that it is likely that the suite of mutations in ZDB564 is identical to those in the first 
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Cit+ cell, or nearly so. Previously, strain ZDB706, a Cit– revertant of ZDB564, was isolated 
by passaging ZDB564 on DM medium lacking citrate to allow for the spontaneous collapse 
of the rnk-citG duplication to the ancestral single-copy state that lacks a copy of the rnk 
promoter upstream of citT (Figure A1A)170.  
We co-cultured ZDB564 and ZDB706 in DM medium to estimate the effect that 
the citT duplication had on competitive fitness when it originally arose. These experiments 
involved reverting an arabinose-utilization allele in one of the two strains to be competed 
from the inactivated state present in all strains from this LTEE population (Ara–) to the 
active state (Ara+) so that cells of each type can be distinguished by the colors of the 
colonies that they form on indicator plates (Methods)164. These Ara+ strain variants were 
assayed to establish that the genetic marker was neutral with respect to fitness and that no 
secondary mutations affecting fitness had accumulated during strain construction prior to 
further competition experiments. When competing ZDB564 and ZDB706, we found a 
slight fitness advantage of 2.2% for the presence of the citT-activating duplication in 
ZDB564 (Figure A1B). This result that was consistent between the competitions utilizing 
Ara+ ZDB706 or Ara+ ZDB564 marked variants (two-tailed t-test, P=0.33, n=12 and 18, 
respectively). 
 
Development of Prnk-citT knock-in assay for potentiation 
We next wanted to add the citT-activating mutation to pre-Cit+ strains in order to test our 
hypothesis that there was a transition in the lineage leading to Cit+ such that this mutation 
became more beneficial once a potentiated genetic background evolved. The effect of 
adding a plasmid containing the evolved Prnk-citT unit has been tested in previous 
studies168,169, but this approach is problematic because these plasmids are multicopy, 
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whereas only a single activated copy of the citT gene was present in the initial Cit+ strains. 
However, engineering the authentic rnk-citG duplication into the chromosome of a strain 
is difficult because this configuration is genetically unstable. It readily collapses via 
homologous recombination if there is not selection to maintain citrate utilization, as was 
utilized in reverting ZDB564 to the Cit– variant ZDB706.  
To address these shortcomings, we developed a Prnk-citT knock-in assay, in which 
a mimic of the evolved configuration is integrated into the chromosome of a pre-Cit+ LTEE 
clone (Figure A1C). Briefly, we created an activated citT module linked to an antibiotic 
selection marker in which the rnk promoter is upstream of the truncated rnk-citG fusion 
ORF formed by the duplication followed by the complete citT reading frame. To control 
for any fitness cost imposed by the selection marker, we also made a null module 
containing only the antibiotic resistance gene. Both of these cassettes are targeted to 
integrate into the E. coli chromosome such that they replace the lac operon, which is 
unrelated to citrate or glucose metabolism.  
We validated this approach by adding the Prnk-citT module to the fully potentiated 
Cit– revertant, ZDB706, and adding the null module to its neutral Ara+ variant. Addition of 
the Prnk-citT cassette to the fully potentiated Cit– strain ZDB706 resulted in increased citT 
mRNA levels equivalent to those seen in ZDB564, the original Cit+ isolate with the actual 
rnk-citG duplication that evolved in the LTEE (two-tailed t-test, P = 0.65, n = 3) (Figure 
A1D). The resulting Cit+ variant of ZDB706 had a fitness advantage of 2.4% over the 
corresponding Cit– variant with the null knock-in cassette (Figure A1B), which was not 
statistically different from the fitness advantage found for the authentic citT-activating 
mutation in the pooled ZDB564 versus ZDB706 competitions (two-tailed t-test, P = 0.71, 
n = 6 and 30, respectively). Therefore, applying the Prnk-citT knock-in assay to additional 
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strains allows us to ask: if the citT-activating mutation had evolved in a genetic background 
that existed earlier in the LTEE, would it have been as beneficial? 
 
Cit+ would have been modestly beneficial if it evolved in the LTEE ancestor  
As a first step in further elucidating the fitness consequences of evolving rudimentary Cit+ 
on other strains from the LTEE, we performed the Prnk-citT knock-in assay on the ancestral 
LTEE strain, REL606. We found a slight fitness benefit of 1.0% for the Cit+ mutation 
(Figure A1B). This effect size is near the limit for the smallest differences that can be 
distinguished in these types of competitive fitness assays, resulting in relatively weak 
support for the hypothesis that there was any fitness advantage at all for the REL606 variant 
with the Prnk-citT module relative to the one with the null module (one-tailed t-test, P = 
0.033, n = 12). There was evidence, though also not very strong, that the benefit of the Prnk-
citT module in the fully potentiated strain ZDB706 was greater than it was in REL606 (one-
tailed t-test, P = 0.018, n = 12 and 6, respectively). Expression of citT was not quite as high 
in the REL606 strain with the Prnk-citT module as it was in ZDB706 with the same module 
(two-tailed t-test, P = 0.00016, n = 3) (Figure A1D), suggesting that mutations during the 
LTEE on the lineage leading to Cit+ may have altered the strength of the rnk promoter. 
Overall, the REL606 measurements indicated, surprisingly, that there was likely a modest 
benefit for a mutation activating expression of citT at the very beginning of the LTEE, and 
that this benefit may have only slightly improved after further mutations that occurred 
during the potentiation stage in the evolution of this metabolic innovation. 
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No evidence for ecological potentiation  
Why did the appearance of citrate utilization take so long and why has it not evolved in 
other LTEE populations? One hypothesis for its rarity is that the evolution of a particular 
ecology in the population was important for enabling the evolution of Cit+. This type of 
situation is known to occur, for example, when nutrient cross-feeding between genetically 
diverged subpopulations yields negative frequency dependence, such that the competitive 
advantage for a newly evolved strain or a certain subpopulation is greater when it is rare 
within the population than when it is common73. The pre-Cit+ clade was rare during the 
time period when the rnk-citG duplication evolved. It constituted <1-5% of the population 
from 30,000 to 32,500 generations170.  
To test whether this kind of ‘ecological potentiation’ was important for the 
evolution of Cit+ in the LTEE, we repeated the Prnk-citT knock-in assay competition for 
strain ZDB706 in the context of the full diversity that existed in the population at 31,000 
generations (Figure A1B). The Cit+ and Cit– variants were mixed together equally and 
added such that they comprised ~1% of the cells in a mixture with the evolved population 
sample. In this context, the Cit+ strain had a 0.9% fitness advantage over the Cit– strain, 
which was less than and only marginally different from the result when the two strains 
were competed versus one another normally (two-tailed t-test, P = 0.053). Thus, we find 
no support for the ecological potentiation hypothesis. If anything, the more diverse mixed 
population context may slightly reduce the benefit of Cit+ evolution. 
 
Anti-potentiated strains evolved at intermediate time points  
We next performed the Prnk-citT knock-in assay on 23 additional clones isolated from the 
LTEE population (Figure A2A). Our goal was to determine whether activating citT 
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expression was similarly beneficial in other evolved genetic backgrounds. We measured 
citT mRNA levels in five of the constructed strains with the Prnk-citT cassette and found 
them to be similar in all of these strains, indicating that the strength of the rnk promoter 
was largely unchanged by the specific suites of evolved mutations present in each of these 
strains. For four of the evolved strains we found strong evidence that the citT cassette 
significantly increased fitness versus the control with the null cassette, as it had in the fully 
potentiated strain ZDB706 (one-tailed bootstrap test incorporating Ara+/Ara– marker and 
Cit+/Cit– competitions described in Methods, P < 0.05). In nine strains, citT activation had 
no significant effect on fitness (two-tailed bootstrap test, P < 0.05), though our 
measurements did not achieve sufficient precision to rule out that there was a fitness benefit 
of 1% or greater in seven of these cases (one-tailed bootstrap test, P < 0.05). 
Unexpectedly, the Cit– variant outcompeted the Cit+ variant for the 11 remaining 
strains of the 23 we tested (one-tailed bootstrap test, P < 0.05). The actualizing step needed 
for subsequently evolving full citrate utilization (Cit++) would have been effectively 
blocked if it occurred in these strain backgrounds; they are ‘anti-potentiated’. For five of 
these strains, activating citT expression was extremely detrimental, decreasing competitive 
fitness by >20% (one-tailed bootstrap test, P < 0.05). For ZDB483 and ZDB14, two of the 
severely anti-potentiated strains, we investigated the nature of this defect by comparing 
growth curves of the Cit+ and Cit– variants. There was very little difference in the growth 
curve for the LTEE ancestor REL606 whether the activated citT cassette or null control 
cassette was added to its genome, which is in keeping with its almost imperceptible effect 
on the competitive fitness of this strain. In contrast, we found that activating citT expression 
drastically increased the lag phase of growth in the severely anti-potentiated strains (Figure 
A2B). This additional lag time can explain the sizable competitive disadvantage versus the 
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Cit– strain, even though the Cit+ variants are able to reach a higher final cell density if 
cultured alone. 
 
Mapping potentiation onto phylogeny  
Identifying specific mutations that contributed to potentiation and anti-potentiation 
requires interpreting the fitness data from the Prnk-citT knock-in assays in a phylogenetic 
context. To improve the resolution of a previously published whole-genome phylogenetic 
tree of 29 clonal isolates from this LTEE population168, we sequenced the genomes of 20 
new clones (A1 Table) and also incorporated 12 other clones sequenced in another recent 
study of the rate of genome evolution through 50,000 generations in all LTEE 
populations83. The 20 newly sequenced isolates were selected to improve our ability to 
temporally order mutations that occurred near when citrate utilization evolved: they were 
minimally diverged from the line of descent to the Cit+ progenitor and were mostly sampled 
at later time points.  
The updated phylogenetic tree (Figure A3) includes all 25 clones we tested with 
the Prnk-citT knock-in assay. We used these strains to identify branches in the tree within 
which the adaptive potential of activating citT expression changed due to one or more 
mutations. Specifically, we clustered phylogenetically-adjacent strains into groups within 
which all pairwise comparisons of the fitness effect of the Prnk-citT module were not 
significantly different (Bonferroni-corrected two-tailed bootstrap tests, P > 0.05). Overall, 
this analysis suggests that there were at least three major step-like changes in the potential 
for evolving the rudimentary Cit+ trait along the pre-Cit– lineage that eventually evolved 
citrate utilization (Figure A4).  
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Proceeding backward in the tree from the earliest known Cit+ isolate (ZDB564), 
two earlier clones (ZDB19 and ZDB13) from as early as 29,000 generations are as fully 
potentiated as the key Cit– revertant (ZDB706). The overall fitness effect of evolving Cit+ 
in this group was +2.4% [+1.4%, +3.4%] (95% confidence interval). The next-earliest 
group comprises three clones isolated at time points from 25,000 to 27,000 generations 
(ZDB478, ZDB486, and ZDB309). Activation of citT had little to no impact on this set of 
strains, with an estimated group-wise effect on fitness of +0.4% [–1.3%, 2.0%]. One 
intermediate strain, ZDB310 from 27,000 generations, was not significantly different from 
either of these two groups immediately before and afterward, although the two groups were 
significantly different from one another.  
It was deleterious to evolve Cit+ in an earlier, intermediate set of isolates composed 
of ZDB425, ZDB458, and ZDB464 with an estimated fitness effect of –5.4% [–7.2%, –
3.6%]. These clones appear to be genetically typical of the pre-Cit+ lineage. ZDB425 at 
10,000 generations and ZDB458 at 20,000 generations have only one and two ‘private’ 
mutations not shared with the main pre-Cit+ lineage, respectively, though we cannot rule 
out that other changes in the impact of citT activation may have occurred on the main line 
of descent within this interval. Before these anti-potentiated clones, there is an initial 
cluster that groups ZDB409 and ZDB429 with the REL606 ancestor. In these three isolates, 
evolution of Cit+ would have been slightly beneficial with a fitness impact of +1.7% 
[+0.0%, +3.3%]. 
Other strains are not classified into these major groups. It is less likely that they are 
representative of how potentiation evolved in the lineage leading to Cit+. For example, the 
four most highly anti-potentiated clones (ZDB467, ZDB483, ZDB14, ZDB18) appear to 
have evolved this property independently and due to ‘private’ mutations not shared with 
the main pre-Cit+ lineage (Figure A3), at least this is the most parsimonious explanation. 
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Similarly, the fitness effects measured in the Prnk-citT knock-in assay for two three-member 
subclades (ZDB334, ZDB339, ZDB317; and ZDB23, ZDB27, ZDB25) indicate that each 
likely shared one or more mutations that altered Cit+ potentiation only within that subclade, 
though the effects are much smaller in these cases. Finally, we excluded ZDB446 from this 
analysis because it was so deeply branched: removed by >5,000 generations from the pre-
Cit+ lineage. It would have been clustered with the earliest group containing REL606 
according to our criteria. 
 
Cit+ evolution in the context of competition with other beneficial mutations  
During the time period when the pre-Cit+ lineage was anti-potentiated, from approximately 
10,000 to 20,000 generations, invasion of a new Cit+ subpopulation would have been nearly 
impossible. Lineages that lost fitness by evolving the rudimentary version of this new trait 
would be rapidly purged by selection before refining mutations (e.g., activating dctA) could 
accumulate to give the decisive benefit of full citrate utilization (the Cit++ phenotype). What 
about the earlier and later time periods when the evolution of Cit+ was neutral or slightly 
beneficial? During these epochs, a newly evolved Cit+ lineage would still have had to 
compete with not only its own ancestor, but also against other lineages that were evolving 
at the same time, many of which would have other beneficial mutations. That is, an 
incipient Cit+ lineage had to survive in competition with alternative adaptive pathways, 
such as those improving fitness on glucose. 
In order to understand when the fitness effects we measured for evolving Cit+ by 
citT activation would have made this metabolic innovation a viable evolutionary pathway 
in the context of competition within the LTEE population, we compared the group-wise 
fitness effects determined from the Prnk-citT knock-in assays to two models of the fitness 
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effects of beneficial mutations that were successful at different generations in this LTEE 
population (Figure A4). The Wiser et al. approach fits the fitness trajectory of this LTEE 
population to a model that incorporates a uniform type of diminishing returns epistasis 
between beneficial mutations and assumes consecutive sweeps172. The Tenaillon et al. 
model fits the number of beneficial mutations accumulating over time from genome 
sequencing data83. We combined this information with the Wiser et al. fitness trajectory to 
infer the representative fitness change for each subsequent beneficial mutation. The larger 
fitness effects in the Wiser et al. model reflect that it estimates the advantages of sweeping 
cohorts that may include more than one beneficial mutation. Overall, both models give 
very similar results that reflect the well-known deceleration in fitness gains during the 
Lenski long-term experiment163,164,173. 
The models demonstrate that even if Cit+ evolution was marginally beneficial in 
the REL606 ancestor and other early isolates, it was initially much less beneficial than was 
needed to be successful at this point. Even by 5,000 generations, citT activation appears to 
have been average, at best, in terms of its fitness effect among all possible beneficial 
mutations. It would have been unlikely for the Cit+ trait to appear and persist at this point 
because there were so many alternative mutations, such as those that required only single-
base substitutions or IS insertions that knocked out gene function, which would have 
occurred at a higher rate than the specific duplications or IS element insertions needed to 
activate citT expression167. After anti-potentiation appeared and receded in this lineage, 
competition would have continued to suppress Cit+ evolution when the citT mutation was 
again neutral. In striking contrast, evolving Cit+ was clearly superior to a typical successful 
beneficial mutation in the final group of strains that first evolved by 29,000 generations. It 
was a viable adaptive pathway at this point. Thus, by comparing Prnk-citT knock-in assays 
to models of the rates of population evolution, we can explain how a variant with a 
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rudimentary Cit+ trait was able to appear and avoid extinction long enough to achieve the 
decisive dctA mutation that led to the dominant Cit++ trait. 
 
DISCUSSION 
Our work reframes and further elucidates why the emergence of citrate utilization is so rare 
in the Lenski long-term evolution experiment (LTEE). Rudimentary citrate utilization (the 
Cit+ phenotype) can apparently evolve at any time when a mutation switches on expression 
of the CitT transporter under the aerobic conditions of the experiment. However, the 
success of a new Cit+ variant is far from guaranteed. It is contingent on whether its 
descendants can survive long enough to incorporate a second mutation, such as one 
activating expression of the DctA transporter, that enables full citrate utilization (the Cit++ 
phenotype). The chance that Cit++ will be realized by this evolutionary pathway is 
dependent on two major factors. First, the initial mutational step conferring the weak Cit+ 
phenotype must be beneficial to fitness. Whether it is advantageous or not depends on the 
context of other mutations present in an evolved genome in which citT activation occurs. 
Second, the benefit of the mutation conferring weak Cit+ must be great enough that it can 
survive in competition with other adaptive mutations. Whether it is sufficiently beneficial 
depends on the population context in which it arises. We found that both genetic and 
population factors limited Cit++ evolution at different times in the LTEE (Figure A4). 
Unexpectedly, evolution of Cit+ by activating citT expression appears to have 
already been slightly beneficial to fitness in the ancestral strain used to found this E. coli 
population on the first day of the LTEE and to have remained so in other early evolved 
isolates. Even though Cit+ strains that evolved in the LTEE population at this point would 
have been capable of displacing their own Cit– ancestors, this first step on the pathway to 
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the full Cit++ innovation was suppressed due to competition with mutations on adaptive 
pathways that improve fitness in the original glucose niche. New cells with highly 
beneficial mutations related to this primary component of the LTEE environment were 
essentially guaranteed to arise in the population and outcompete any cells with mutations 
activating citT expression. By 10,000 generations, the lineage in which Cit+ eventually 
evolved became ‘anti-potentiated’ after it accumulated additional mutations. Now, the 
pathway to innovation was blocked because it was deleterious to evolve rudimentary Cit+ 
in this genetic background. There was a fitness valley separating the evolved Cit- strains 
from the full Cit++ phenotype. Finally, further mutations appeared in the focal LTEE 
lineage by 29,000 generations that altered the fitness impact of activating citT expression 
such that it was again beneficial to evolve the Cit+ phenotype, and perhaps even more so 
than it had been in the ancestor. At this point, the rate of adaptation of the population had 
slowed enough that evolving rudimentary Cit+ was now among the most beneficial 
mutational steps remaining. The two-step mutational pathway to Cit++ was no longer 
suppressed by genetic or population factors, and the Cit++ innovation evolved. 
Cit++ mutants of E. coli capable of growth on citrate as a sole carbon source under 
aerobic conditions have been isolated in other studies167,168,174,175. In all of these cases, 
multiple mutations have been required to achieve the Cit++ phenotype. When they have 
been identified, the mutations that yield Cit++ activate expression of the CitT and DctA 
transporters, as is observed in the LTEE. These studies have isolated Cit++ mutants in much 
shorter periods of time (<1-8 weeks) than it took to evolve in the LTEE (~15 years) because 
they involve starving E. coli cells for days to weeks under conditions in which citrate was 
present as a potential carbon source. In the context of our results and as previously noted 
by others176, this difference in environmental conditions relative to the glucose-limited 
transfer regime of the LTEE, in which cells are in stationary phase for only ~16-18 hours 
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each day, dramatically increases the fitness benefit of evolving the rudimentary Cit+ 
phenotype. Therefore, these stark conditions are expected to completely mask and 
overwhelm the dependency on potentiating genetic and population factors found in the 
LTEE. Activating citT expression would be universally beneficial in any genetic 
background in these types of experiments. Any increase in lag phase or other trade-off with 
respect to growth rate that might accompany this intermediate step in the pathway to Cit++ 
is irrelevant when cells without the mutation simply cannot replicate at all. The citrate-only 
starvation conditions also eliminate any interference from alternative mutations with 
benefits related to glucose utilization that suppress Cit++ evolution in the LTEE.  
Why is evolution of Cit+ beneficial in some evolved genetic backgrounds and 
deleterious in others under the conditions of the LTEE? Activation of CitT expression 
under these aerobic conditions via the rnk-citG duplication leads to coupled import of 
citrate (a C6-tricarboxyate) and export of C4-dicarboxylates (e.g., succinate)177. In wild-
type E. coli strains, CitT is normally expressed only under anaerobic conditions, and the 
imported citrate can only be assimilated when a fermentable co-substrate, such as glucose, 
is also present178. Under these conditions, citrate is cleaved to acetate and oxaloacetate by 
citrate lyase. The structural proteins and accessory factors necessary for producing this 
enzyme complex are encoded in the same operon as citT. When glucose is co-utilized with 
citrate, the resulting oxaloacetate is reduced to succinate by reverse tricarboxylic acid 
(TCA) cycle reactions. This process consumes reduced cofactors produced by breakdown 
of the sugar to balance redox metabolism without the need for O2. The succinate or other 
C4-dicarboxylates produced can be exchanged for more citrate import via CitT to continue 
this mixed fermentation mode of growth, or these TCA cycle intermediates can be siphoned 
off into biosynthetic pathways as necessary for cellular replication. 
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Under the aerobic conditions of the LTEE, citrate lyase is not expressed and 
succinate to balance citrate import by CitT must be produced in a different manner, from 
citrate or glucose using reactions of central metabolism. The availability of O2 makes it 
possible to maintain redox balance while synthesizing succinate via the TCA cycle, the 
glyoxylate bypass, or anaplerotic reactions (e.g., phosphoenolpyruvate carboxylase). E. 
coli growing under aerobic conditions ferments glucose to acetate, and mutations in genes 
related to the ability to re-uptake and utilize acetate are widespread in the LTEE83,179,180. 
These mutations affect acetate transporters and also pathways for assimilating acetate as 
acetyl-CoA through citrate synthase, the TCA cycle, and the glyoxylate bypass. Therefore, 
how these pathways are altered by adaptation to better utilize glucose and acetate is likely 
an important determinant of the genetic background that affects the ability to evolve citrate 
utilization. If introduction of the CitT transport reaction misbalances the redox state of the 
cell or the distribution of carbon compound intermediates between anabolism and 
catabolism, then it would be deleterious to fitness. Therefore, mutations altering central 
metabolism are candidates for explaining the changes in the fitness effect of citT activation 
along the LTEE lineage that ultimately evolved citrate utilization (Figure A4).  
Starting with the ancestor and examining when changes in the potential for evolving 
Cit+ were observed in the LTEE, a mutation in nadR, a repressor of NAD coenzyme 
biosynthesis181, occurs along the branch in the phylogenetic tree when anti-potentiation 
first evolved, before 10,000 generations. Mutations in nadR have appeared and swept to 
fixation in all twelve LTEE populations. These mutations include frameshift mutations and 
IS element insertions83, indicating that they are loss-of-function mutations, and deleting 
this gene from the genome of the LTEE ancestor has been shown to be beneficial173. 
Reducing or eliminating NadR activity is predicted to increase the NAD/NADH pool in 
the cell and could enable increased rates of glucose fermentation. Since NADH is a potent 
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allosteric regulator of enzymes in central metabolism, including citrate synthase (gltA) for 
entry into the TCA cycle, this mutation may also reconfigure other cellular fluxes in ways 
that make CitT transport deleterious to fitness. 
Between 10,000 and 25,000 generations mutations occurred in this LTEE 
population in three key genes that affected the activities of enzymes in central metabolism: 
iclR, arcB, and gltA1. These mutations have all been shown to improve growth on 
acetate170. Two of these mutations are in negative regulators; they are expected to derepress 
enzymes of the glyoxylate bypass (iclR)182 and TCA cycle (arcB)183, leading to increased 
metabolic flux through these pathways. Mutations in both of these genes are found in nearly 
all LTEE populations83. The citrate synthase mutation (gltA1) reduces allosteric inhibition 
of this enzyme by NADH170, which increases flux of acetyl-CoA into the TCA cycle. 
Evolved strains with mutations in gltA have only persisted in one other LTEE population 
that maintained the low ancestral mutation rate through 50,000 generations83. Both the 
arcB and gltA1 mutations occurred on a branch in the phylogenetic tree for the citrate LTEE 
population when the effect of citT activation reverted to being neutral with respect to 
competitive fitness, so they are candidates for reversing anti-potentiation. The iclR 
mutation does not seem to have had an effect on genetic potentiation on its own, but it may 
have interacted with the arcB and/or gltA1 mutations in a way that contributes to this anti-
potentiation effect. 
Only one mutation in a gene known to be involved in central metabolism occurred 
around 27,000 to 29,000 generations, at the point in the phylogenetic tree when adding the 
citT mutation seems to have again become beneficial to fitness. This mutation is upstream 
of the ilv operon for branched chain amino acid biosynthesis in the yifB/ilvL intergenic 
region. This pathway consumes pyruvate and acetyl-CoA, and its products can be used to 
synthesize the pantothenate moiety of coenzyme A (CoA)184. If this mutation affects gene 
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expression of the ilv operon, then it could impact the balance of citric acid cycle 
intermediates flowing into or out of the TCA cycle to sustain cellular growth directly or 
indirectly via changing CoA/acetyl-CoA availability. 
While the functions of the genes that we have highlighted in central metabolism 
suggest that they may be especially important for altering the potential for Cit+ evolution, 
other mutations also accumulated on the branches in the phylogenetic tree where the effects 
of citT activation on E. coli fitness changed (Figure A3). In future work, the Prnk-citT 
knock-in assay can be used to further dissect this adaptive pathway by testing strains in 
which various evolved alleles have been removed or added. As an example of this type of 
approach, we have previously shown that removing the gltA1 mutation from the earliest 
Cit+ isolate (ZDB564) makes the citT-activating duplication highly deleterious because it 
introduces a growth lag like that observed in the strongly anti-potentiated LTEE isolates in 
this study170. Similar studies could be conducted on strains that represent as closely as 
possible the genotypes present at critical junctures in the phylogenetic tree to determine 
which mutations altered the chances of achieving this innovation. 
Another remaining question is whether the Cit+ innovation will ever evolve in the 
other eleven LTEE populations. It has not as of more than 60,000 generations180, nearly 
twice the amount of time that was required for it to evolve in the population analyzed 
here167. The ‘innovation interference’ of other highly beneficial mutations within a 
population suppressing Cit+ evolution has undoubtedly faded in all eleven of these 
populations as the pace of fitness increase has slowed similarly in all of them172,185. 
However, the ubiquity of nadR mutations in the LTEE may indicate that other populations 
similarly descended into a genetically anti-potentiated state. Our results suggest that Cit++ 
may still appear in the future if mutations suitably adjust fluxes in central metabolism to 
make evolving rudimentary Cit+ by activating citT expression a beneficial step on the 
 144 
pathway to innovation, as long as no critical components have been irrecoverably lost from 
the genome. Through 50,000 generations, no population has deleted either citT or dctA, 
and these genes have not accumulated any mutations in most populations83, so the latent 
genetic potential to evolve Cit+ seems to have remained intact so far. 
The LTEE is an open-ended evolution experiment186; it did not begin with the aim 
of isolating E. coli that utilize citrate. There was never strong selection for this novel 
capability. Because evolving citrate utilization allowed the new Cit++ clade to colonize an 
untapped nutrient niche and rapidly diversify, this new metabolic capacity is an example 
of a key evolutionary innovation187. The evolution of Cit++ initiated a new round of rapid 
evolutionary optimization that included mutations that reduced the activity of citrate 
synthase (gltA2) and eliminated flux through the glyoxylate shunt (aceA), both of which 
reversed the effects of pre-Cit+ adaptive mutations170. The many new possibilities for 
improving fitness in this alternative niche also likely contributed to the evolution of 
hypermutation within the Cit++ clade by 36,000 generations168. Lastly, new ecological 
interactions arose in this population such that Cit– and Cit++ types co-existed via negative-
frequency dependent interactions for at least 10,000 generations after Cit++ evolved167,168. 
Continuing evolution of interactions between these and other E. coli lineages led to the 
emergence of an ecology that is unique to this flask in the LTEE171. 
We found that a metabolic innovation in a laboratory population of E. coli was 
contingent on both a history of genetic adaptation and ongoing population dynamics. 
Evolution of metabolic capabilities has been found to be crucial to the emergence and 
continued success of bacterial pathogens in several instances188,189. For example, 
Salmonella acquired the ability to use tetrathionate as an electron acceptor, giving it a 
growth advantage relative to other bacteria in the environment that it creates in the gut 
during infection by inducing inflammation190. On a shorter timescale, mutations in the 
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opportunistic pathogen Pseudomonas aeruginosa that accumulate during chronic 
infections in the cystic fibrosis lung lead to an increased ability to acquire iron from 
hemoglobin191. Even in the simple environment of the LTEE, both genetic and population 
factors suppress the evolution of an innovation that allows a new niche to be exploited by 
a new bacterial species. It may be useful in the treatment of disease to understand when 
these and other factors, including competition for specific nutrients by commensal species 
in a microbiome, can be used to suppress evolutionary outcomes that are harmful to human 
health45. 
 
MATERIALS AND METHODS 
Media conditions and strains 
E. coli were cultured in Davis-Mingioli (DM) medium and Lysogeny Broth (LB)170. As 
necessary, media were supplemented with 50 µg/mL kanamycin and 80 µg/mL 5-bromo-
4-chloro-3-indolyl β-d-galactopyranoside (X-gal). Evolved clones characterized in this 
study from archived LTEE populations and strain ZDB706 (the spontaneous Cit– revertant 
of ZDB564) were isolated in previous studies167,168,170. New strains constructed in this 
study are listed in Table A2. 
 
Prnk-citT knock-in assay 
The activated Prnk-citT module was constructed by amplifying the evolved rnk-citG 
duplication junction from the pCit plasmid along with a linked kanamycin resistance gene 
(Kanr)169. The Prnk-citT construct in pCit is originally from evolved strain CZB154169. As 
a control, another module was created which only contains the Kanr marker. These modules 
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were integrated into the genomes of several Cit– strains (REL607, REL1166A, ZDB429, 
ZDB467, and ZDB483) via lambda Red recombination111 such that they replaced the lac 
locus (lacA to lacZ), spanning positions 333,862-337,485 in the REL606 genome 
(GenBank:NC_012967.1)130. We transferred the cassettes to other strains using P1 
bacteriophage transduction110. Successful transductants were scored based on blue/white 
screening in the presence of X-gal and kanamycin. All Cit+ strains were made by 
transduction of the Prnk-citT module into an Ara– LTEE clone. Isogenic Cit– strains were 
constructed by insertion of the control Kanr module into an Ara+ version of the same clone 
generated as described in the next section. To determine whether any other mutations 
present in the evolved strains from the LTEE were altered during transduction, we screened 
for mutations identified by whole-genome sequencing in the recipient strain that were 
within 100 kb upstream or downstream of the Prnk-citT insertion site. Strains from three 
Cit+/Cit– pairs were found to have gained or lost evolved alleles in this process. 
 
Selection for spontaneous Ara+ mutants 
All Ara– strains inherited a point mutation in araA present in the REL606 LTEE ancestor 
that prevents arabinose utilization173. To isolate spontaneous Ara+ mutants, Ara– strains 
were revived overnight at 37°C in DM containing 1 mg/mL glucose (DM1000). For each 
strain, three separate flasks containing 10 ml of DM1000 were each inoculated with ~500 
cells from the first DM1000 culture to reduce the chance that they might share any 
secondary mutations affecting fitness. After incubating overnight at 37°C, cells were 
harvested by centrifugation at 4,000 rpm for 15 min and the entire volume was plated on 
minimal arabinose (MA) plates. Plates were incubated for 36-48 h and colonies were 
streaked and grown on new MA plates before picking single-colonies as candidate Ara+ 
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revertants. The presence of secondary mutations affecting fitness was assessed by 
competing the original Ara– and selected Ara+ strains, as described below. In most cases, 
we identified an Ara+ revertant with a fitness that was not significantly different from its 
Ara– progenitor. 
 
Relative fitness measurements 
Relative fitness was measured using co-culture competition assays164,192. Two strains to be 
competed are differentiated based on their ability to ferment arabinose. Ara– strains form 
red colonies on tetrazolium arabinose (TA) media, and Ara+ strains form pink colonies. 
Strains were revived overnight in LB then were diluted 10,000-fold into separate cultures 
for each replicate competition assay in DM containing 25 µg/mL glucose (DM25). These 
cultures were preconditioned and competed under the same conditions as used in the 
LTEE164,193, in 10 mL of DM25 in 50 mL Erlenmeyer flasks shaken at 120 rpm over a 
diameter of 1 inch with incubation at 37°C. After 24 h of growth separately to precondition 
strains to these conditions, two replicate cultures for each Ara– and Ara+ pair were mixed 
at equal volumes in fresh DM25 media such that there was an overall 1:100 dilution. 
Dilutions of these initial mixtures were plated on TA plates to determine the initial 
representation of each strain in each replicate flask. Then, the competition was carried out 
over three days of transferring 1:100 dilutions into fresh medium each day. A dilution of 
each culture after growth on day three was again plated to determine the final representation 
of each strain. Relative fitness was calculated as the ratio of the realized growth rates of 
each strain between the final and initial platings164,192. 
For comparisons of the effect of the authentic rnk-citG duplication versus the 
addition of the Prnk-citT module to REL606 and ZDB706 (Figure A1) we first established 
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neutrality of an Ara+ revertant and then judged whether there was significant difference 
between the fitnesses of the Cit- and Cit+ strains pairs. For comparing the fitness impact of 
evolving Cit+ in other strains (Figure A2), we measured the relative fitness of the Ara– Cit+ 
variant of the strain with the Prnk-citT module added versus the Ara+ Cit– revertant of its 
Cit– progenitor (Cit competition) and multiplied this by the relative fitness of the Ara+ Cit– 
revertant versus the Ara– Cit– clone with the null module added (Ara competition). To 
account for how error in each of these two competitions impacts confidence in the overall 
fitness change inferred for evolving Cit+, we performed 10,000 bootstrap resamplings of 
the Ara and Cit competition replicates to estimate 95% fitness intervals and significance 
on the combined measurements. The same bootstrapping procedure was used for 
comparing the fitnesses of different strains in the population phylogeny in the procedure 
that combined them into equivalence groups along the lineage to Cit+ (Figure A4). 
 
qRT-PCR measurement of citT expression 
Cells were cultured according to the method described in Blount et al.168. Briefly, cells 
were initially grown to saturation in a 5 ml LB culture and transferred into 10 ml of DM25 
media (1:10,000 dilution) followed by two 24-hour preconditioning cycles in DM25 with 
1:100 dilutions. For each preconditioning cycle, cells were diluted by 1:100 into fresh 
DM25 media. At this point, we performed a final dilution of 1:100 into DM25. Cells were 
grown until they reached ~50% of the final OD420 and the entire culture (10 ml) was 
harvested for extracting RNA. RNA was extracted from frozen cell pellets using 
the RNASnap protocol194. The resulting supernatant was column purified, incorporating 
on-column DNase treatment (RNA Clean & Concentrator-25, Zymo Research). 
TapeStation analysis (Agilent) was used to verify RNA integrity (all 
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RIN scores ≥ 8.0). Samples were then reverse transcribed in parallel using random primers, 
with 200ng of RNA as template (High Capacity Reverse Transcription Kit, Applied 
Biosystems). 
qPCR was run in 384 well plates on an Applied Biosystems ViiA 7, using SYBR 
Green (Thermo Fisher) as fluorophore in a 5 µl reaction. QuantStudio was used to 
determine quantification cycle (Cq) values. All samples were run in technical triplicates. 
We selected two reference genes (refs), 16S RNA and idnT, from an initial pool of 
candidates based on primer efficiency, primer specificity (as judged by melt curve) and 
stability of expression in a subset of our strains of interest. Primer efficiency was calculated 
from the slope of a plot of log(dilution) versus Cq, using a 5-fold or 10-fold dilution series 
of a pool of cDNA from every sample. Final primer sequences and efficiencies were as 
follows: citT (forward = GTTATAGCGGGTAATGTCTTTC, reverse = 
CACTGATTGGCCTTGTATTG, efficiency = 99.25%); idnT (forward = 
CCCGACACCGCTATCTACTAATAC, reverse = CGCACCATCGAGCAAATCAT, 
efficiency = 100.5%); 16S (forward = CCCGAAGGTTAAGCTACCTACT, reverse = 
CATGAAGTCGGAATCGCTAGTAATC, efficiency = 97.6%). In our final analysis 
comparing citT expression across strains, we used three biological replicates per strain, and 
2 µl of a 1:100 dilution of cDNA as template. Relative expression (R) of citT in the strain 
of interest relative to ancestral REL606 was calculated as follows. First, DCq was 
calculated for individual biological replicates according to DCq = CqcitT – 𝑥(Cqrefs), where 𝑥(X) represents the mean of the values for quantity X. Then, DDCq and R were calculated 
from the mean DCq of three biological replicates for each strain tested as DDCq = 𝑥(DCqstrain) – 𝑥(DCqREL606) and R = 2–DDCq. 
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Genome sequencing and phylogenetic tree construction 
Genome sequences were analyzed for 61 evolved strains from the LTEE population in this 
study (Table A1). For the 20 newly sequenced strains, genomic DNA was purified using 
the GenElute Bacterial Genomic DNA kit (Sigma) and then sequenced using standard 
procedures on an Illumina HiSeq 2500 instrument to generate 101-base paired-end reads 
by the University of Texas at Austin Genome Sequencing and Analysis Facility. Data files 
for these 20 genomes have been deposited in the NCBI Sequence Read Archive 
(SRP120037). Raw sequencing reads for all 61 genomes are available via links from the 
main LTEE NCBI BioProject page (PRJNA414462). 
We initially predicted mutations in each re-sequenced genome by comparing 
Illumina reads to the REL606 reference genome [37] using breseq (v0.31.1)108,195. Then, 
we further curated the lists of predicted mutations as previously described83. Briefly, a 
maximum-parsimony phylogenetic tree for all 61 strains from the LTEE population was 
constructed using the DNAPARS program from the PHYLIP package (v3.69)196. Where 
necessary, we manually corrected mutation predictions, including adding mutations that 
were hidden by later deletions or splitting sequence differences into multiple mutational 
events to construct the most parsimonious phylogeny possible. In the current study, we did 
not discard mutations in repetitive regions before analysis, except we did ignore changes 
in the hypervariable 7´CCAG repeat at reference coordinates 2103891-2103918 in the 
final lists of mutations predicted in all clones. 
 
 Beneficial mutation fitness effect models 
To construct the curve for the Wiser et al. model172 in Figure A4 we calculated the 
expected time in generations (t) and fitness increase (s) for each subsequent sweep of a 
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cohort of beneficial mutations using equations S3, S4, and S7 from the supplement of that 
study using parameter values (a0 = 58.4, µ = 10–7, and N = 3.3´107) that they found to be 
compatible with the fitness trajectories of the non-mutator LTEE populations. For the 
Tenaillon et al. model83, we first calculated a curve describing the number of beneficial 
mutations expected in an evolved isolate (n) according to the term, 𝑛 = 𝑐√𝑡, with the best-
fit coefficient value (c = 0.135) found in that study for all non-mutator LTEE populations 
considered together. Next, we combined this model with the fitness (W) model from Wiser 
et al., 𝑊(𝑡) = (𝑎𝑡 + 1)-, with best-fit parameters (a = 0.0842 and b = 0.00611) found 
specifically for the citrate population (Ara–3)172. Finally, the Tenaillon et al.83 curve in 
Figure A4 was graphed by calculating each generation (tn) at which the number of 
beneficial mutations (n) was an integral value, 𝑡. = (𝑛/𝑐)0. The graphed selection 
coefficient was estimated as the fitness at that time W(tn) minus the fitness at the time of 
the previous beneficial mutation W(tn-1).  
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Figure A1. Evolution of rudimentary citrate utilization by activating citT expression 
is slightly beneficial in the genetic background in which it evolved and in the LTEE 
ancestor  
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Figure A1 continued (A) The rnk-citG duplication that evolved in the LTEE creates a 
genomic configuration in which a novel mRNA encoding the CitT transporter is expressed 
from the rnk promoter (Prnk) (right). This mutation alone is sufficient for weak citrate 
utilization (Cit+ phenotype). It is the ‘actualizing mutation’ in the evolution of this key 
innovation. Strain ZDB564 is the earliest Cit+ isolate from the LTEE. In order to measure 
the effect that this mutation had on competitive fitness when it evolved, a spontaneous Cit– 
revertant of ZDB564 in which the duplication collapsed back to the ancestral state was 
isolated (left). (B) Competitive fitness of Cit+ versus Cit– strain variants. The ZDB564 
versus ZDB706 competitions measure the fitness effect of the rnk-citG duplication when 
it evolved. The ZDB706 and REL606 competitions test the effect of adding one copy of 
the evolved Prnk-citT module into a strain (+) versus adding an empty version of the same 
cassette (Ø), as pictured in C. An additional ZDB706 competition (in population) was 
conducted with the two strains together mixed at a 1:99 ratio with the evolved LTEE 
population from at 31,000 generations to determine if the mutation had a different effect 
on fitness when rare in the population. Starred strains (*) have a change to the Ara+ marker 
state to allow competition with the corresponding Ara– strain. The marker change had no 
effect on competitive fitness in each case. Error bars are 95% confidence intervals. (C) 
Schematic of the gene cassettes used in the Prnk-citT knock-in assay showing how they 
were integrated into the E. coli chromosome in a way that replaces the native lac locus. (D) 
citT mRNA expression levels measured relative to the REL606 LTEE ancestor in the 
evolved Cit+ isolate from the LTEE (ZDB564) and strains with the Prnk-citT and 
corresponding empty control cassettes integrated into their chromosomes. Error bars are 
95% confidence intervals. 
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Figure A2. Fitness consequences of evolving Cit+ in different evolved genetic 
backgrounds  
(A) Results of the Prnk-citT knock-in assay on 23 pre-Cit+ evolved strains. The clones are 
ordered by the generation from which they were isolated. Error bars are 95% confidence 
intervals. Strain construction details and how the results of competition assays were 
combined into these fitness estimates are described in the Methods. (B) Increased lag 
phase upon addition of the Prnk-citT module in anti-potentiated strains. Growth curves for 
the ancestor, REL606, and two anti-potentiated strains, ZDB483 and ZDB14, are shown. 
Error bars are standard deviations of four replicate cultures.   
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Figure A3. Potential for evolving Cit+ mapped onto phylogeny  
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Figure A3 continued Phylogeny of isolates from the LTEE population including 20 new 
clones sequenced for this study to provide better resolution of the timing of mutations on 
the lineage leading to Cit+ (names in italics). In order to identify changes in the degree of 
potentiation due to mutations, we mapped the results of the Prnk-citT knock-in assay onto 
this phylogenetic tree. Colored symbols reflect the Cit+ to Cit– relative fitness measured 
for those strains. The ancestor and 61 evolved isolates were used to construct this 
phylogenetic tree (Table A1). Two clones isolated at 50,000 generations are not shown. 
Two strains that evolved citrate utilization in replay experiments under the LTEE 
conditions in a previous study167 are marked with plus signs (++), and three strains that 
had evolved alleles added or removed during strain construction are starred (*). 
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Figure A4. Changes in the potential for innovation along the lineage leading to Cit+ 
due to genetic and population factors  
 
 
 
 
 
 
 
–10%
–5% 
0%
+5%
+10%
0 5,000 10,000 15,000 20,000 25,000 30,000
Fit
ne
ss
 ef
fec
t
Generation
Cit+ evolution
Successful mutations
Model 1
Model 2
REL606
ZDB409
ZDB425
ZDB464
ZDB458
ZDB478
ZDB309
ZDB486
ZDB310
ZDB19
ZDB13ZDB429
ZDB564
(ZDB706)
nadR
iclR arcB
gltA1
yifB/ilvL
 158 
Figure A4 continued We clustered phylogenetically adjacent strains in which activating 
citT expression had a similar effect on fitness to reconstruct when major changes in 
potentiation occurred due to new mutations accumulating in the evolved strain (the 
genetic background). Each cluster is represented by a different color and symbol in the 
simplified phylogenetic tree (upper panel) and the graph showing the group-wise fitness 
estimate over a time period (horizontal lines) in which these strains were representative 
of the main pre-Cit+ lineage (lower panel). Error bars are 95% confidence intervals. Two 
models of the rate of adaptation of the LTEE populations at different generations are 
superimposed on the lower panel. Model 1 estimates the fitness effects of winning 
cohorts of beneficial mutations sequentially sweeping through the population at each 
generation according to modelling from Wiser et al.172. Model 2 estimates the fitness 
effects of each consecutive beneficial mutation accrued by the winning lineage over time 
using additional information from Tenaillon et al.83 (see Methods). These curves 
represent competing beneficial mutations that can suppress the evolution of Cit+ (the 
population context). If the fitness effect of activating citT is above these curves, as it is by 
29,000 generations, then it is predicted to be among the most beneficial new mutations 
that could appear at that time in the LTEE. This means that rudimentary citrate utilization 
(Cit+) can persist in the population long enough to be refined by further mutations to full 
citrate utilization (Cit++); the metabolic innovation can be achieved. 
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Table A1. Genome sequencing of E. coli isolates from the LTEE population  
 
Clade designations describe placement in the phylogenetic tree of all sequenced strains 
from the Ara-3 population and relative to key evolutionary transitions in this population: 
UC, Unsuccessful Clade; C1, Clade 1; C2, Clade 2; C3, Clade 3; C3+, Clade 3 Cit+; C3+H, 
Clade 3 Cit+ hypermutator. 
 
 
 	 7 
Supplementary Table S1 | Genome sequencing of E. coli isolates from the LTEE population  
 
Strain Generation Clade Reference 
REL764A 500  Tenaillon et al. 2016 
REL764B 500  Tenaillon et al. 2016 
REL966A 1,000  Tenaillon et al. 2016 
REL966B 1,000  Tenaillon et al. 2016 
REL1070A 1,500  Tenaillon et al. 2016 
REL1070B 1,500  Tenaillon et al. 2016 
REL1166A 2,000  Blount et al. 2012 
REL1166B 2,000  Tenaillon et al. 2016 
REL2181A 5,000  Tenaillon et al. 2016 
ZDB409 5,000  Blount et al. 2012 
REL4538A 10,000 UC Tenaillon et al. 2016 
ZDB1 10,000  This study 
ZDB425 10,000  This study 
ZDB429 10,000 UC Blount et al. 2012 
REL7179B 15,000  Tenaillon et al. 2016 
ZDB445 15,000  This study 
ZDB446 15,000 UC Blount et al. 2012 
ZDB458 20,000  Blount et al. 2012 
ZDB464 20,000  Blount et al. 2012 
ZDB467 20,000  Blount et al. 2012 
ZDB477 25,000 C1 Blount et al. 2012 
ZDB478 25,000 C3 This study 
ZDB483 25,000 C3 Blount et al. 2012 
ZDB486 25,000 C3 This study 
ZDB488 25,000 C3 This study 
ZDB309 27,000 C3 This study 
ZDB310 27,000 C3 This study 
ZDB317 27,000 C3 This study 
ZDB334 28,000 C3 This study 
ZDB339 28,000 C3 This study 
ZDB13 29,000 C3 This study 
 
Strain Generation Clade Reference 
ZDB14 29,000 C3 This study 
ZDB16 30,000 C1 Blount et al. 2012 
ZDB17 30,000 C3 This study 
ZDB18 30,000 C3 This study 
ZDB357 30,000 C2 Blount et al. 2012 
ZDB19 30,500 C3 This study 
ZDB20 30,500 C3 This study 
ZDB23 31,000 C3 This study 
ZDB25 31,500 C3 This study 
ZDB27 31,500 C3 This study 
ZDB199 31,500 C1 Blount et al. 2012 
ZDB200 31,500 C2 Blount et al. 2012 
ZDB564 31,500 C3+ Blount et al. 2012 
ZDB30 32,000 C3+ Blount et al. 2012 
ZDB172 32,000 C3+ Blount et al. 2012 
ZDB143 32,500 C2 Blount et al. 2012 
ZDB158 32,500 C2 Blount et al. 2012 
CZB152 33,000 C3+ Blount et al. 2012 
CZB154 33,000 C3+ Blount et al. 2012 
CZB199 33,000 C1 Blount et al. 2012 
ZDB83 34,000 C3+ Blount et al. 2012 
ZDB87 34,000 C2 Blount et al. 2012 
ZDB96 36,000 C3+H Blount et al. 2012 
ZDB99 36,000 C2 Blount et al. 2012 
ZDB107 38,000 C3+H Blount et al. 2012 
ZDB111 38,000 C2 Blount et al. 2012 
REL10979 40,000 C3+H Blount et al. 2012 
REL10988 40,000 C2 Blount et al. 2012 
REL11364 50,000 C3+H Tenaillon et al. 2016 
REL11365 50,000 C3+H Tenaillon et al. 2016 
Clade designations describe placement in the phylogenetic tree of all sequenced strains from the Ara-3 
population and relative to key evolutionary transitions in this population: UC, Unsuccessful Clade; C1, 
Clade 1; C2, Clade 2; C3, Clade 3; C3+, Clade 3 Cit+; C3+H, Clade 3 Cit+ hypermutator. 
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Table A2. Strains constructed in this study  
 
†Symbol legend: *for Ara+ revertant, (+) for Prnk-citT cassette, (Ø) for empty control 
cassette 	 9 
Supplementary Table S3 | Strains constructed in this study 
 
Strain  Generation Description† 
DL82 0 REL606(+) 
DL86 0 REL607(Ø)* 
DL426 2,000 REL1166A* 
EQ966 2,000 REL1166A(+) 
DL631 2,000 REL1166A(Ø)* 
DL403 5,000 ZDB409* 
DL479 5,000 ZDB409(+) 
DL945 5,000 ZDB409(Ø)* 
DL418 10,000 ZDB425* 
DL439 10,000 ZDB425(+) 
DL959 10,000 ZDB425(Ø)* 
DL424 10,000 ZDB429* 
EQ972 10,000 ZDB429(+) 
DL480 10,000 ZDB429(Ø)* 
DL406 15,000 ZDB446* 
DL475 15,000 ZDB446(+) 
DL633 15,000 ZDB446(Ø)* 
DL415 20,000 ZDB458* 
DL13 20,000 ZDB458(+) 
DL376 20,000 ZDB458(Ø)* 
DL368 20,000 ZDB464* 
DL11 20,000 ZDB464(+) 
DL379 20,000 ZDB464(Ø)* 
DL366 20,000 ZDB467* 
DL12 20,000 ZDB467(+) 
DL377 20,000 ZDB467(Ø)* 
DL76 25,000 ZDB478* 
DL84 25,000 ZDB478(+) 
DL93 25,000 ZDB478(Ø)* 
DL363 25,000 ZDB483* 
DL15 25,000 ZDB483(+) 
DL374 25,000 ZDB483(Ø)* 
DL129 25,000 ZDB486* 
DL433 25,000 ZDB486(+) 
DL612 25,000 ZDB486(Ø)* 
DL137 27,000 ZDB309* 
 
Strain  Generation Description† 
DL158 27,000 ZDB309(+) 
DL159 27,000 ZDB309(Ø)* 
DL412 27,000 ZDB310* 
DL463 27,000 ZDB310(+) 
DL533 27,000 ZDB310(Ø)* 
DL409 27,000 ZDB317* 
DL471 27,000 ZDB317(+) 
DL957 27,000 ZDB317(Ø)* 
DL421 28,000 ZDB334* 
DL467 28,000 ZDB334(+) 
DL485 28,000 ZDB334(Ø)* 
DL359 28,000 ZDB339* 
EQ1104 28,000 ZDB339(+) 
DL370 28,000 ZDB339(Ø)* 
DL161 29,000 ZDB13* 
DL617 29,000 ZDB13(+) 
DL175 29,000 ZDB13(Ø)* 
DL361 29,000 ZDB14* 
EQ1068 29,000 ZDB14(+) 
DL372 29,000 ZDB14(Ø)* 
DL163 30,000 ZDB18* 
EQ1111 30,000 ZDB18(+) 
DL176 30,000 ZDB18(Ø)* 
DL164 30,500 ZDB19* 
EQ1113 30,500 ZDB19(+) 
DL180 30,500 ZDB19(Ø)* 
DL266 31,000 ZDB23* 
DL310 31,000 ZDB23(+) 
DL308 31,000 ZDB23(Ø)* 
DL167 31,500 ZDB25* 
DL201 31,500 ZDB25(+) 
DL185 31,500 ZDB25(Ø)* 
DL261 31,500 ZDB27* 
DL314 31,500 ZDB27(+) 
DL312 31,500 ZDB27(Ø)* 
†Symbol legend: *for Ara+ revertant, (+) for Prnk-citT cassette, (Ø) for empty control cassette 
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Appendix B: Bacterial production of gellan gum as a do-it-yourself 
alternative to agar 
 
This chapter is reproduced (with minor modifications) from its initial publication: 
 
McGuffey JC‡ and Leon D‡, Dhanji EZ, Mishler DM, Barrick JE. (2018) Bacterial 
production of gellan gum as a do-it-yourself alternative to agar. J Microbiol Biol Educ 
19,182-184. 
 
‡ designates equal contribution 
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ABSTRACT 
Lack of access to expensive reagents and equipment are barriers to performing 
microbiology experiments in K-12 classrooms and do-it-yourself (DIY) science settings. 
We describe a procedure for using the bacterium Sphingomonas paucimobilis to synthesize 
gellan gum as an affordable alternative to purchasing agar for educators and DIY scientists. 
The method involves microwaving gelatinous cultures of S. paucimobilis ATCC 31461 
after a two-step growth procedure, and then pouring plates. Gellan gum produced by S. 
paucimobilis acts as a solidifying agent and provides a resilient surface that supports the 
growth of microbial colonies. This DIY procedure offers an opportunity to experiment with 
microbial production of an extracellular polysaccharide and to cheaply and sustainably 
source a reagent for research. 
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INTRODUCTION 
Cost can be a steep barrier to participation in science. As a result, most research takes place 
in universities, government, and industry. Recently, a do-it-yourself (DIY) biology 
community has emerged outside of this system197. DIY scientists often conduct their 
experiments in non-traditional settings (e.g., kitchens, garages, maker spaces) and fund 
their own work. To make microbiology more affordable in this and other educational 
environments, we became interested in a DIY replacement for agar. 
Agar is one of the most expensive and routinely utilized reagents in microbiology 
labs. It is used as a gelling agent in solid media for growing colonies. Agar is a mixture of 
polysaccharides that is processed from the cell walls of seaweed (red algae). These algae 
are currently harvested from the wild, which has contributed to fluctuations and shortages 
in the agar supply, most recently in 2015198. Microbes are already the source of many 
nutrients (e.g., yeast extract) and supplements (e.g., amino acids and antibiotics) used in 
common culture media. What if microbes could also cheaply produce a gelling agent? 
They can! Gellan gum is a capsular exopolysaccharide (EPS) that is naturally 
synthesized by the bacterium Sphingomonas paucimobilis ATCC 31461199,200. Gellan gum 
is widely used as a solidifying agent in the food industry, and it is sold as a chemically 
purified product (e.g., Gelrite®) for use in microbial growth media199. Purification of gellan 
gum normally involves cultivating S. paucimobilis, several precipitation steps to separate 
the polysaccharide from cells, and a final drying phase201. Here, we present a streamlined 
procedure for affordably producing gellan gum plates that requires only DIY equipment 
and ingredients. 
METHODS AND RESULTS 
I. Prepare DIY media for gellan gum production  
Culturing S. paucimobilis for gellan gum production is a two-step process in which a starter 
culture is propagated in a rich medium and then transferred to a minimal medium. The 
initial culture phase allows cells to rapidly achieve high densities before they are used to 
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inoculate gellan production medium, where little further growth occurs202. Gellan gum 
production is induced under nitrogen starvation in the presence of excess carbon, which 
serves as the substrate for EPS synthesis. Therefore, gellan production media contains a 
high C:N ratio to favor maximal EPS accumulation199.  
When carrying out this procedure, you should wear appropriate personal protective 
equipment such as safety goggles, gloves, and a lab coat and use heat resistant glassware 
(e.g., Pyrex). For the two-step culturing method, you will need to first make a DIY rich 
medium, General Kitchen Broth (GKB) 203, which substitutes for a conventional S. 
paucimobilis rich medium used in the first step (e.g., YPG). To make GKB, mix the 
following ingredients in 100 mL of water: 0.5 g dried skim milk, 0.25 g marmite, and 0.1 
g honey. For the second step, we developed a minimal medium recipe (DIY-GPM) by 
identifying DIY equivalents for components of standard gellan production medium202. To 
make DIY-GPM, mix the following in 1 L of water: 0.03 g dried skim milk, 0.5 g marmite, 
24.35 g honey, 1 g table salt, 1.2 g Epsom salt, 10 g trisodium phosphate, 3.75 mL clear 
ammonia (e.g., Austin’s brand, ~2.5% w/v ammonium hydroxide) and 3.1 g citric acid. 
Ensure that the GKB and DIY-GPM components are well mixed and sterilize them, using 
an autoclave or pressure cooker203. 
 
II. Culture S. paucimobilis for gellan gum production  
Once the media has cooled to room temperature, start a 100 mL culture of Sphingomonas 
paucimobilis ATCC 31461 in GKB. Allow this to grow to saturation by incubating for 2 
days, with shaking and at 30°C if possible (Figure B1A). Next, add this entire culture to 1 
L of sterile DIY-GPM and incubate under the same conditions until the culture becomes 
gelatinous and homogenous. We found that incubating for eight days at 30°C with shaking 
produced a sufficient yield of gellan gum. You should inspect these cultures every day. A 
culture that is ready for pouring plates should be highly viscous and adhere to the side of 
the flask when it is tilted (Figure B1B). 
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III. Pour gellan gum plates  
Next, add 0.4 g/L more of Epsom salt to the S. paucimobilis culture. This provides 
magnesium to strengthen the gellan polymer matrix199. Also, add any other nutrients 
needed by your microbe of interest203. For example, we found that adding 10 g/L of 
marmite improved growth of E. coli and S. cerevisiae. Heat the entire culture in a 
microwave using a medium setting until it becomes fluid and homogenous, watching 
carefully to avoid overboiling. At this point, the mixture is sterile and can be poured into 
petri dishes to make ~40 standard plates. We observed normal colony growth rates and 
morphology on these DIY gellan gum plates (Figure B1C).  
 
Safety issues 
S. paucimobilis ATCC 31461 is classified as a biosafety level 1 (BSL1) organism. Students 
and DIY scientists should follow the American Society for Microbiology’s guidelines for 
teaching laboratories which describe appropriate personal protective equipment and sterile 
procedures for working safely with BSL1 microbes204. 
 
DISCUSSION 
This protocol can be used sustainably and affordably source a homegrown agar 
replacement. We estimate that the cost of the culture components needed for DIY gellan 
gum production is roughly one tenth the cost of agar ($0.58 versus $5.60 per liter of media). 
Cultures of S. paucimobilis become extremely gelatinous, which also makes it an 
interesting microbe for classroom demonstrations related to the materials properties of 
extracellular polysaccharides. S. paucimobilis strains used for commercial production have 
mutations to make them unpigmented or to produce deacetylated variants of gellan gum 
with improved gelling properties205,206. It is possible that DIY researchers or students could 
also alter these properties or even engineer S. paucimobilis variants that incorporate 
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metabolic pathways for manufacturing other expensive media components (e.g., cofactors 
or antibiotics) in the future. 
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Figure B1. DIY gellan gum plates  
(A) Initial phase of culturing S. paucimobilis in rich media. GKB medium before 
inoculation with S. paucimobilis (left) and after 2 days of growth (right). (B) Second 
stage of culturing for gellan gum production. DIY-GPM medium before inoculation 
(left), immediately after inoculation (middle), and after 8 days of growth (right). The 
arrow points to gellan gum adhering to the side of the flask. (C) DIY gellan gum plates 
supplemented with marmite support the growth of colonies of S. paucimobilis, S. 
cerevisiae, and E. coli (not shown).             
 
 
 
 
 
 
 
 9 
 
Figure 1. DIY gellan gum plates. (a) Initial phase of culturing S. paucimobilis in rich 
media. GKB medium before inoculation with S. paucimobilis (left) and after 2 days of 
grow h (righ ). (b) Second stage of culturing for gellan gum production. DIY-GPM 
med um befor  inoculation (left), im ediately after inoculation (middle), and after 8 days 
of growth (right). The arrow points to gellan gum adhering t  the side of the flask. (c) 
DIY gellan gum plates supplemented with marmite support the growth of colonies of S. 
paucimobilis, S. cerevisiae, and E. coli (not shown).             
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